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Abstract 
 
This thesis is divided into three chapters. 
The first chapter provides a brief review on recent work in the application of cascade 
cyclisations to the total synthesis of natural products. This is followed by a review of 
the decarboxylative Claisen rearrangement (dCr), a novel variant of the 
Ireland-Claisen reaction in which tosylacetic esters of allylic alcohols are transformed 
into homoallylic sulfones using BSA and potassium acetate, and its applications. 
 
The second chapter discusses the results of our studies towards the total synthesis of 
1!,25-dihydroxylumisterol via a proposed route containing two key steps; a 
cascade-inspired, Lewis-acid mediated cyclisation to form the steroid B-ring in I, and 
the dCr reaction of tosylacetic ester IV to give diene III. Successful syntheses, as 
well as problems encountered along this route will be discussed, as well as the 
measures taken to adapt the synthesis to circumvent these problems. 
 
The third and final chapter contains experimental procedures and characterisation 
data for the prepared compounds. 
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Stereochemical Notation 
 
The Maehr convention for indicating relative and absolute stereochemistry has been 
used throughout this report.1 Therefore, solid and broken lines are used to denote 
racemates, and solid and broken wedges denote absolute configuration. 
 
 
 
Steroid Notation 
 
During this report the following steroidal numbering system will be used. 
 
 
 
                                                
1 Maehr, H. J. Chem. Ed. 1985, 62, 114. 
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1.1 Cascade cyclisations in natural product synthesis 
 
1.1.1 Introduction 
Traditionally, the pursuit of chemical synthesis has involved combining individual 
bond-forming processes into reaction sequences, with workup, and often purification, 
required between each step. Advances made over decades of modern chemical 
research have provided us with a range of synthetic tools that enable the construction 
of almost any complex molecule. But, in addition, a modern chemist must also 
consider the efficiency of their work, both to limit environmental impact and 
maximise the economic viability of a synthetic process.1 There are many ways in 
which to approach improved efficiency in chemical synthesis,2 but arguably one of 
the most academically exciting and burgeoning areas is the development of processes 
in which multiple, often chemically distinct, bonds are installed in a controlled 
sequential fashion in a single synthetic procedure. These cascade (or domino) 
processes have received a great deal of attention in recent years,3 with the most 
impressive examples allowing multiple stereocentres and complex cyclic structures to 
be installed in a single step. Although there is some argument in the literature as to 
how best to describe and differentiate between these processes, for the purposes of 
this piece, the terms “cascade” and “domino” will be used interchangeably under the 
definition provided by Tietze as “two or more bond-forming reactions under identical 
reaction conditions, in which the latter transformations take place at the 
functionalities obtained in the former bond-forming reactions”.4 This type of cascade 
is not to be confused with other distinctly different processes such as photochemical, 
biochemical or electronic cascades. 
The following mini-review is not intended as a comprehensive discussion of the work 
in this fascinating area; a number of excellent recent reviews already provide greater 
scope.1 Instead, it highlights interesting examples of ring-forming cascades 
incorporated into natural product syntheses since 2006. 
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1.1.2 Background 
Whilst cascade reactions are becoming more commonplace in natural product 
synthesis, they are by no means a new concept. Nature, of course, utilises 
enzyme-catalyzed cascades in biosynthesis. As understanding of these biosyntheses 
developed, so did the work of chemists looking to recreate these cascades in 
biomimetic approaches to total syntheses. Interestingly, the first biomimetic cascade 
total synthesis was achieved before knowledge of the biosynthesis was revealed; 
Robinson’s one-pot synthesis of tropinone (9, Scheme 1).5 Tropinone contains the 
bicyclic tropane motif, a feature shared with several other alkaloids such as cocaine 
(10) and atropine (11). The cascade involves the double Mannich reaction of 
succinaldehyde (1), methylamine (2) and acetonedicarboxylic acid (3) to give 
tropinone (9) in good yield, and in a considerably more concise synthesis than those 
achieved previously.6 
Scheme 1. Robinson’s total synthesis of tropinone (9). 
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In 1955 Stork7,8a and Eschenmoser8 rationalised that polyalkenes undergo cyclisation 
in well-defined conformations, dependent only upon the alkene geometry. The 
biosynthesis of lanosterol (13, Scheme 2) from 2,3-oxidosqualene (12) is just one 
example of this type of stereospecific transformation. 
Scheme 2. Biosynthesis of lanosterol (13). 
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An improved understanding of steroid biosynthesis inspired the first forays into 
biomimetic syntheses of steroidal structures by van Tamelen9 and Corey,10 leading to 
Johnson’s classic total synthesis of progesterone (18, Scheme 3).11 The key step in 
this synthesis was the acid-catalyzed polycyclisation cascade of polyalkene 14, 
achieved in the presence of cation-trapping agent ethylene carbonate. The reaction 
yielded the desired tetracycle 17 as a 5:1 mixture of C-17 epimers, with subsequent 
oxidative scission and intramolecular aldol/dehydration delivering progesterone in 
high yield. 
Scheme 3. Johnson’s total synthesis of progesterone (18). 
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cascade, which terminates with a Diels-Alder cycloaddition to give endiandric acid 
methyl esters 24, 25 and 26 in good yield. 
Scheme 4. Biomimetic synthesis of Endiandric acid A, B and C methyl esters. 
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Later, in one of the landmark developments in synthetic radical chemistry, Curran 
demonstrated the power of controlled, tandem cascade radical cyclisations as key 
steps in the synthesis of hirsutene14 (31, Scheme 5) and !9(12)–capnellene (36).15 
Cyclopentene precursors 27 and 32 were treated with tributyltin hydride and catalytic 
AIBN to form radical intermediates 28 and 33 that undergo tandem 5-exo cyclisations 
which, due to conformational constraints, proceed in a cis fashion to give the desired 
products in excellent yield. 
Scheme 5. Synthesis of (±)–hirsutene (31) and (±)-!9(12)–capnellene (36) via a radical 
cyclisation cascade. 
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Finally, Heathcock’s total synthesis of dihydro-proto-daphniphylline (45, Scheme 
6),16 a biosynthetic precursor to several members of the Daphniphyllum alkaloid 
family, is a classic demonstration of an iminium-mediated cascade. Dihydrosqualene 
dialdehyde 37 was treated with methylamine, then acetic acid, and heated to give the 
target 45 in excellent yield via a 1,4 addition/hetero Diels-Alder cascade. In just one 
process eight new stereocentres and five rings were installed in a diastereoselective 
fashion. 
Scheme 6. Heathcock’s synthesis of dihydro-proto-daphniphylline (45). 
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1.1.3 Recent examples of cascade cyclisations in natural product synthesis 
For convenience, the following examples have been grouped according to what is 
considered the main theme of the cascade, although the intrinsic multi-faceted nature 
of cascades means that they may also contain other reaction types. 
1.1.3.1 Pericyclic cascades 
As can be seen from examples in Section 1.1.2, pericyclic reactions have been 
prevalent in the pioneering cascade cyclisations for natural product synthesis. This is 
no coincidence, as electrocyclisations and cycloadditions are particularly suited to 
installing multiple rings sequentially in a single process. 
Hirsutellone B (50, Scheme 7), a fungal secondary metabolite, shows impressive 
activity against the pathogen that leads to tuberculosis. Of synthetic interest was the 
enantioselective construction of the tricyclic core. The groups of Sorensen,17 Liu,18 
and Nicolaou19 each independently approached this construction via a key 
intramolecular Diels-Alder (IMDA) reaction. Nicolaou’s approach utilised a cascade 
intramolecular epoxide-opening/Diels-Alder reaction of TMS-epoxy tetraene 46. 
Lewis acid activation of epoxide 46 with Et2AlCl gave rise to the first six-membered 
ring and the triene moieties in 48, which were then in close enough proximity to 
undergo the IMDA reaction to give 49 exclusively as the endo product in 50 % yield. 
49 was converted to hirsutellone B (50) in further steps. 
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Scheme 7. Nicolaou’s approach to hirsutellone B (50). 
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Another impressive use of Diels-Alder chemistry was demonstrated by Nakada and 
co-workers in the total synthesis of polyketide-derived (–)-FR182877 (54, 
Scheme 8),20 a potent anticancer agent. A biomimetic intramolecular 
Diels-Alder/hetero-Diels-Alder  (IMDA/HDA) cascade of acyclic pentaene substrate 
51 was used to install the four rings and seven stereocentres in tetracycle 53. The 
cascade was triggered by MnO2 allylic oxidation of 51, giving rise to transient dienal 
52 that underwent IMDA/HDA cascade cyclisation to give 53 in 28 % yield.  A 
subsequent 13 steps led to natural product (–)-FR182877 (54). 
Scheme 8. Nakada’s total synthesis of (–)-FR182877 (54). 
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Coldham and co-workers recently reported the total synthesis of three Aspidosperma 
alkaloids, namely (±)-aspidospermine (60, Scheme 9), (±)-aspidospermidine (61), and 
(±)-quebrachamine (62), using a cyclisation/cycloaddition cascade to install the 
tricyclic amine core 59 shared by this class of alkaloids.21 Inspired by the work of 
Pearson et al.,22 they prepared substrate 55, and treated it with glycine under acidic 
conditions to give condensation/alkylation intermediate 56. Concomitant 
decarboxylation gave rise to azomethine ylide 57 which then underwent 
[3+2]-cycloaddition with the dipolarophilic alkene to give the desired tricycle 58. 
Acetal removal delivered ketoamine 59, which was in turn converted to 
(±)-aspidospermine (60), (±)-aspidospermidine (61), and (±)-quebrachamine (62). 
Scheme 9. Total synthesis of Aspidosperma alkaloids 60, 61 and 62. 
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1.1.3.2 Heteroatom-mediated cascades 
Cascade cyclisations that give rise to heterocyclic natural products have also received 
a lot of attention in the literature recently. 
Nicolaou et al. were able to install the pentacyclic framework in substrate 66 
(Scheme 10) en route to the total synthesis of (+)-cortistatin A (67),23 using a unique 
intramolecular 1,4-addition/aldol/dehydration cascade. The cascade proceeds by 
treatment of enone-enal 63 with K2CO3 at reflux in dioxane, to deliver 66 in 52 % 
yield, presumably through the pathway of intermediates 64 and 65. Synthesis of 
(+)-cortistatin A (67) was completed in a further 13 steps. 
Scheme 10. Nicolaou’s total synthesis of (+)-cortistatin A (67). 
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Another simple but powerful cascade was used to install the carbocycle and 
heterocycle of (+)-angelichalcone (70, Scheme 11) by Wiemer et al.24 
MOM-protected phenol 68, when treated with BF3.OEt2 underwent a rapid 
stereoselective cyclization/electrophilic aromatic substitution cascade to deliver 
tricycle 69 in which a new C-C bond had formed between the arene and transient 
MOM cation. Further embellishment of the newly installed benzylic methyl ether 
over 5 steps led to (+)-angelichalcone (70) in good yield. 
Scheme 11. Wiemer’s total synthesis of (+)-angelichalcone (70). 
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Scheme 12. Total syntheses of (+)-omaezakianol (79). 
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An example of cascade synthesis of spiroketals is demonstrated by Fürstner et al. in 
their synthesis of (–)-berkelic acid27 (84, Scheme 13). Treatment of enone 80 with 
acid triggered, what Fürstner proposed to be, a well-orchestrated triple 
deprotection/1,4-addition/spirocyclisation cascade to give tetracyclic product 83 in 92 
% yield.  Further steps yielded (–)-berkelic acid (84). 
Scheme 13. Fürstner’s total synthesis of berkelic acid (84). 
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1.1.3.3 Cation-mediated cascades 
Another common motif in cascade chemistry is the utilisation of iminium/enamine 
intermediates in ring formation. As a first example, Chen and Xhu completed the 
total synthesis of tetrahydroisoquinoline natural product (–)-cribostatin 4 (91, Scheme 
14).28 An acyliminium-mediated cascade cyclisation of a mixture of aldehyde 85 and 
cyclic hemiaminal 86 led to pentacyclic core 90 in 51 % yield (with a further 15 % of 
a regioisomer). The authors rationalise that the process occurs via !-elimination of 
enamide 88 to give conjugated iminium species 89 that underwent nucleophilic 
addition to the tethered arene to give pentacycle 90. Increased concentration of the 
mesic acid reagent led to reduced regioselectivity in this step. A subsequent eight 
steps delivered (–)-cribostatin 4 (91) in 4.3 % yield, and 26 steps overall. 
Scheme 14. Cascade approach to (–)-cribostatin 4 (91). 
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A Michael/Mannich cascade sequence was used by Funk et al. as a key feature in the 
total synthesis of (–)-nakadomarin A (96, Scheme 15).29 Activation of the enoate 
moiety in substrate 92 with catalytic indium trichloride led to intramolecular attack of 
the enamide portion. Nucleophilic addition of the resultant iminium species 94 to the 
furan gave desired tetracycle 95. 
Scheme 15. Funk’s total synthesis of (–)-nakadomarin A (96). 
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Scheme 16. Non-bimimetic cascade approach to (+)-vincadifformine (101). 
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Scheme 17. Cascade total synthesis of (±)-tashiromine (108). 
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In the final example, Shair and co-workers reported the first synthesis of Lycopodium 
alkaloid (+)-fastigiatine (114, Scheme 18).32 Treatment of ketal with acid furnished 
activated enone 110. The first C-C bond is formed by 1,4-addition of the enamine to 
give enol-iminium species 111, which in turn tautomerises to activated 
ketone-enamine 112 that undergoes a second C-C bond forming reaction to complete 
the formal [3+3] cycloaddition to give 113. (+)-Fastigiatine (114) is furnished in a 
further four steps. 
Scheme 18. Total synthesis of (+)-fastigiatine (114). 
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1.1.3.4 Transition metal-mediated cascades 
The continuing development of new transition metal-catalysed reactions makes this 
one of the most exciting areas of cascade chemistry, offering a catalytic approach to a 
host of regioselective and stereoselective transformations. Palladium-catalysed 
cascades have so far dominated this field due to the diversity of C-C bonds they are 
capable of installing. A recent example allowed the total synthesis of 
(±)-schindilactone A (120, Scheme 19) to be achieved using a Pd-catalysed 
carbonylative annulation cascade construction of the GH ring.33 Diol 115 was treated 
with PdII and a chiral thiourea catalyst under a CO atmosphere to deliver only lactone 
119 in 78 % yield. (±)-Schindilactone A (120) was furnished in a further six steps. 
The key step is initiated by the formation of allylic alcohol derived Pd-complex 116, 
which undergoes intramolecular nucleophilic attack across the double bond to give 
alkoxy-Pd species 117. CO-insertion followed by reductive elimination delivered the 
lactone product 119.34  
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Scheme 19. Pd-catalyzed cascade for the synthesis of (±)-schindilactone A (120). 
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!-Acid catalysis, particularly gold catalysis, has become increasingly popular in 
recent years, leading to the development of numerous new methodologies, including 
cyclisations. !-Acid catalysis has been particularly effective in spiroketal synthesis. 
One recent deployment of this reactivity was in the study of Forsyth et al. towards the 
total synthesis of azaspiracids (127, Scheme 20).35 Bis-spiroketalisation of ynol 121 
was achieved by treating with AuCl and PPTS in MeOH to give spiroketal 126 in 75 
% yield. The reaction is presumed to proceed via enol ether 123, the result of 
hydroxyl addition to the !-coordinated alkyne-AuI complex. 
Scheme 20. Gold-catalysed spiroketalisation for the total synthesis of azaspiracids. 
 
 
O
O
H
OTBDPS
OO
H
OPMB
O
O
H
OTBDPS
O
O
OPMB
AuCl, PPTS
MeOH
O
O
H
OTBDPS
O
OH
OPMB
122121
[Au]
H
AuI
O
O
H
OTBDPS
O
O
OPMB H+
123
O
O
H
OTBDPS
124
O
PMBO
O
125MeOH
- MeOMe
- H+
75 %
O
O
H
OTBDPS
OO
H
OPMB 126
O O
O
O
H
H R
HHO
O
H
azaspiracids (127)
Introduction 
 34 
The rhodium-catalysed degradation of diazocarbonyl compounds to give 1,3-dipoles 
has been utilised by the Padwa group in their recent racemic synthesis of alkaloid 
aspidophytine (131, Scheme 21).36 Treatment of diazo compound 128 with RhII 
generated carbonyl ylide 129 which underwent an intramolecular 1,3-dipolar 
cycloaddition to give pentacycle 130 in excellent yield. Subsequent steps led to the 
natural product 131. 
Scheme 21. Padwa’s route to (±)-aspidophytine (131). 
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1.1.3.5 Radical cascades 
As seen with the examples of (±)–hirsutene and (±)-!9(12)–capnellene (Section 1.1.2), 
organic radicals are well suited to cascade chemistry, and have been utilised 
extensively. Samarium–promoted radical cascades have been used extensively in total 
synthesis.37 One recent example is Reissig’s formal synthesis of (±)-strychnine.38 
Tetracyclic intermediate 136 (Scheme 22) was prepared by a samarium-mediated 
ketyl-radical cyclisation cascade of amide 132. Ketyl radical 133 was generated by 
treatment of 132 with SmI2 and HMPA and underwent a 6-exo-trig cyclisation to give 
benzyl radical intermediate 134. Reduction to alkylsamarium intermediate 135, 
followed by intramolecular acylation gave tetracyclic product 136 in 80 % yield. 
Subsequent steps led to (±)-isostrychnine (137) via Rawal’s intermediate.39 
Scheme 22. Reissig’s formal synthesis of (±)-strychnine. 
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A SmI2-induced ketyl radical cascade was also utilised by Nicolaou et al. in the total 
synthesis of vannusal B (143, Scheme 23). Aldehyde 138 gave intermediate ketyl 
radical 139 when treated with SmI2 and HMPA. Ketyl-alkene cyclisation gave 
tertiary radical 140, which underwent reduction followed by carbonate elimination to 
deliver 142 in good yield as a 2:1 mixture of epimers. 
Scheme 23. SmI2-mediated ring closure cascade in the synthesis of vannusal B (143). 
 
Radical cascades have also recently been utilised in the total synthesis of polycyclic 
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acylphloroglucinol 144, involving two sequential 5-exo-trig cyclisations, to deliver 
ialibinones A (149) and B (150) in 35 % yield. Independently, George et al. 
published an identical strategy, using alternative oxidant PhI(OAc)2, that afforded an 
improved yield (58 %) of ialibinones A (149) and B (150) as a 1:1 mixture. 
Scheme 24. Radical cascade polycyclisation for the total synthesis of ialibinones. 
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short succession. The Macmillan group has been particularly active in this area, with 
an impressive recent publication demonstrating a powerful asymmetric 
organocatalytic cascade approach to a common intermediate in the synthesis of 
various members of the Strychnos, Aspidosperma and Kopsia families of alkaloids.42 
Synthesis of this spiroindoline intermediate (160, Scheme 25) is achieved from vinyl 
indole 152 and propynal (151) using imidazolidinone catalyst 153, and is understood 
to proceed via an organocatalysed Diels-Alder/!-elimination/conjugate addition 
sequence. 
Scheme 25. Proposed mechanism for the organocatalysed cascade generation of 
tetracyclic intermediate 160. 
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Scheme 26. Synthesis of Strychnos, Aspidosperma and Kopsia alkaloids from 
common spiroindoline intermediate 160. 
 
 
1.1.4 Summary 
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1.2 The decarboxylative Claisen rearrangement 
 
1.2.1 Introduction 
Since its discovery nearly a century ago, the Claisen rearrangement43 has remained 
one of the most powerful carbon-carbon bond forming reactions in organic 
synthesis.44 This [3,3]-sigmatropic process delivers new C-C bonds in a regiospecific, 
and often stereoselective, manner from synthetically readily accessible substrates. 
These assets, as well as a compatibility with a wide range of functionalities, make the 
Claisen rearrangement particularly suited to total synthesis. 
Of the many variations of the original method, the Ireland-Claisen rearrangement of 
silyl ketene acetals has become one of the most versatile and widely used.45 These 
species, formed by the treatment of allylic esters with a silylating agent in the 
presence of base, undergo facile sigmatropic rearrangement under mild conditions to 
give !,"-unsaturated carboxylic acids after silyl ester hydrolysis. (Scheme 27) 
Scheme 27. The Ireland-Claisen rearrangement. 
 
The Craig group has recently introduced a novel variant of the Ireland-Claisen 
rearrangement, termed the decarboxylative Claisen rearrangement (dCr).46 
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ester 165 to give silyl ketene acetal 167, with regeneration of KOAc. Following 
[3,3]-sigmatropic rearrangement to give silyl ester 168, nucleophilic acetate 
desilylates 168 resulting in decarboxylation. Proton abstraction from either 
N-trimethylsilylacetamide or another molecule of substrate A gives homoallylic 
sulfone 166. (Scheme 28) 
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Scheme 28. The proposed catalytic cycle of the dCr reaction. 
 
The dCr substrates can be derived from both primary and secondary allylic alcohols, 
and rearrangement occurs regardless of the level of olefin substitution.47 
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1.2.2 Diastereoselectivity in the dCr reaction 
A diastereoselective version of the dCr reaction has been achieved using 
N-arylsulfonyl sulfoximine groups instead of tosyl groups.48 Enantiopure 
sulfoximines are readily accessible from the racemate and are an ideal functionality 
for mimicking tosyl reactivity. A variety of different nitrogen substituents were 
investigated and the diastereomeric ratios of their dCr products recorded. (Scheme 
29) 
Scheme 29. dCr reaction of racemic sulfoximine-substituted esters. 
 
Of the substituents investigated, N-(2,4,6-triisopropylphenylsulfonyl)-S-phenyl 
sulfoximine (Tris) gave the best diastereomeric ratio of 82:18. (Scheme 30) 
Scheme 30. dCr of Tris-sulfoximine 171. 
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Scheme 31. Proposed transition state model.48  
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1.2.3 dCr reactions of allylic malonate substrates 
The effect of an electron-withdrawing substituent at the !-position of the allylic 
tosylesters has been investigated.49 Methyl allyl 2-tosylmalonates were prepared, and 
underwent dCr reaction at ambient temperature in the presence of stoichiometric 
BSA. The reactions were also successful with alternative reagents TBSOTf and DBU. 
(Table 1) 
Table 1. dCr reaction of 178 at ambient temperature. 
 
 Reagents Yield of 179 
1 TBSOTf (2.1 equiv), DBU (2.1 equiv) 83 % 
2 BSA (1.0 equiv), KOAc (0.1 equiv) 81 % 
 
Due to the lack of a nucleophilic species to facilitate desilylation in the 
TBSOTf-DBU system, the normal mode of desilylation-decarboxylation as seen with 
BSA-KOAc could not be occurring, and an alternative mechanism was proposed. 
(Scheme 32) 
Scheme 32. Proposed mechanism of decarboxylation mediated by TBSOTf-DBU.49  
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The dCr reaction of unsymmetrical diallyl tosylmalonates (186) at ambient 
temperature has also been demonstrated.50 Only mono-rearrangement occurs under 
these conditions to give allylic tosylesters 187. These species no longer bear the 
electron-withdrawing group required for rearrangement under such mild conditions 
and so no further reaction takes place. In general, electron-rich allylic side chains 
were observed to react preferentially. (Table 2) 
Table 2. Examples of the dCr reaction of unsymmetrical diallyl tosylmalonates 186. 
 
Entry Substrate R1 R2 T (°C) t (h) Product (%) 
1 186a 4-MeOC6H4 E-MeCH=CH 0 2 187a (95) 
2 186b 4-MeOC6H4 Ph 25 2 187b (81) 
3 186c E-MeCH=CH Ph 25 16 187c (79) 
 
It was subsequently shown that the first-order rate constants for dCr reactions were 
dependent upon the electron density of the aryl group attached to the allylic portion.51 
This indicates that there is a significant build-up of positive charge at the benzylic 
position during rearrangement. The effect is greater than that found in investigations 
into other [3,3]-sigmatropic processes.52 
The double dCr reaction of unsymmetrical diallyl tosylmalonates can be achieved 
using BSA-KOAc under microwave conditions. This has been applied in the de novo 
synthesis of pyridines.53 (Scheme 33) 
Scheme 33. Synthesis of pyridines using diallyl 2-tosylmalonates. 
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1.2.4 Application of dCr to the total synthesis of (+)-cananodine 
The dCr reaction has also been used as a key step in the total synthesis of 
(+)-cananodine (194, Scheme 34).54 Intermediate 191 was treated under microwave-
assisted dCr conditions to give diene 192 as a mixture of two epimers in 71% yield. 
Ozonolysis, then exposure to ethanolic ammonia gave pyridine intermediate 193 in 
48% yield. Exposure of 193 to excess methylmagnesium bromide gave 
(+)-cananodine 194 in 97% yield. 
Scheme 34. Application of the dCr reaction in the synthesis of (+)-cananodine (194). 
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1.2.5 dCr reactions of heteroaromatic substrates 
Furan-2-ylmethyl, thien-2-ylmethyl and pyrrol-2-ylmethyl 2-tosylacetates have 
undergone dCr reactions under microwave or thermal conditions to deliver 
corresponding 2,3-disubstituted heteroaromatic products (Scheme 35).55 
Scheme 35. dCr reaction of heteroaromatic substrates. 
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Scheme 36. Dearomatising dCr reactions of heteroaromatic substrates. 
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Further investigations have shown these dearomatised products to be highly useful 
substrates for further synthetic embellishment. Novel dearomatised furan 203 was 
found to react diastereoselectively with a variety of aldehydes under relatively mild 
conditions.56 (Scheme 37) 
Scheme 37. Diastereoselective reaction of dearomatised furan dCr products with 
electrophiles. 
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methods.57 Of particular interest was the dCr of cyanoacetate ester 204 under standard 
conditions, which gave dearomatised substrate 205 possessing a C-2 quaternary 
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process, including potential applications in natural product synthesis, is ongoing. 
Scheme 38. Dearomatising dCr of ester 204. 
 
O
Ts
O
Ts
200
200
H R
O
ZnCl2, CH2Cl2
0 °C, 1 h
H
O
O
O
O
OH
Ts
R
O
OH
Ts
CH2Cl2, rt, 2 h
91 %
203a-e
203f
a R = Me, 60 %
b R = Et, 62 %
c R = Ph, 75 %
(10:1 syn:anti)
(10:1 syn:anti)
d R = (CH2)2Ph, 59 %
e R = CH=CHCH2, 58 %
O
O
BSA (1.5 equiv)
KOAc (1.0 equiv)
N
Ts
O
CN
O
N
Boc
PhMe, MW
150 °C, 3!1 min
204 205
Ph
CN
Ph
56 %
Introduction 
 49 
1.2.6 Transannular dCr reactions 
Finally, ring contraction of !-lactones was achieved using a transannular dCr reaction, 
giving access to cyclopropanes possessing quaternary centres.58 A modest degree of 
diastereoselectivity was observed when bulkier aromatic groups were used to increase 
steric demand in the allylic moiety (Table 3). 
Table 3. Transannular dCr reactions of "-tosyl-#-aryl-!-lactones 206a-c.58 
 
Substrate Ar Products Ratio 207:208a Yield (%) 
206a Ph 207a + 208a 1 : 1 87 
206b 2,4-F2C6H3 207b + 208b 1.3 : 1 75 
206c 2,6-F2C6H3 207c + 208c 2.2 : 1 82 
a) Determined by 1H NMR analysis of crude products. 
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1.3 Proposed synthesis of 1!,25-dihydroxylumisterol 
 
Workers at the Wellcome Centre for Research in Clinical Tropical Medicine have 
investigated the immunomodulatory properties of vitamin D in tuberculosis 
infection.59 They have shown that Vitamin D stimulates macrophage superoxide burst 
by rapid membrane-initiated signalling; as well as down-regulating protective 
cytokine responses in vitro.60 6-s-cis-locked calcitriol analogues, such as 1!,25-
dihydroxylumisterol (Scheme 39), are proposed as potential candidates for selective 
stimulation of membrane-initiated macrophage anti-mycobacterial activity without 
affecting cytokine response.61 This presents a potential area for the development of 
novel agents for tuberculosis treatment. Currently, no synthetic route to 
1!,25-dihydroxylumisterol exists. 
Our proposed synthetic route to calcitriol analogue 1!,25-dihydroxylumisterol 
intends to make use of a dCr reaction of ester 212 as a key step. C-3 hydroxy-directed 
epoxidation of the resultant 1,6-heptadiene 211 will deliver !-epoxyalkene 210, the 
substrate for the second key step; a Lewis acid-mediated cyclisation in which the 
nucleophilic C-ring olefin intercepts the A-ring epoxide in a stereospecific manner 
akin to, and inspired by, the squalene epoxide ring-closure cascade.62 Completion of 
the synthesis will involve elimination of TsH under basic conditions, Mitsunobu 
inversion of the C-1 alcohol, and deprotection steps to give the desired natural 
product (Scheme 39). 
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Scheme 39. Retrosynthetic approach to 1!,25-dihydroxylumisterol. 
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2.1 Progress towards the synthesis of 1!,25-dihydroxylumisterol 
 
2.1.1 Synthesis of carboxylic acid 220 
For the synthesis of carboxylic acid 220 it was envisaged that known 
!-hydroxyketone 2171 could be coupled with commercially available 2-tosylacetic 
acid, then methylenated to give allylic ester 219. Subsequent rearrangement under 
Ireland-Claisen conditions would deliver desired acid 220. (Scheme 40) 
Scheme 40. Proposed synthesis of carboxylic acid 220. 
 
During these initial studies we chose to omit the 25-hydroxy moiety from our 
synthesis. The early incorporation of this moiety, via oxidation of the 
Windaus-Grundmann ketone 2162 with dioxirane reagents3 or RuO44 is well 
established (Scheme 41), but due to the poor scalability of the former method, and the 
expense of the latter, we felt the chemistry did not lend itself to early-stage synthesis. 
Also, given the relative distance of this moiety from the other reactive centres in the 
molecule, its omission was unlikely to lead to a synthetic route to the natural product 
that could not be repeated upon its inclusion, protected as either a silyl or benzyl 
ether. 
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Scheme 41. Oxidation of Grundmann’s ketone to 25-hydroxy analogue 221. 
 
a) RuCl3 (0.15 equiv), NaIO4 (3.6 equiv), H2O/CCl4/CH3CN, rt, 120 h, 43 %; b) DMDO (3 equiv), 
CH2Cl2/acetone, 20 °C, 48 h, 86%. 
2.1.1.1 Synthesis of !-hydroxyketone 217 
There are numerous literature procedures for the ozonolysis of vitamin-D3 to 
Grundmann’s ketone but we chose to follow a procedure that had previously been 
used successfully in the Craig group.5 Thus, bubbling ozone through a CH2Cl2 
solution of (+)-vitamin D3 (215) at !78 °C, followed by addition of PPh3 to reduce 
the intermediate ozonide gave 216 in 84% yield after chromatography. On scale-up 
we found that alternative conditions, using MeOH as solvent and Me2S as reductant,6 
facilitated an easier work-up, and gave 216 in up to 98% yield. (Scheme 42) 
Scheme 42. Ozonolysis of vitamin D3 to give Windaus-Grundmann ketone 216. 
 
a) O3, CH2Cl2, !78 °C; then PPh3, 84% or b) O3, MeOH, !78 °C; then Me2S, 98%. 
Oxidation of ketone 216 to !-hydroxyketone 217 has been reported using 
oxodiperoxymolybdenum(pyridine)(hexamethylphosphoric triamide) (MoOPH) to 
oxidise the kinetic lithium enolate of 216 in 75% yield.1 Given the poor atom 
economy of this stoichiometric reagent, and the toxic reagents involved in its 
preparation, we decided to look at other methods. 
We first investigated forming 217 by oxidising silyl enol ether 222 under Rubottom 
conditions (Table 4).7 Unfortunately, forming the desired silyl enol ether proved more 
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challenging than expected. Initial attempts using Et3N and TESOTf8 favoured the 
silylated thermodynamic enolate as the major product (1:2 222/223) in quantitative 
yield (Table 4, Entry 1). It was thought we could make the kinetic enolate more 
favoured by changing solvent from CH2Cl2 to Et2O as the reduced solubility of triflic 
acid salt in Et2O may have helped to limit reversibility of enol ether formation. In 
practice this change had the opposite effect and gave 223 as the only product, 
quantitatively (Table 4, Entry 2). We expected switching the base to LDA would 
improve selectivity, but the reaction failed to go to completion, with NMR analysis of 
the crude mixture showing a 6:1 mixture of starting material and silyl enol ether 222 
respectively (Table 4, Entry 3). We suspected that this poor conversion might be a 
result of acidic impurities in TMSCl causing hydrolysis of the lithium enolate, or 
perhaps even the silyl enol ether product, so the reaction was repeated, this time using 
Et3N-treated solution of TMSCl in THF. This gave only a small improvement (5:2 
216/222) (Table 4, Entry 4). Another attempt, using a larger excess of base, still gave 
only a 2:1 216/222 mixture (Table 4, Entry 5). Clearly any acidic entity present was 
reacting with the lithium enolate before it could be neutralised by base. With this in 
mind, we reversed the addition of ketone and TMSCl to the reaction mixture. And so, 
to an excess of LDA in THF was added TMSCl followed by ketone 216. The workup 
gave pure silyl enol ether 222 in quantitative yield without chromatography (Table 4, 
Entry 6). On repeat we found that the same result could be achieved using only a 
small excess of base (Table 4, Entry 7). 
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Table 4. Synthesis of silyl enol ethers 222/223. 
 
Entry Conditions R Ratio 216/222/223a 
1 Et3N, TESOTf, CH2Cl2, !78 °C TES 0 : 1 : 2 
2 Et3N, TESOTf, Et2O, !78 °C TES 223 (>99%) 
3 LDA (1.2 equiv), TMSCl (1.1 equiv), 
THF, !78 °C 
TMS 6 : 1 : 0 
4 LDA (1.2 equiv), base-treated TMSCl 
(1.1 equiv), THF, !78 °C 
TMS 5 : 2 : 0 
5 LDA (2 equiv), TMSCl (1.1 equiv), 
THF, !78 °C 
TMS 2 : 1 : 0 
6 LDA (3 equiv), TMSCl (1.1 equiv), 
THF, !78 °C, ketone added last 
TMS 222 (>99%) 
7 LDA (1.2 equiv), TMSCl (1.1 equiv), 
THF, !78 °C, ketone added last 
TMS 222 (>99%) 
a) All reactions gave a quantitative recovery; ratios determined from the 1H-NMR spectrum of the 
mixture. 
Oxidation of silyl enol ether 222 under Rubottom conditions also proved problematic. 
The susceptibility of bicyclic silyl enol ethers to hydrolysis by the m-chlorobenzoic 
acid present in mCPBA is known and can be negated by using non-polar solvents, 
and pre-stirring mCPBA with NaHCO3 for a short time.9 Accordingly, treatment of 
silyl enol ether 216 in CH2Cl2 at –30 °C with a pre-stirred mixture of mCPBA and 
NaHCO3 in pentane followed by acid hydrolysis,10 gave a best yield of 38 % 217, 
with a 48% recovery of ketone 216. (Scheme 43) 
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Scheme 43. Rubottom oxidation of silyl enol ether 222. 
 
a) mCPBA (2 equiv), excess NaHCO3, CH2Cl2/pentane, 0 °C, 3 h, then AcOH/H2O/THF. 
Given that, despite measures taken, hydrolysis was still an issue, it was decided 
instead to use ozone to achieve this oxidation step.11 Silyl enol ether 222 in 
CH2Cl2/pyridine at !78 °C was treated with ozone. After acidic workup 
!-hydroxyketone 217 was isolated in 65 % yield. Unfortunately on scale-up the yield 
of this reaction fell to below 50 %, but it was found that performing ozonolysis in 
MeOH/CH2Cl2, and using a reductive workup,12 we could isolate 217 in a 54% yield 
that remained consistent on large scale. (Scheme 44) 
Scheme 44. Oxidation of silyl enol ether 222 to !-hydroxyketone 217 with ozone. 
 
a) O3, MeOH/CH2Cl2 (4:1), !78 °C, 15 min; then Me2S, !78 °C!rt, o/n. 
Allylic ester 219 was the next target, requiring methylenation and esterification with 
2-tosylacetic acid, although it was not obvious in which order these steps would be 
most effective. (Scheme 45) 
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Scheme 45. Two possible routes to allylic ester 219 from !-hydroxyketone 217. 
 
Route A was the first to be explored. Methylenation was first attempted under Wittig 
conditions. Ketone 217 was treated with Ph3PCH2 in THF at 0 °C. Although starting 
material appeared to be consumed, the only isolated product was the C-14 epimer of 
217 in 52 % yield, produced as result of the basic conditions. The stereochemistry of 
the C-9 position in the product was not determined. (Scheme 46) 
Scheme 46. Attempted Wittig reaction of !-hydroxyketone 217. 
 
a) Ph3PCH3I (2 equiv), n-BuLi (2 equiv), THF, 0 °C!rt, 2 h. 
Hydroxyketones have been successfully methylenated using gem-dimetallic reagent 
CH2(ZnI)2 (made using Zn-Cu couple and diiodomethane).13,14 A proposed 
mechanism is shown in Scheme 47. 
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Scheme 47. Methylenation of hydroxyketones using CH2(ZnI)2.13 
 
On treatment with CH2(ZnI)2, hydroxyketone 217 gave a mixture of two inseparable 
isomers of the desired product 223 (isomer ratio 1.3:1) in 79% yield. The isomers 
were initially considered to be diastereomers as both seemed to have NMR spectra 
consistent with the desired product. By coupling the mixture with 2-tosylacetic acid, 
the resultant allylic ester products could be separated by chromatography. Analysis 
by NMR spectroscopy showed that the major isomer was the desired allylic ester 219. 
Further analysis using a variety of 2D NMR techniques showed strong support for the 
minor product being isomer 225 rather than another diastereomer of 219 (Scheme 
48). 
Scheme 48. Synthesis of isomers 219 and 225 from !-hydroxyketone 217. 
 
a) CH2(ZnI)2 (9 equiv), Et2O, rt, 3 h; b) 2-tosylacetic acid (1 equiv), DCC (1.1 equiv), DMAP 
(0.1 equiv), CH2Cl2, rt, o/n. 
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Another attempted methylenation, treating 217 with the Petasis reagent (Cp2TiMe2)15 
at reflux in THF/PhMe gave a similar result to the dimetallic zinc reagent, delivering 
an inseparable 4:1 mixture of 223 and 224 in only 18% yield (Scheme 49). 
Scheme 49. Methylenation of !-hydroxyketone 217 with the Petasis reagent. 
 
a) Cp2TiMe2 (3 equiv), PhMe/THF, 70 °C, 18 h. 
Given the problems with Route A, Route B was explored (Scheme 45). 217 was 
coupled to 2-tosylacetic acid by treatment with DIC and DMAP to give 218 in 91% 
yield on a 100 mg scale (Scheme 50). 
Scheme 50. Small-scale coupling of !-hydroxyketone 217 with 2-tosylacetic acid. 
 
a) 2-tosylacetic acid (1 equiv), DIC (1.1 equiv), DMAP 0.1 equiv), CH2Cl2, 0 °C!rt, 15 min. 
However, when repeated on a larger scale (700 mg) an unexpected reaction occurred. 
Although TLC assay showed that the majority of starting material had been 
consumed and the desired product forming after 15 min, after a further 15 min the 
initial product had been mostly consumed to give a new product with a higher Rf. 
After immediate workup and chromatography, the desired product 218 was isolated 
in just 15% yield, with "-lactone 226, as the major product (65 %), most probably 
formed by DMAP-catalysed intramolecular aldol reaction of the ketoester (Scheme 
51). 218 was also observed to undergo partial cyclisation to 226 during 
chromatography and whilst being stored. As such the prospect of improving the yield 
of 218 by halting the coupling reaction before cyclisation could occur was deemed 
not to be a viable option. 
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Scheme 51. Synthesis of !-lactone 226 from !-hydroxyketone 217. 
 
a) 2-tosylacetic acid (1 equiv), DIC (1.1 equiv), DMAP (0.1 equiv), CH2Cl2, rt, 30 min. 
When Wittig methylenation of ketoester 218 was attempted it led, unsurprisingly 
given the basic conditions, to a mixture of the desired allylic ester 219 and !-lactone 
226 as a 2:1 mixture in 49 % yield (Scheme 52). Attempts to achieve the same 
methylenation with Cp2TiMe2 led to total decomposition of starting material over 
72 h. 
Scheme 52. Synthesis of allylic ester 219 and !-lactone 226 from 218. 
 
a) Ph3PCH3I (1.3 equiv), n-BuLi (1.1 equiv), THF, 0 °C"rt, 2 h. 
Another potential route to allylic alcohol 223 was by methylenation of Grundmann’s 
ketone 216 followed by a Riley oxidation. Methylenation was successfully achieved 
with under both Wittig16 and Petasis conditions, giving olefin 227 in 81% and 84% 
respectively. Selenium dioxide oxidation of a C-17 analogue of 227 (R=OAc instead 
of C8H17) had been reported in 55% yield.17 Unfortunately a procedure for 
transformation was not included within the paper and attempted oxidation gave only 
an intractable mixture of products.18 (Scheme 53) 
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Scheme 53. Methylenation and attempted Riley oxidation. 
 
a) Ph3PCH3I (1.3 equiv), n-BuLi (1.1 equiv), THF, 0 °C!rt, 4 h; b) Cp2TiMe2, PhMe/THF, 65°C, 
48 h; c) SeO2 (0.3 equiv), tBuOOH (2 equiv), CH2Cl2, 0 °C!rt, 24 h. 
After these failed attempts to access allylic ester 219 we decided to proceed by 
protecting !-hydroxyketone 217, followed by methylenation, deprotection and then 
esterification. Consequently, TBS protection of the alcohol, carried out under 
standard conditions,19 followed by Wittig methylenation and TBS removal with 
TBAF gave 223 in 78 % yield over 3 steps. Furthermore, the yield of this sequence 
was only modestly diminished (74 %) when purification was omitted from all but the 
final step. (Scheme 54) 
Scheme 54. Synthesis of allylic alcohol 223. 
 
a) TBSCl (3 equiv), imidazole (3 equiv), CH2Cl2, 18 h, rt; b) Ph3PCH3I (1.3 equiv), n-BuLi 
(1.1 equiv), THF, 0 °C, 1 h; c) TBAF.3H2O (3 equiv) THF, rt, 72 h. 
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Coupling of 223 with 2-tosylacetic acid under standard Steglich conditions20 was 
rapid and gave allylic ester 219 in 76 % yield. Ireland-Claisen rearrangement of 219 
to give carboxylic acid 220 was achieved under mild conditions by treatment with 
BSA and Et3N in acetonitrile.21 The rearrangement proved facile and high-yielding, 
giving 220 as a mixture of C-Ts epimers. (Scheme 55) 
Scheme 55. Synthesis of carboxylic acid 220. 
 
a) 2-tosylacetic acid (1 equiv), DIC (1.1 equiv), DMAP (0.05 equiv), CH2Cl2, 0 °C, 30 min; b) BSA 
(3 equiv), Et3N (1.2 equiv), CH3CN, 60 °C, 30 min. 
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2.1.2 Synthesis of racemic alcohol 214 
Differentially protected cyclohexenediols such as 214 have been synthesised via 
multi-step sequences from (R)-carvone (230).22 Despite this, we envisaged a simpler 
route via 1,3-anti-diol derivative 231 that would provide 214 when subjected to 
ring-closing metathesis. We intended to make 231 itself by the diastereoselective 
allylation of aldehyde 232. (Scheme 56) 
Scheme 56. Literature approach22 and our proposed approach to 214. 
 
Our synthesis of 236 began with an aldol addition of EtOAc to methacrolein (233) to 
give racemic !-hydroxyester 234. The kinetic resolution of 234 to its (R)-enantiomer 
in 98 % ee by Sharpless epoxidation was known in the literature and was key to our 
planned strategy for the asymmetric synthesis of 214,23 but during early 
investigations we chose to continue with the racemate. Hydroxy protection followed 
by DIBAL-H reduction gave aldehyde 236 in good yield (Scheme 57). Compounds 
235 and 236 could not be stored for longer than 24 h otherwise significant loss of the 
MIP protecting group was observed. 
Scheme 57. Synthesis of aldehyde 236 from methacrolein. 
 
a) LDA (1.1 equiv), EtOAc (1.1 equiv), THF, !78 °C, 90 min; b) PPTS (5 mol%), 2-methoxypropene, 
0 °C!rt, 90 min; c) DIBAL-H (1.05 equiv), CH2Cl2, !78 °C, 1 h. 
Chelation-controlled 1,3-asymmetric induction is well studied.24 Allylic addition to 
protected !-hydroxyaldehydes using TiCl4 and allyltrimethylsilane can be used to 
give differentially protected anti-1,3-diols with good diastereoselectivity.25 (Scheme 
58) 
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Scheme 58. Chelate-controlled addition to !-alkoxyaldehydes. 
 
This approach gives the best results for benzyl-protected alcohols. At this stage we 
chose not to use this protecting group as we had intended to use benzyl protection on 
the other hydroxy moiety in anti-1,3-diol 231. We had believed MIP-protection to be 
a suitable alternative, but when aldehyde 236 was treated with TiCl4 and 
trimethylallylsilane at !78 °C, the starting material was consumed immediately, with 
only baseline material visible by TLC. The desired product 237 was not observed in 
the crude isolate by NMR or mass analysis. (Scheme 59) 
Scheme 59. Attempted synthesis of differentially-protected anti-1,3-diol 237. 
 
a) TiCl4 (0.5 equiv), CH2Cl2, 0 °C!–78 °C, then allylSiMe3 (1 equiv), 5 min. 
At this stage we realised we had overlooked a potentially more convenient and 
diastereoselective route to 231 involving an Evans-Tishchenko reaction of allylketone 
238. This methodology generally delivers differentially protected anti-1,3-diols in 
high yield and excellent diastereoselectivities (often >99:1 dr).26 It is proposed that 
this reaction proceeds by coordination of the aldehyde and ketone to the samarium 
catalyst, followed by hemiacetal formation and donation of aldehydic hydride to 
reduce the ketone. The highly-ordered transition state contributes to the high 
diastereoselectivity of the reaction and the favoured product is that of the 
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intermediate in which all alkyl/aryl substituents are equatorial (Scheme 60).26  
Scheme 60. Potential Evans-Tishchenko reaction of 238. 
 
For the synthesis of allylketone 238, !-hydroxyester 234 was converted to the 
corresponding Weinreb amide 240 using isopropylmagnesium chloride and 
N,O-dimethylhydroxylamine hydrochloride.27 Subsequent treatment with 
allylmagnesium chloride gave crude 238 in excellent yield (Scheme 61). 238 was not 
further purified as this led to significant isomerisation to its ",!-unsaturated 
analogue. This degradation was also observed if crude 238 was stored for more than 2 
h in the freezer. 
Scheme 61. Synthesis of allylic ketone 238. 
 
a) MeONHMe.HCl (3 equiv), iPrMgCl (5.95 equiv), THF, –30 °C!0 °C, 3 h; b) allylMgCl (2 equiv), 
0 °C!rt, 2 h. 
The Evans-Tishchenko reaction was initially performed using 15 mol% SmI2.26 After 
stirring overnight, completion was observed, but the desired product 241 was 
recovered in only 18% yield, albeit with excellent diastereoselectivity (only one 
diastereomer was present in the NMR spectrum). Doubling the catalyst loading to 30 
mol% gave an improved 39 % yield after only 1 h with no drop in selectivity 
(Scheme 62). 
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Scheme 62. Evans-Tishchenko reaction of allylketone 282. 
 
a) SmI2 (0.3 equiv), PhCHO (4 equiv), THF, –10 °C, 1 h. 
Further investigations, in which concentration, temperature, benzaldehyde 
equivalents and catalyst loading  were altered gave no further improvement. In all 
cases, the major by-product was observed to be a viscous gum that we were unable to 
identify by conventional analysis, although we suspect it to have been a result of 
polymerisation of the starting material. 
Attempted ring-closing metathesis of 241 using Grubbs 2nd generation catalyst28 
showed no conversion at room temperature, but when heated to 40 °C, the reaction 
proceeded quickly to give 242 in almost quantitative yield. Subsequent TBS 
protection of the free alcohol, followed by ester cleavage under basic conditions29 
gave the desired allylic alcohol 243 in good yield (Scheme 63). 
Scheme 63. Synthesis of 243 from anti-1,3-diol 241. 
 
 
a) Grubbs 2nd generation catalyst (0.05 equiv), CH2Cl2, 40 °C, 2 h; b) TBSCl (1.2 equiv), imidazole 
(2.5 equiv), DMF, rt, 3 h, 82 %; c) KOH (1.5 equiv), MeOH, rt, o/n, 93 %. 
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2.1.3 Synthesis of a generic analogue of allylic alcohol 243 
As carboxylic acid 220 and allylic alcohol 243 both required multi-step syntheses, the 
decision was taken to conserve material by using a simple structural analogue of 243 
in the initial investigation and optimisation of the coupling with acid 220 and the 
subsequent dCr reaction. 
The simplest potential analogue, 2-methyl-2-cyclohexenol (247) was chosen as it had 
previously been prepared in the Craig group.30 Thus, treatment of commercially 
available cyclohexenone 244 with I2 in Et2O/pyridine gave 2-iodo-2-cyclohexenone 
245 in 31% yield after recrystallisation. Methylation using Fe(acac)3 and 
methylmagnesium chloride gave 2-methyl-2-cyclohexenone 246 in 72 % yield. 
Asymmetric reduction using (S)-methyl CBS (Corey-Bashi-Shibata) reagent31 had 
previously furnished alcohol (S)-247 in up to 84 % ee,30 but we observed no 
conversion, probably due to poor quality of the CBS reagent. As 246 was beginning 
to decompose in storage we converted it to the more stable rac-247 in 65 % yield by 
standard NaBH4 reduction. (Scheme 64) 
Scheme 64. Synthesis of rac-247. 
 
a) I2 (2.1 equiv), Et2O/pyridine, 0 °C!rt, 2 h; b) Fe(acac)3 (5 mol%), MeMgCl (1.1 equiv), 
NMP/THF, 15 °C, 1 h; c) NaBH4 (1.1 equiv), MeOH, 0 °C!rt, o/n. 
As we had originally intended to use an optically pure allylic alcohol in our synthetic 
studies, in an effort to best mimic our real system, we decided to prepare another 
analogue. In accordance with the literature, Luche reduction32 of (S)-carvone (248) 
gave (+)-carveol 249 with 95:5 dr (determined by 1H-NMR spectroscopy). Inversion 
of the hydroxyl stereocentre under Mitsunobu conditions33 and subsequent ester 
methanolysis delivered the desired analogue, (+)-carveol (251), in good yield and 9:1 
dr (determined by 1H-NMR spectroscopy).34 (Scheme 65) 
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Scheme 65. Synthesis of (4S,6R)-(+)-carveol (251). 
 
a) CeCl3.7H2O (1 equiv), NaBH4 (1 equiv), MeOH, rt, 10 min; b) DIAD (3 equiv), PPh3 (3 equiv), 
PhCOOH (3 equiv), THF, 0 °C!rt, 20 h; c) 2M KOH in MeOH (1.5 equiv), rt, 14 h. 
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2.1.4 Synthesis and attempted dCr of ester 252 
Coupling of the allylic alcohol analogue 251 and carboxylic acid 220 with 
DIC/DMAP proceeded very slowly, even at high concentration (~2 M in CH2Cl2). A 
first attempt, gave ester 252 in just 23% yield with 76% recovery of starting material 
after 24 h. Increasing the reaction time to 96 h gave a 54% yield of 252 (33% 
recovery of starting material). Despite the poor conversion observed for this step, 
with material in hand we attempted the key dCr reaction. Under standard thermal 
conditions using BSA (3 equiv) and KOAc (0.2 equiv) in PhMe at reflux starting 
material was unchanged. Investigation was continued using microwave irradiation, 
making use of a pulse sequence previously found to be optimal within our group.35 
Thus, 252 was treated with KOAc (0.2 equiv) neat in BSA (6 equiv). After heating at 
180 °C in a 3!1 min cycle (cooling between each heat cycle) TLC showed significant 
starting material consumption, but numerous products. Silica gel chromatography of 
the crude reaction mixture yielded an intractable mixture, none of which could be 
identified as the desired product 253 by NMR or MS analysis. Subsequent attempts in 
the microwave at lower temperature yielded no conversion whatsoever (Scheme 66). 
Scheme 66. Synthesis and attempted dCr of ester 252. 
 
a) DIC (1.1 equiv), DMAP (0.1 equiv), CH2Cl2, rt, 4 days. 
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2.1.5 Testing the reactivity of model dCr substrates 
In order to assess the reactivity of the carveyl moiety as the allylic portion in the dCr 
reaction, simple tosyl acetates 254 and 255 were prepared and subjected to dCr 
conditions (Scheme 67). Thus, 251 was coupled with 2-tosylacetic acid to give ester 
254 in good yield. Next, 254 was treated with DBU and in-situ generated allyl iodide 
to give the desired mono-allyl product 255 in 79 % yield, alongside 15 % of the 
unwanted bis-allylation product.36 Ester 254 was heated at 180 °C for 3!1 min under 
microwave irradiation to give homoallylic sulfone 256 in 88 % yield. Heating at 
lower temperatures significantly slowed conversion, though no other products were 
observed. In contrast, when 255 was subjected to the same reaction conditions only 
26 % of the desired dCr product 257 was isolated, with allyl p-tolyl sulfone 258 the 
major product in 39 % yield. Again, reducing the reaction temperature resulted in 
reduced conversion, but with little change in the product distribution. 
Scheme 67. dCr reactions of tosylacetic esters 254 and 255. 
 
a) 2-tosylacetic acid (1 equiv), DIC (1.1 equiv), DMAP (0.1 equiv), rt, 2 h; b) allyl bromide (1 equiv), 
n-Bu4NI (1 equiv), DBU (2 equiv), DMF, rt, 2 h; c) KOAc (0.1 equiv) BSA (5 equiv), microwave 
(3!1 min, 180 °C); d) KOAc (0.2 equiv), BSA (5 equiv), microwave (3 x 1 min, 180 °C). 
Clearly, the poor recovery of the desired products when model substrates were 
subjected to dCr conditions did not bode well for our original synthetic strategy. 
However, there was an alternative route available to 1,6-heptadiene 253, simply 
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requiring the sequence of the two Claisen reactions currently in the synthesis to be 
switched. 
In the original route (Route A, Scheme 68), carboxylic acid 220 is formed by an 
Ireland-Claisen reaction, with the reacting allylic portion in 219 containing the 
exocyclic methylene group of the C,D-ring system. After coupling 220 with allylic 
alcohol 243 a dCr reaction of the resulting ester 259 would furnish diene 263. An 
alternative route (Route B) would see Ireland-Claisen reaction of easily accessible 
ester 260 deliver carboxylic acid 261, which could then be coupled with allylic 
alcohol 223 to give a dCr substrate 262 in which the reacting allylic portion is now 
the exocyclic methylene. 
Scheme 68. Original and alternative routes to key 1,6-heptadiene 263. 
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2.1.6 Feasibility study of alternative dCr on model substrates 
The most efficient strategy to assess whether this alternative approach would be facile 
was to investigate model substrates for both routes and compare them directly. 
Substrates 264 and 266 were selected for their similarity to the desired dCr substrates 
and relative ease of synthesis (Scheme 69). 
Scheme 69. Model investigation of alternative routes to dCr product 265. 
 
Substrate 264, representative of Route A (Scheme 68), was prepared in four steps 
from cyclohexanone. In accordance with the literature, one-step transformation of 
cyclohexanone to allylic alcohol 268 in modest yield was achieved by heating with 
superbasic KOH in DMSO (Scheme 70).37 This reaction is believed to occur via 
dimsyl anion attack on the ketone, followed by elimination to give allyl sulfoxide 
272, then [2,3]-sigmatropic rearrangement and subsequent hydrolysis to give allylic 
alcohol 268. Coupling with 2-tosylacetic acid, achieved under conditions described 
previously, gave ester 269, which underwent Ireland-Claisen rearrangement to 
carboxylic acid 270 in 97 % yield under conditions identical to those used previously 
(BSA, Et3N, CH3CN, 60 °C). Another DIC/DMAP coupling, with allylic alcohol 251, 
furnished the desired model dCr substrate 264 in good yield. 
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Scheme 70. Preparation of model dCr substrate 264, including the proposed 
mechanism for synthesis of 268. 
 
a) KOH (3 equiv), DMSO, 110 °C, 90 min; b) 2-tosylacetic acid (1 equiv), DMAP (0.1 equiv), DIC 
(1.1 equiv), CH2Cl2, rt, 1 h; c) Et3N (1.2 equiv), BSA (3 equiv), CH3CN, 60 °C, 30 min; d) 251 
(1 equiv), DMAP (0.1 equiv), DIC (1.1 equiv), CH2Cl2, 0 °C!rt, 1 h. 
Substrate 266 (Scheme 71), representative of Route B (Scheme 68), was prepared in a 
further two steps. Ireland-Claisen rearrangement of previously synthesised ester 254 
was achieved in excellent yield, but required slightly more forcing conditions (reflux 
in CH3CN, compared with 60 °C) than the Ireland-Claisen in Route A. DIC/DMAP 
coupling of the resultant carboxylic acid 273 with allylic alcohol 268 furnished the 
second desired model dCr substrate 266 in modest yield. 
Scheme 71. Preparation of model alternative dCr substrate 266. 
 
a) Et3N (1.2 equiv), BSA (3 equiv), CH3CN, reflux, 2 h; b) 268 (1.0 equiv), DMAP (0.1 equiv), DIC 
(1.1 equiv), CH2Cl2, rt, 18 h. 
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With both ester substrates in hand, dCr reactions were attempted as previously 
described, using catalytic KOAc and excess BSA in the absence of solvent under 
microwave irradiation at 180 °C for 3 x 1 min. After the reaction period ester 264 was 
consumed to furnish the desired product 265 in only 26 % yield, with the major 
product the homoallylic sulfone 274 in 49 % yield (Scheme 72). As found previously, 
reducing the reaction temperature only served to reduce conversion and had little 
effect on the relative distribution of products. In contrast, and to our delight, when 
substrate 266 was subjected to the aforementioned conditions it was fully consumed, 
giving desired 265 as the sole product in essentially quantitative yield. 
Scheme 72. dCr reactions of substrates 264 and 266. 
 
a) KOAc (0.2 equiv), BSA (5 equiv), microwave (3!1 min, 180 °C). 
In summary, substrate 266 possessing the allylic portion containing the exocyclic 
methylene was demonstrably more reactive in the Claisen rearrangement than that 
containing the cyclohexenyl moiety, under both Ireland and decarboxylative 
conditions. Given that rearrangement of both moieties could be achieved in excellent 
yield under Ireland-Claisen conditions, we had good reason to believe that the new 
alternative pathway to substrate 263 was worth pursuing. To confirm this, previously 
synthesised allylic alcohol 223 was coupled with carveol-derived carboxylic acid 273 
in modest yield to give ester 275, an even more representative model dCr substrate, 
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that subsequently underwent dCr reaction in the microwave to afford the desired dCr 
product 276 in 90 % yield (Scheme 73). 
Scheme 73. dCr of model substrate 275. 
 
a) DMAP (0.1 equiv), DIC (1.1 equiv), CH2Cl2, rt, 6 h; b) KOAc (0.2 equiv), BSA (5 equiv), 
microwave (3!1 min, 180 °C). 
2.1.7 Asymmetric synthesis of carboxylic acid 261 
In order to apply this alternative dCr to our actual system 262, the asymmetric 
synthesis of allylic alcohol 243 had to be completed before coupling with 
2-tosylacetic acid and Ireland-Claisen rearrangement would furnish desired 
carboxylic acid 261. (Scheme 74) 
Scheme 74. Retrosynthetic approach to dCr substrate 262. 
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As previously discussed in Section 2.1.2, our already-developed synthesis of racemic 
243 could be rendered asymmetric by the known kinetic resolution of !-hydroxyester 
234 using a Sharpless asymmetric epoxidation.23 Following the literature procedure, 
234 was treated with sub-stoichiometric Ti(Oi-Pr)4 and L-(+)-DIPT, and 
stoichiometric t-BuOOH, in the presence of 4Å molecular sieves. Tracking 
conversion quantitatively by GC or LCMS was found to be somewhat unreliable, 
hence reaction progress was followed by workup and purification of small aliquots at 
8-15 h intervals, assessing the ee by addition of chiral lanthanide shift reagent 
tris[3-[(trifluoromethyl)hydroxymethylene]-(+)-camphorato]europium(III) to the 
1H-NMR sample. The reaction was stopped once the ee increase had levelled off. As 
a result (R)-234 was afforded in 45 % yield and 86 % ee after 96 h, a moderate result 
compared with the literature value of 49 %, 98 % ee after 24 h.23 Despite efforts to 
improve this result, these reaction conditions remained the most effective, with 
difficulty in quantitative monitoring of reaction progression perhaps limiting our 
ability to improve the ee further. (Scheme 75) 
Scheme 75. Kinetic resolution of !-hydroxyester 234. 
 
a) L-(+)-DIPT (0.45 equiv), Ti(Oi-Pr)4 (0.4 equiv), t-BuOOH (1 equiv), 4 Å MS, CH2Cl2, –25 °C, 
96 h. 
The synthetic sequence to allylic alcohol 243 employed the same chemistry as the 
racemic synthesis (see Section 2.1.2), but entailed some optimisation to improve 
yields. Conditions for generation of Weinreb amide 240 were changed to the more 
commonly-used method of treating of N,O-dimethylhydroxylamine hydrochloride 
with AlMe3, rather than isopropylmagnesium chloride (Scheme 76). This resulted in 
an improved yield of 89 % from 66 %. Inspired by the Evans-Tishchenko reaction of 
a structure very similar to 238 (an ethyl moiety in place of our isopropenyl moiety) 
published in the interim,38 we assessed the use of propionaldehyde instead of 
benzaldehyde in our reaction. To our delight the alternative aldehyde improved the 
yield from 45 % to 88 %, affording propionate ester 277. When 277 was subjected to 
ring-closing metathesis, it was found that a reduced catalyst loading of 3 mol%, 
OH O
OEt
a
45 %
86 % ee
(±)-234
OH O
OEt
(R)-234
Results & Discussion 
    81 
added in three portions at hourly intervals, gave only a slight reduction in yield. All 
other reaction conditions in the sequence remained unchanged from those used for the 
racemate, with similar yields. 
Scheme 76. Synthesis of cyclohexenol (R)-243. 
 
a) MeONHMe.HCl (2.2 equiv), AlMe3 (2.2 equiv), THF, rt, 45 min; b) allylMgCl (2 equiv), THF, 
0 °C, 2 h; c) RCHO (4 equiv), SmI2 (0.1 equiv), THF, –10 °C, 1 h; d) R=Ph: Grubbs II (0.05 equiv), 
CH2Cl2, 40 °C, 90 min; R=Et: Grubbs II (0.03 equiv), CH2Cl2, 40 °C, 3 h; e) TBSCl (2 equiv), 
imidazole (2 equiv), CH2Cl2, 0 °C!rt, 5-15 h; f) KOH (3 equiv), MeOH, 0 °C!rt, 12-16 h. 
Coupling of 243 with 2-tosylacetic acid using DIC and DMAP gave the desired ester 
260 in 92 % yield (Scheme 77). When 260 was subjected to the Ireland-Claisen 
conditions used previously for the corresponding model substrate 273 (see Scheme 
71), it underwent full conversion in 3 h to furnish desired carboxylic acid 261 in 92 % 
yield. 
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Scheme 77. Synthesis of carboxylic acid 261. 
 
a) 2-tosylacetic acid (1 equiv), DMAP (0.1 equiv), DIC (1.1 equiv), CH2Cl2, 0 °C!rt, 2 h; b) Et3N 
(1.2 equiv), BSA (3 equiv), CH3CN, reflux, 3 h. 
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2.1.8 Synthesis and dCr of ester 262 
Carboxylic acid 261 and allylic alcohol 223 coupled more readily under DIC/DMAP 
conditions than some of the model substrates, to give dCr substrate 262 in 79 % yield 
after 6 h (Scheme 78). When 262 was treated with KOAc and BSA in the microwave, 
it underwent complete conversion to the desired product 263, isolated in 88 % yield 
after chromatography as a mixture of C-Ts epimers. Pleasingly, a second round of 
careful chromatography allowed the epimers to be separated, delivering the less polar 
major epimer 263a in 56 % yield, and more polar minor epimer 263b in 30 % yield. 
The stereochemistry of the C-Ts centres was not determined. 
Scheme 78. Synthesis and dCr reaction of ester 262. 
 
a) DMAP (0.1 equiv), DIC (1.1 equiv), CH2Cl2, rt, 6 h; b) KOAc (0.1 equiv), BSA (3.5 equiv), 
microwave (5!1 min, 180 °C). 
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2.1.9 Synthesis of epoxide 283 
With our desired dCr product in hand we continued with the next stages of our 
synthetic strategy, namely the preparation of epoxide 283, the substrate for our key 
acid-mediated cyclisation step. Our intention was to prepare 283 by a 
facially-selective, hydroxy-directed epoxidation of homoallylic alcohol 281. (Scheme 
79) 
Scheme 79. Proposed synthesis of epoxide 283. 
 
In order to simplify the characterisation of compounds made in the continuing 
synthesis, we elected to take only major epimer 263a through subsequent 
investigations. 
Desilylation of 263a with excess TBAF trihydrate was slow, taking 3 days to go to 
completion, but nevertheless delivered homoallylic alcohol 281 in 86 % yield. We 
found that using anhydrous TBAF improved both the reaction time and yield of 281 
to 15 h and 95 % respectively. (Scheme 80) 
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Scheme 80. Silyl-deprotection of 1,6-heptadiene 263a. 
 
a) TBAF (2 equiv), THF, rt, 15 h. 
Hydroxy-directed epoxidation of homallylic alcohols has been well studied.39 
Assessment of the literature led us to conclude that using catalytic VO(acac)2 with 
t-BuOOH40 as oxidant would be the most effective method for the facially-selective 
epoxidation of our substrate. Firstly, 281 was treated with stoichiometric t-BuOOH in 
the presence of 5 mol% VO(acac)2 at 0 °C. After 1 h, LCMS analysis showed two 
separate products, both with a mass corresponding to mono-epoxidation, and 
remaining starting material in a 1:5:1 ratio. Given that the alkene contained within the 
bicycle would be unlikely to react under these conditions, we predicted the two 
products to be a result of poor facial-selectivity as opposed to poor regioselectivity. 
This was confirmed by 1H-NMR analysis of the crude reaction mixture, which 
showed the bicyclic alkene to be intact. A second attempt with reduced catalyst 
loading (3 mol% VO(acac)2 and lower temperature (–10 °C) was designed to improve 
selectivity, and did so, affording the desired epoxide 282 as a single epimer, isolated 
in 96 % yield (Scheme 81). Another reagent known to perform hydroxy-directed 
stereoselective epoxidation is mCPBA.41 However, when screened in this reaction, 
poor facial and regioselectivity was observed, with LCMS analysis of the reaction 
mixture showing multiple products of both mono- and bis-epoxidation. In 
conjunction with t-BuOOH, Mo(CO)6 has also been used as a catalyst for similar 
transformations.40 However, treatment of 281 with these reagents at reflux led only to 
decomposition. 
With 282 in hand, reprotection of the free alcohol with TBS was achieved under 
standard conditions to give our cyclisation substrate 283 in excellent yield. (Scheme 
81) 
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Scheme 81. Synthesis of key epoxide substrate 283. 
 
a) VO(acac)2 (0.03 equiv), t-BuOOH (1.5 equiv), CH2Cl2, –10 °C, 4 h; b) TBSCl (2 equiv), imidazole 
(2 equiv), CH2Cl2, rt, 18 h. 
2.1.10 Attempted cyclisation of epoxide 283 
As the second key step of our synthesis we predicted that Lewis acid activation of 
epoxide 283 would initiate intramolecular attack of the C-8(9) alkene, giving rise to a 
transient tertiary carbocation 284 that would be spontaneously quenched by 
elimination of a proton. Our hope was that this elimination would be favoured from 
the adjacent methylene, as opposed to the two adjacent methynes, to give desired 
tetracycle 285. The stereochemistry observed in 285 is predicted as a result of back 
face of the nucleophilic alkene preferentially attacking into the activated epoxide. 
This assumption is based on huge degree of steric hindrance that would need to be 
overcome in order for the top face of the alkene to attack (Scheme 82). 
Scheme 82. Predicted regiochemistry and stereochemistry of the desired 
intramolecular cyclisation of 283. 
 
This reaction was attempted under numerous conditions, summarised in Table 5 
below. Strong Lewis acids such as MeAlCl242, BF3.Et2O43 and SnCl444 are commonly 
employed to activate epoxides to nucleophilic attack by weak nucleophiles such as 
alkenes. When our substrate was treated with MeAlCl2 (Table 5, Entry 1), starting 
material was consumed instantly, but no cyclisation products were observed. The 
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major product was identified as aldehyde 286, the product of a 1,2-shift (also known 
as a Meinwald rearrangement45) of the alkyl group attached to the tertiary epoxide 
carbon, resulting in ring contraction. Treatment with BF3.Et2O (Table 5, Entry 2) 
again resulted in a fast reaction, with some aldehyde 286 isolated, but with new 
product ketone 287 isolated as the major product. 287 could be rationalised as a result 
of another Meinwald rearrangement in which hydride had undergone a 1,2-shift. 
When SnCl4 was employed (Table 5, Entry 3), no aldehyde product was isolated, and 
only a little of the undesired ketone. The major product was identified as cyclised 
substrate 288 as a single stereoisomer and regioisomer, containing a tetra-substituted 
alkene as opposed to the to the desired tri-substituted isomer. After extensive NMR 
studies we were unable to determine conclusively whether the double bond was 
positioned between the C-8 and C-14 centres or the C-8 and C-9 centres. Using TiCl4 
gave a similar result to SnCl4, but gave better recovery of the products (Table 5, 
Entry 4). Yamamoto’s hindered dialkylaluminium amides have been effective 
reagents for the rearrangement of epoxides to allylic alcohols,46 but it was hoped that 
we could utilise the bulky basic amide ligand to direct post-cyclisation deprotonation 
from the methylene centre. As it transpired, Me2AlN(i-Pr)2, prepared from LDA and 
Me2AlCl, gave a very similar result to MeAlCl2, delivering aldehyde 286 as the sole 
product (Table 5, Entry 5). With strong Lewis acids giving a large degree of 
unwanted 1,2-rearrangement, as well as some cyclisation, focus shifted to milder 
Lewis acids that might promote preferential cyclisation. Metal triflates are effective 
mild Lewis acids used in a variety of transformations.47 A variety of triflates were 
tested in cyclisation of 283 (Table 5, Entries 6-12). The M3+ triflates were ineffective 
in favouring cyclisation over alkyl/hydride migration, with only Yb(OTf)3 delivering 
cyclisation product, albeit as a minor product and still as the undesired regioisomer 
288 (Table 5, Entry 6). Zn(OTf)2 was more effective, delivering almost equal 
amounts of cyclisation and migration products in good recovery (Table 5, Entry 10). 
Monovalent triflates AgOTf and LiOTf were not sufficiently Lewis acidic to activate 
the epoxide substate, with no starting material consumed after stirring for a long 
period. With desired cyclisation product 285 still not observed, our attention turned to 
utilising BrØnsted acids to activate the epoxides instead. Phosphoric acid has been 
used to achieve similar cyclisations.48 When employed here (Table 5, Entry 13), 
H3PO4 again gave a mixture of the three previously observed products, slightly 
favouring cyclised 288. In contrast CSA, a slightly stronger organic acid, gave only 
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migration products (Table 5, Entry 14). An even stronger organic acid, TFA, gave the 
best result yet, with cyclisation product 288 delivered in 65 % yield, almost three 
times more abundant than the combined migration products (Table 5, Entry 15). 
Finally, the best result was achieved using organic superacid triflic acid, delivering 
288 in 68 % yield, and as the sole product (Table 5, Entry 16). 
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Table 5. Reaction conditions investigated for the intramolecular cyclisation of 283 
and products 286, 287, 288. 
 
Entry Reagenta Conditions Isolated Products 
1 MeAlCl2 CH2Cl2, –78 °C, 5 min 30 % 286 
2 BF3.Et2Ob CH2Cl2, –78 °C, 5 min 35 % 286, 50 % 287 
3 SnCl4 CH2Cl2, –78 °C, 5 min 18 % 287, 34 % 288 
4 TiCl4 CH2Cl2, –78 °C, 1 h 32 % 287, 51 % 288 
5 Me2AlN(i-Pr)2b PhMe, –78 °C!rt, 2 h 59 % 286 
6 Yb(OTf)3 CH2Cl2, 0 °C, 1 h 18 % 286, 43 %, 287, 22 % 288 
7 Sc(OTf)3 CH2Cl2, 0 °C, 30 min 55 % 287 
8 Bi(OTf)3 CH2Cl2, 0 °C, 10 min 12 % 286, 49 % 287 
9 In(OTf)3 CH2Cl2, 0 °C, 30 min 62 % 287 
10 Zn(OTf)2 CH2Cl2, rt, 18 h 10 % 286, 36 % 287, 42 % 288 
11 AgOTf CH2Cl2, rt, 18 h  No reaction 
12 LiOTf CH2Cl2, 0 °C!rt, 24 h No reaction 
13 H3PO4c CH2Cl2, rt, 18 h 19 % 286, 29 % 287, 35 % 288 
14 (-)-CSA CH2Cl2, –78 °C!rt, 2 h 22 % 286, 9 % 287 
15 TFA CH2Cl2, –78 °C, 2 h 17 % 286, 6 % 287, 65 % 288 
16 TfOH CH2Cl2, –78 °C, 2 h 68 % 288 
a) 1 equivalent unless otherwise stated; b) 2 equivalents; c) in excess as an 85 % aqueous solution. 
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Derivatives of 288 were synthesised in an attempt to produce compounds more suited 
to crystallisation, so that the cyclised structure could be unambiguously determined 
by X-ray crystallography (Scheme 83). 
Scheme 83. Synthesis of 288 derivatives 289 and 290. 
 
a) TBAF (2 equiv), THF, rt, 18 h; b) p-BrPhCOOH (2.0 equiv), DMAP (0.1 equiv), DIC (2.1 equiv), 
CH2Cl2, rt, o/n. 
Unfortunately, after numerous attempts under various conditions, crystals of 289 or 
290 could not be grown. Despite this disappointment we believed that the 
spectroscopic evidence obtained provided robust support for our assigned structure 
and so we continued under the assumption that our assignment was correct. In 
addition, we strongly suspected, though could not prove outright, that the isomer of 
288 in hand contained the C-C double bond between C8 and C14. Any attempts to 
isomerise this compound to the desired C8-C7 double bond would have resulted in an 
unwanted cis-fused ring system in the product, so the decision was taken to explore 
other routes.  
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2.1.11 Investigation of an alternative route to cyclised product 285 
Now that suitable conditions for preferential cyclisation of our epoxide substrate had 
been identified, measures had to be taken in order to direct the cyclised substrate to 
undergo proton elimination at the desired carbon centre. Silylated substrate 291 was 
proposed as a potential cyclisation substrate. It was predicted that if substrate 291 
underwent cyclisation, the silyl moiety would not only stabilise the transient 
!-carbocation 292, but preferentially act as the leaving group, given the greater 
capacity of a TMS group to stabilise positive charge. The result would be the desired 
cyclisation substrate 293 (Scheme 84). 
Scheme 84. Predicted regiochemistry of the intramolecular cyclisation of 291. 
 
Cyclisation substrate 292 could be prepared using a same route as before, 
incorporating exocyclic silylalkene 297, prepared from protected hydroxyketone 217, 
in place of the exocyclic methylene group incorporated previously (Scheme 85). 
Scheme 85. Retrosynthesis of epoxide 291.  
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2.1.11.1 Synthesis of allylic alcohol 297 
Literature precedent for converting ketones directly to silylalkenes is limited, and so 
our immediate proposal was to prepare 297 via lithiation of the bromoalkene 299, and 
subsequent treatment with TMSCl; compound 299 would be prepared from ketone 
298 under Wittig conditions. (Scheme 86) 
Scheme 86. Proposed synthesis of exocyclic silylalkene 297. 
 
We began by TES-protecting !-hydroxyketone 217 in excellent yield (Scheme 87). 
We chose TES-protection as this group could be later removed under mild oxidative 
conditions49 that would be more compatible with the silylalkene than the more 
strongly basic conditions required for TBS-removal. 
Scheme 87. TES-protection of !-hydroxyketone 217. 
 
a) TESCl (2 equiv), imidazole (2 equiv), CH2Cl2, 0°C"rt, 1 h. 
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The synthesis of bromoalkenes from C-25 analogues of Grundmann’s ketone has 
been reported,50 giving products as the E-isomer only. (Scheme 88) 
Scheme 88. Bromomethylenation of Grundmann’s ketone analogues.50 
 
We first tried bromomethylenation with bromomethyltriphenylphosphonium bromide 
and KOtBu as base, as these conditions had achieved the best results for other ketone 
analogues.50b Unfortunately, under these conditions we observed no conversion at all, 
perhaps due to greater hindrance of the ketone at the !-position. When the reaction 
was repeated using Trost’s original conditions50a using NaHMDS as base, an 
inseparable mixture of desired bromoalkene 301 (as only one isomer) and alkene 302 
(68 % and 19 % yield respectively, determined by 1H-NMR) was obtained. This 
mixture was then treated with t-BuLi, then TMSCl, to furnish the desired silylalkene 
303 in 98 % yield, still as an inseparable mixture with alkene 302, of which a further 
2 % yield had been produced during this step. Removal of the TES protecting group 
using catalytic DDQ in aqueous THF furnished pure silylallylic alcohol 297 after 
chromatography. This reaction is believed to be a single electron transfer process, 
going via an intermediate O-centred radical cation.49 At this stage, nOe studies 
showed that the isomer obtained was the unexpected E-isomer, with the alkenyl 
proton shown to be close in space to the equatorial H-9 proton (Scheme 89). 
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Scheme 89. Synthesis of E-silylalkene 297. 
 
a) bromomethyltriphenylphosphonium bromide (3 equiv), NaHMDS (2.75 equiv), THF, –60!–5°C, 
15 h; b) t-BuLi (2 equiv), TMSCl (2 equiv), Et2O/pentane, –78°C!rt, o/n; c) DDQ (0.1 equiv), 
10 % H2O in THF, 0°C!rt, o/n. 
The only literature example of direct conversion of exocyclic ketones to silyl alkenes 
found was achieved by employing an easily prepared "-lithioalkoxysilane Peterson 
reagent.51 When we attempted the reaction, starting material was consumed after 
stirring at rt overnight, but crude NMR of the isolate showed no alkenyl protons. The 
original paper postulates that endocylic isomers of the desired products can be 
removed by heating at 100 °C for 2 h. To our delight, after two hours in an oven at 
that temperature, two strong alkenyl peaks had begun to appear in the 1H-NMR 
spectrum. After chromatography, the desired silylalkene 303 was isolated cleanly in 
26 % yield as a 5:1 mixture of Z/E isomers. When repeated on a larger scale the yield 
was improved to 33 %, although the selectivity dropped to 3:2 Z/E. Heating the crude 
product at 100 °C for longer than 2 h only succeeded in diminishing the yield. Again, 
TES-deprotection using DDQ was achieved in 72 % yield. Further careful 
chromatography allowed the mixture to be enriched further, providing 297 in 41 % 
yield and 15:1 Z/E ratio, with a remaining 17:10 E/Z mixture in 31 % yield. (Scheme 
90) 
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Scheme 90. Synthesis of Z-silylalkene 297. 
 
a) TMSCH2SiMe2OMe (1.2 equiv), t-BuLi (1.2 equiv), pentane, –78°C!rt, o/n; b) DDQ (0.1 equiv), 
10 % H2O in THF, 0°C!rt, 18 h. 
2.1.11.2 Synthesis of carboxylic acid 307 
Again, our concern for the compatibility of the chemistry required to cleave a 
TBS-ether with the silylalkene moiety resulted in a change to the protection used on 
our carboxylic acid substrate. The PMB protecting group was selected as a suitable 
alternative. Attempted alkylation of alcohol 278 with sodium hydride and in situ 
generated p-methoxybenzyl iodide resulted in ester cleavage, with no PMB-ether 
formed. A second attempt using a catalytic amount of Lewis acid BF3.Et2O, and the 
trichloroacetimidate of p-methoxyybenzyl alcohol (PMBTCA) resulted in an 
intractable mixture of numerous products. A milder variant of this method was 
ultimately successful, using 3 mol% La(OTf)3 and PMBTCA52 to give the desired 
PMB-ether 304 in 89 % yield. A similar result could also be achieved with Sc(OTf)3. 
With the differentially protected diol 304 in hand we were in a position to use the 
same chemistry as for TBS ether 280 in order to complete the synthesis of carboxylic 
acid 261. Thus, ester methanolysis, coupling with 2-tosylacetic acid and Ireland-
Claisen rearrangement provided acid 307 in high yield. (Scheme 91) 
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Scheme 91. Synthesis of carboxylic acid 307. 
 
a) La(OTf)3.xH2O (0.05 equiv), PMBTCA (1.5 equiv), PhMe, rt, 40 min; b) KOH (2 equiv), MeOH, rt, 
15 h; c) 2-tosylacetic acid (1 equiv), DMAP (0.1 equiv), DIC (1.1 equiv), CH2Cl2, 0°C!rt, 3 h; d) 
Et3N (1.2 equiv), BSA (3 equiv), CH3CN, reflux, 6 h. 
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2.1.11.3 Synthesis of dCr substrates E/Z-308 
With both E and Z isomers of 297 in hand, silylalkene dCr substrates E-308 and Z-
308 were prepared separately by coupling with carboxylic acid 307 using 
DIC/DMAP, delivering the desired esters in good yield. (Scheme 92) 
Scheme 92. Synthesis of esters E-308 and Z-308. 
 
a) DMAP (0.1 equiv), DIC (1.1 equiv), CH2Cl2, rt, 48 h; b) DMAP (0.1 equiv), DIC (1.1 equiv), 
CH2Cl2, rt, 96 h. 
2.1.11.4 Attempted rearrangement of ester 308 
With the ester substrates in hand, the dCr reaction was attempted. E-308 was treated 
with BSA and KOAc before heating in the microwave. After 3!1 min at 120 °C, no 
starting material had been consumed. A further 3!1 min at 150 °C showed small 
amounts of new products forming in the TLC assay, but the reaction mixture still 
consisted predominantly of starting material. A further 3!1 min at 180 °C showed 
that E-308 had been largely consumed. Disappointingly, the desired rearrangement 
product 311 was not present. The two products isolated from this reaction were the 
result of elimination (309 in 60 % yield) followed by decarboxylation (310 in 56 % 
yield), with some remaining starting material. When the same reaction conditions 
were applied to Z-308, similar products were observed, with some remaining starting 
material. (Scheme 93) 
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Scheme 93. Attempted dCr of E-308 and Z-308. 
 
a) KOAc (0.25 equiv), BSA (15 equiv), microwave (3 x 1 min, 180 °C). 
E-308 was heated in the microwave in DMF in the presence of 0.2 equivalents of 
KOAc to assess whether the same unwanted reaction would occur. After heating for 
3!1 min at 180 °C, only starting material was returned. 
The rearrangement of 308 to carboxylic acid 312, under the Ireland-Claisen 
conditions used previously, was also attempted. 312 would then be subjected to a 
separate decarboxylation step to furnish the desired product 311. After heating E-308 
at 60 °C for 2 h, then under reflux for 2 h, no starting material had been consumed. 
An aliquot was taken from the reaction and subjected to microwave heating at 160 °C 
for 10 min, after which still no reaction was observed. A further 10 min at 180 °C 
saw E-308 consumed, but 1H-NMR analysis of the crude reaction mixture after 
workup showed only a mixture of unwanted by-products Z-309 and 310 (Scheme 94). 
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Scheme 94. Attempted Ireland-Claisen rearrangement of E-308. 
 
a) Et3N (1.2 equiv), BSA (3 equiv), CH3CN, microwave (160 °C, 3!1 min, then 180 °C 3!1 min). 
Intramolecular decarboxylative allylations of simple allyl "-sulfonylesters, essentially 
Pd-allyl variant of the dCr, have been reported.53 Rearrangement was attempted under 
the reported best conditions; heating the substrate in the presence of Pd2(dba)3 and 
ligand BINAP at 95 °C in PhMe. After 2 days, the reactions were stopped. Again, the 
only products isolated were 309 and 310 along with the return of remaining starting 
materials (Scheme 95). 
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Scheme 95. Attempted decarboxylative allylation of E-308 and Z-308. 
 
a) Pd2(dba)3 (0.05 equiv), BINAP (0.1 equiv), PhMe, 95 °C, 48 h. 
Decarboxylative allylation was also attempted using Pd(PPh3)4 at reflux in THF for 
48 h, both with and without pre-treatment of the substrate with NaH. Under both 
conditions, and for both isomers of 308, only starting material was returned. 
A report in the literature described PdII-catalysed Ireland-Claisen rearrangement of a 
pre-formed silyl ketene acetal, using PdCl2(CH3CN)2.54 Therefore, E-308 was 
submitted to these conditions, pre-treating with LDA and TMSCl to pre-form silyl 
ketene acetal 313, and subsequent treatment with PdCl2(CH3CN)2, followed by 
heating at reflux for 24 h. TLC assay showed some conversion. After workup and 
purification 36 % starting material was recovered, along with a complex mixture of 
products from the baseline equating to a 42 % mass recovery. Analysis by NMR 
spectroscopy and MS did not indicate the presence in this mixture of any of the 
desired carboxylic acid 312, or the decarboxylated form, 311 (Scheme 96). 
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Scheme 96. Attempted Pd-catalysed Ireland-Claisen rearrangement of 308. 
 
a) DIPA (1 equiv), n-BuLi (1 equiv), TMSCl, (1.1 equiv), THF, –78 °C!rt. 
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2.1.12 Investigation of Tsuji-Trost approach to 311 
With intramolecular palladium-catalysed allylations failing to yield the desired 
product, we decided to explore the intermolecular alternative under classic 
Tsuji-Trost allylation conditions.55 !-Sulfonylesters have been shown to act as 
competent nucleophiles in reactions with "-allyl palladium complexes to deliver 
homoallylic !-sulfonylesters.56 We proposed treating substrate 314 with Pd0 to 
produce "-allyl complex 315 that would react with an !-sulfonylester in the presence 
of base to give 316 regioselectively. Subsequent ester hydrolysis and decarboxylation 
would deliver desired substrate 311 (Scheme 97) 
Scheme 97. Proposed Tsuji-Trost approach to homoallylic sulfone 311. 
 
In order to test this hypothesis on a simple model substrate we prepared acetate ester 
317 and methyl carbonate 318 of allylic alcohol 223 under standard conditions. 
Methyl 2-tosylacetate was also prepared in good yield. (Scheme 98) 
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Scheme 98. Synthesis of Tsuji-Trost test substrates 317 and 318. 
 
a) pyridine (4 equiv), DMAP (0.05 equiv), Ac2O (1.2 equiv), rt, 3 h; b) pyridine (3 equiv), DMAP 
(0.05 equiv), methyl chloroformate (1.2 equiv), CH2Cl2, rt, 48 h; c) H2SO4, MeOH, reflux, 8 h. 
Firstly, acetate 317 in the presence of catalytic Pd(PPh3)4 was treated with the sodium 
salt of deprotonated methyl 2-tosylacetate (generated by pre-treating with NaH). 
After refluxing the mixture in THF for 48 h the reaction was stopped, with starting 
material still present in the TLC assay. The desired product 319 was isolated in 40 % 
yield, with 57 % starting material remaining. Carbonate 318, a more reactive 
substrate under Tsuji-Trost conditions, was treated with Pd(PPh3)4 in the presence of 
methyl 2-tosylacetate (pre-treatment with base was not required as formation of the 
!-allyl complex produces methoxide in situ). After refluxing for 5 h, TLC assay 
appeared to show reaction completion. The desired product 319 was isolated in 32 % 
yield, however the major product was elimination product 320 in 46 % yield, with 22 
% starting material also remaining. (Scheme 99) 
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Scheme 99. Tsuji-Trost reaction of 317 and 318 with methyl 2-tosylacetate. 
 
a) Pd(PPh3) (0.05 equiv), PPh3 (0.1 equiv), NaH (1.1 equiv), methyl 2-tosylacetate (1.1 equiv), THF, 
reflux, 48 h; b) Pd(PPh3) (0.05 equiv), methyl 2-tosylacetate (1.1 equiv), THF, reflux, 5 h. 
Given the slow conversion of acetate 317 under these conditions, we chose to pursue 
optimisation of the reaction of carbonate 318. It was believed that performing the 
reaction at milder temperatures might improve the yield. However, when repeated at 
60 °C no conversion was observed. To our dismay, we were also unable to repeat the 
previous result either. When treated at reflux as previously, 318 underwent no 
conversion at all. Despite preparing fresh methyl 2-tosylacetate, repurifying 318, 
using new samples of Pd(PPh3)4, and even preparing Pd(PPh3)4 in situ from Pd(OAc)2 
and PPh3, failed to give conversion. At this stage there was no time left in the 
laboratory to continue investigating this new approach and the reaction was 
abandoned. 
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2.2 Summary 
Our initial proposal for the total synthesis of 1!,25-dihydroxylumisterol involved two 
late-stage key steps. The first, a dCr reaction to give 1,6-heptadiene 263, was 
ultimately successful, albeit via an alternative ester substrate to that initially 
anticipated. The interesting study of model dCr substrates that led to this success gave 
us some insight into the relative reactivities of different allyl moieties under dCr 
conditions. The dCr substrate, ester 262, was prepared in good yield via the 
convergent coupling of allylic alcohol 223 and carboxylic acid 261, both having been 
prepared in high-yielding synthetic routes. 
The continuation of the synthesis to epoxide substrate 283 was also successful and, 
through reagent screening, we were able to identify suitable conditions for the second 
key step, a cyclisation to form the steroid B-ring, although the product delivered was 
an undesired isomer 288. A proposal to direct this reaction to yield the desired isomer 
led to the successful, if challenging, synthesis of silylated ester substrates E-308 and 
Z-308. Attempts were made to get them to undergo sigmatropic rearrangement to 
deliver the desired silyl-1,6-heptadiene 311 under dCr and a variety of other 
conditions, however none were successful. 
Finally, preliminary investigations into forming desired TMS-diene 311 via Pd-
catalysed intermolecular allylation chemistry showed some promise, but more 
investigation would be required for a full conclusion to be drawn. 
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2.3 Future Work 
Had the intermolecular allylation chemistry failed to deliver the desired product, an 
alternative approach to 1!,25-dihydroxylumisterol was proposed that circumvented 
the use of a Claisen rearrangement altogether, but there was not sufficient laboratory 
time left to test the hypothesis. 
It was proposed that alternative cyclisation substrate 322 (Scheme 100) could be 
prepared from Sonogashira coupling of vinyl triflate 324 and alkyne 325, followed by 
selective cis-hydrogenation of intermediate enyne 323. It was hoped that the 
cyclisation would lead to the desired alkene isomer, driven by formation of the 
conjugated diene in 1!,25-dihydroxylumisterol. Vinyl triflate 324 would be easily 
accessible from Grundmann’s ketone 216, and synthesis of alkynyl epoxide 325 
could be envisioned from previously made allylic alcohol 243 by a pathway using 
hydroxy-directed epoxidation followed by conversion of alcohol to tosylate 326. 
Treatment with an ethynyl organometallic reagent would yield 325. 
Scheme 100. Proposed alternative synthesis of 1!,25-dihydroxylumisterol. 
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3.1 General Laboratory Procedures 
 
All reactions were performed under an atmosphere of nitrogen unless otherwise 
stated. Melting points were determined using Stuart Scientific SMP1 melting point 
apparatus and are uncorrected. Proton (1H) and carbon (13C) nuclear magnetic 
resonance spectra were recorded on a Bruker AV–400 spectrometer. Chemical shifts 
are reported in parts per million (ppm) and are referenced relative to the residual 
proton–containing solvent (1H NMR: 7.26 ppm for CDCl3; 13C NMR: 77.0 ppm for 
CDCl3) or in the case of 31P NMR, to an external standard (H3PO4). Coupling 
constants (J) are reported to the nearest 0.5 Hertz. Infrared spectra were recorded on a 
Perkin–Elmer Spectrum RX FT–IR System spectrometer with samples prepared as 
thin films on NaCl plates. Mass spectra (CI, ES and ESI) were recorded using 
Micromass AutoSpec–Q, Micromass Platform II or Micromass AutoSpec Premier 
instruments. Elemental analyses were performed at the microanalytical laboratories of 
the London Metropolitan University. Optical rotation were determined on an Optical 
Activity AA-10 Automatic polarimeter at 589nm (Na D-line) with a path length of 1 
dm. Concentrations (c) are quoted in g/100 mL and specific rotations ([!]DT) are 
quoted in 10-1 deg cm2 g-1 at the specified temperature. Analytical thin layer 
chromatography (TLC) was performed on aluminium plates pre-coated with silica gel 
(0.2 mm, Merck 60 F254) and development was effected with UV light or potassium 
permanganate as appropriate. Flash column chromatography was performed using 
BDH (40-63 !m) silica gel according to the method of W.C Still et al.1 Kugelrohr 
distillations were performed using a Büchi D56 Kugelrohr oven and controller 
system. Standard solvents were distilled under nitrogen prior to use; THF from 
sodium–benzophenone ketyl, CH2Cl2 and acetonitrile from CaH2 and toluene from 
sodium. All other solvents used were distilled prior to use. Petrol refers to petroleum 
ether b.p. 40–60 °C. Potassium acetate was oven-dried at 120 ˚C for several days 
prior to use. Microwave reactions were performed in a Biotage Initiator and cooled 
using compressed air (4 bar). Ozone gas was generated from oxygen gas using a 
Triogen LAB2B ozone generator. 
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3.2 Individual Procedures 
 
De-A,B-cholestan-8-one (Windaus-Grundmann ketone) (216) 
 
 
 
Ozone was bubbled through a solution of (+)-vitamin D3 (215) (10.0 g, 26.0 mmol, 1 
equiv) in MeOH (520 mL) at –78 ºC until a blue colour persisted (~90 min). The 
solution was flushed with nitrogen until the blue colour abated. Me2S (9.50 mL, 130 
mmol, 7 equiv) was added and the mixture allowed to warm to rt overnight. MeOH 
was removed under reduced pressure, and the remaining oil taken up in Et2O (600 
mL) and washed with H2O (3 x 200 mL). The aqueous layers were back-extracted 
with Et2O (2 x 200 mL). The combined organic layers were dried (Na2SO4) and 
concentrated under reduced pressure. Silica gel chromatography (5 % Et2O in petrol) 
gave 216 as a colourless oil (6.74 g, 98 %); Rf 0.50 (10 % Et2O in petrol); [!]D25 +6.1 
(c 0.89, CHCl3); !max (film) 2955, 2870, 1715, 1464, 1380 cm-1; "H (CDCl3, 400 
MHz) 2.46 (1H, m, H-14), 2.34"0.99 (22H, m), 0.96 (3H, d, J 6.0 Hz, H-21), 0.89 
(3H, d, J 2.0 Hz, H-26/27), 0.87 (3H, d, J 2.0 Hz, H-26/27), 0.66 (3H, s, H-18); "C 
(CDCl3, 100 MHz) 212.2 (C-8), 62.0 (C-14), 56.7 (C-9), 49.9 (C-13), 41.0, 39.4, 
39.0, 36.0, 35.5, 28.0, 27.5, 24.1, 23.8, 22.8, 22.5, 19.1, 18.7 (C-21), 12.5 (C-18); m/z 
(EI) 264 [M]+, 249, 221. In agreement with published data.2 
 
H
HO
H
HO
H
215 216
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8-[(Trimethylsilyl)oxy]des-A,B-8(9)-cholestene (222) 
 
 
 
To diisopropylamine (0.35 mL, 2.46 mmol, 1.3 equiv) in THF (10 mL) at –78 ºC was 
added n-BuLi (0.91 mL, 2.50 M in hexanes, 2.27 mmol, 1.2 equiv). After 45 min 
stirring, TMSCl (0.26 mL, 2.08 mmol, 1.1 equiv) was added. After a further 5 min, a 
solution of 216 (500 mg, 1.89 mmol, 1 equiv) in THF (1 mL) was added dropwise. 
Stirring was continued at –78 ºC for 1 h. After warming to rt the reaction mixture was 
diluted with Et2O (100 mL) and washed with sat. NaHCO3 (50 mL) and brine (50 
mL), dried (Na2SO4) and concentrated under reduced pressure to give 222 as a 
colourless oil (628 mg, >99 %); Rf 0.95 (5 % Et2O in petrol); !max (film) 2951, 1716, 
1658, 1378, 1252, 1206 cm-1; "H (CDCl3, 400 MHz) 4.66 (1H, m, H-9), 2.28!0.98 
(18H, m), 0.95 (3H, d, J 6.5 Hz, H-21), 0.90 (3H, d, J 2.0 Hz, H-26/27), 0.88 (3H, d, 
J 2.0 Hz, H-26/27), 0.75 (3H, s, H-18), 0.19 (9H, s, CH3Si); "C (CDCl3, 100 MHz) 
151.3 (C-9), 101.6 (C-8), 54.8 (C-14), 51.8, 43.7 (C-13), 39.5, 36.2, 36.1, 28.4, 28.0, 
23.9, 23.4, 22.8, 22.6, 22.1, 18.7 (C-21), 11.3 (C-18), 0.4 (CH3Si); m/z (EI) 337 
[M+H]+. In agreement with published data.3 
O H
C8H17
Me3SiO
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C8H17
216 222
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De-A,B-9!-hydroxycholestan-8-one (217) 
          
 
 
Ozone was bubbled through a solution of 222 (17.3 g, 51.4 mmol, 1 equiv) in MeOH 
(700 mL) and CH2Cl2 (150 mL) at –78 ºC until a blue colour persisted. The solution 
was flushed with nitrogen until the blue colour abated. Me2S (19.1 mL, 260 mmol, 5 
equiv) was added and the mixture allowed to warm to rt overnight. MeOH was 
removed under reduced pressure, and the remaining oil taken up in Et2O (400 mL) 
and washed with H2O (3 x 150 mL). The aqueous layers were back-extracted with 
Et2O (2 x 250 mL). The combined organic layers were dried (Na2SO4) and 
concentrated under reduced pressure. Silica gel chromatography (10 % EtOAc in 
petrol) gave 217 as a colourless oil (8.24 g, 57 %); Rf 0.50 (10 % EtOAc in petrol); 
[!]D25 –22.4 (c 1.20, CHCl3); !max (film) 3418, 2954, 2926, 2868, 1719, 1466, 1383, 
1260, 1014 cm-1; "H (CDCl3, 400 MHz) 4.01 (1H, t, J 3.5 Hz, H-8), 3.15 (1H, dd, 
J 12.0, 4.5 Hz, H-14), 2.58 (1H, bs, OH), 2.08"1.00 (17H, m), 0.96 (3H, d, J 6.5 Hz, 
H-21), 0.90 (3H, d, J 2.0 Hz, H-26/27), 0.88 (3H, d, J 2.0 Hz, H-26/27), 0.65 (3H, s, 
H-18); "C (CDCl3, 100 MHz) 212.3 (C-8), 74.4 (C-9), 56.8 (C-14), 50.2 (C-13), 39.4, 
35.9, 35.5, 34.1, 31.4, 28.0, 27.6, 23.8, 22.8, 22.5, 18.6 (C-21), 12.9 (C-18); m/z (EI) 
280 [M]+, 221, 168. In agreement with published data.4 
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De-A,B-cholestan-8-onyl-9!-2-tosylacetate (218) 
        
 
 
To 217 (110 mg, 0.39 mmol, 1 equiv) and 2-tosylacetic acid (85 mg, 0.39 mmol, 1 
equiv) in CH2Cl2 (2 mL) at 0 ºC was added DMAP (2 mg, 0.02 mmol, 0.05 equiv) 
followed by DIC (67 µL, 0.43 mmol, 1.1 equiv) dropwise. After 15 min the reaction 
mixture was filtered through Celite® and the filtrate concentrated under reduced 
pressure. Silica gel chromatography (10 % EtOAc in petrol) gave 218 as a colourless 
oil (170 mg, 91 %); Rf 0.25 (10 % EtOAc in petrol); [!]D25 –11.4 (c 0.95, CHCl3); 
!max (film) 2955, 2932, 2870, 1747, 1729, 1598, 1469, 1385, 1330, 1267, 1151, 1085 
cm-1; "H (CDCl3, 400 MHz) 7.79 (2H, d, J 8.0 Hz, o-Ts), 7.39 (2H, d, J 8.0 Hz, m-
Ts), 4.90 (1H, t, J 3.0 Hz, H-9), 4.15 (2H, s, TsCH2), 2.92, (1H, dd, J 12.0, 4.5 Hz, H-
14), 2.48 (3H, s, CH3Ar), 2.16"1.00 (17H, m), 0.96 (3H, d, J 6.5 Hz, H-21), 0.89 (3H, 
d, J 2.0 Hz, H-26/27), 0.87 (3H, d, J 2.0 Hz, H-26/27), 0.64 (3H, s, H-18); "C (CDCl3, 
100 MHz) 205.2 (C-8), 161.3 (CO-ester), 145.7 (Ar), 135.5 (Ar), 130.0 (m-Ts), 128.4 
(o-Ts), 78.4 (C-9), 61.1 (TsCH2), 58.2 (C-14), 56.8, 51.1 (C-13), 39.4, 35.9, 35.5, 
34.3, 29.6, 28.0, 27.5, 23.8, 22.8, 22.5, 21.7 (CH3Ar), 18.7, 18.5, 12.3 (C-18); m/z 
(CI) 494 [M+NH4]+, 476 [M]+, 322, 174 (Found [M+NH4]+, 494.2944. C27H40O5S 
requires [M+NH4]+, 494.2935). 
OO H
C8H17
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217
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!-Lactone (226) 
 
 
 
To 217 (675 mg, 2.41 mmol, 1 equiv) and 2-tosylacetic acid (516 mg, 2.41 mmol, 1 
equiv) in CH2Cl2 (5 mL) at 0 ºC was added DMAP (15 mg, 0.12 mmol, 0.05 equiv) 
followed by DIC (412 µL, 2.65 mmol, 1.1 equiv) dropwise. After 30 min the reaction 
mixture was filtered through Celite® and the filtrate concentrated under reduced 
pressure. Silica gel chromatography (10 % EtOAc in petrol) gave 226 as a white 
powder (743 mg, 65 %); Rf 0.60 (10 % EtOAc in petrol); mp 180-182 °C (decomp.); 
["]D25 +52.6 (c 0.57, CHCl3); !max (film) 3486, 2950, 2926, 2867, 1760, 1597, 1470, 
1330, 1214, 1184, 1140, 1084, 1008 cm-1; "H (CDCl3, 400 MHz) 7.83 (2H, d, J 
8.0Hz, o-Ts), 7.41 (2H, d, J 8.0 Hz, m-Ts), 4.80 (1H, m, H-9), 3.90 (1H, s, OH), 3.75 
(1H, s, TsCH), 2.50 (3H, s, CH3Ar), 2.11#0.96 (14H, m), 0.94 (3H, s, C-18), 0.91 
(3H, d, J 6.5 Hz, C-21), 0.89 (3H, d, J 2.0 Hz, H-26/27), 0.87 (3H, d, J 2.0 Hz, H-
26/27); "C (CDCl3, 100 MHz) 166.5 (CO), 146.4 (Ar), 135.0 (Ar), 130.0 (m-Ts), 
129.2 (o-Ts), 82.3 (C-9), 78.6 (C-8), 71.2 (TsCH), 56.3 (C-14), 52.1, 41.8, 39.4, 35.8, 
35.2, 33.0, 28.0, 26.4, 23.7, 22.8, 22.5, 21.9 (CH3Ar), 18.8, 18.5, 12.1 (C-18); m/z 
(CI) 494 [M+NH4]+, 476 [M]+, 322, 174 (Found [M+NH4]+ ,494.2944. C27H40O5S 
requires [M+NH4]+, 494.2935). 
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De-A,B-8-methylenecholestane (227) 
 
 
 
Method A: To a slurry of methyltriphenylphosphonium iodide (397 mg, 0.98 mmol, 
1.3 equiv) in THF (4 mL) at 0 ºC was added n-BuLi (425 µL, 0.83 mmol, 1.1 equiv) 
dropwise. After 30 min, 216 (200 mg, 0.76 mmol, 1 equiv) in THF (1 mL) was added 
dropwise. The reaction mixture was stirred at 0 ºC for 15 min, then rt for 4 h. Water 
(5 mL) was added and the mixture extracted with Et2O (3 x 10 mL). The combined 
organic layers were dried (Na2SO4) and concentrated under reduced pressure. The 
crude oil was passed through a short silica gel plug, eluting with petrol, to afford 227 
as a colourless oil (162 mg, 81 %). 
Method B: A round-bottomed flask fitted with reflux condenser and covered in foil 
was charged with 216 (200 mg, 0.76 mmol, 1 equiv) and Cp2TiMe2 (7.3 mL, 5 % in 
PhMe/THF, 1.52 mmol, 2 equiv). The reaction mixture was heated at 65 ºC for 48 h. 
Petrol (25 mL) was added and the reaction mixture filtered through Celite® to remove 
titanium solids. The filtrate was passed through a silica gel plug, eluting with petrol, 
to afford 227 as a colourless oil (167 mg, 84 %). 
Rf 1.00 (petrol); [!]D25 +68.4 (c 0.93, CHCl3); !max (film) 2951, 2930, 2869, 1651, 
1468, 1378 cm-1; "H (CDCl3, 400 MHz) 4.75 (1H, s, C=CH2), 4.48 (1H, s, C=CH2), 
2.34"2.24 (1H, m), 2.06"1.83 (4H, m), 1.69"0.99 (15H, m), 0.95 (3H, d, J 6.0 Hz, 
H-21), 0.89 (3H, d, J 2.0 Hz, H-26/27), 0.87 (3H, d, J 2.0 Hz, H-26/27), 0.58 (3H, s, 
H-18); "C (CDCl3, 100 MHz) 149.7 (C-8), 105.0 (C=CH2), 56.4 (C-17), 55.4 (C-14), 
45.1 (C-13), 40.2, 39.5, 36.2, 36.1, 35.5, 28.0, 27.7, 23.9, 23.8, 22.8, 22.6, 22.3, 18.8 
(C-21), 11.7 (C-18); m/z (CI) 280 [M+NH4]+, 263 [M]+, 149 (Found [M+H]+, 
263.2732. C19H34 requires [M+H]+, 263.2739). In agreement with published data.5 
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De-A,B-9!-(tert-butyldimethylsilyloxy)cholestan-8-one (228) 
 
 
 
To 217 (4.00 g, 14.3 mmol, 1 equiv) in CH2Cl2 (50 mL) at 0 ºC was added imidazole 
(2.92 g, 42.79 mmol, 3 equiv), followed after 5 min by 
tert-butyldimethylsilylchloride (6.45 g, 42.8 mmol, 3 equiv). The reaction mixture 
was stirred at rt for 18 h then diluted with CH2Cl2 (200 mL), washed with H2O (100 
mL) and brine (100 mL), dried (MgSO4) and concentrated under reduced pressure. 
Purification by silica gel chromatography (0-20 % EtOAc in heptane) afforded 228 as 
a colourless oil (5.20 g, 92 %); Rf 0.90 (5 % EtOAc in petrol); [!]D24 –19.0 (c 1.40, 
CHCl3); !max (film) 2954, 2929, 2858, 1724, 1464, 1384, 1363, 1252, 1083, 1034 
cm-1; "H (CDCl3, 400 MHz) 3.89 (1H, bm, H-9), 3.13 (1H, dd, J 12.0, 7.0 Hz, H-14), 
1.98-1.80 (5H, m), 1.78-1.65 (1H, m), 1.56-0.97 (11H, m), 0.94 (3H, d, H-21), 0.88 
(9H, s, C(CH3)3), 0.87 (6H, m, H-26/27), 0.59 (3H, s, H-18), 0.06 (3H, s, CH3Si), 
0.00 (3H, s, CH3Si); "C (CDCl3, 100 MHz) 211.06 (C-8), 75.5 (C-9), 56.8 (C-14), 
56.5 (C-17), 39.5 (C-13), 36.1, 35.6, 34.2, 32.9, 31.9, 29.0, 28.0, 27.6, 25.7 
((CH3)3CSi), 23.9, 22.8, 22.7, 22.6, 18.7, 18.5, 18.0, 14.1, 12.1 (C-18), –4.9 (CH3Si), 
–5.0 (CH3Si); m/z (CI) 412 [M+NH4]+, 395 [M+H]+, 337, 280 [M+NH4-TBSOH]+ 
(Found [M+H]+, 395.3358. C24H46O2Si requires [M+H]+, 395.3345). 
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De-A,B-9!-(tert-butyldimethylsilyloxy)-8-methylenecholestane (229) 
 
 
 
To a suspension of methyltriphenylphosphonium iodide (1.29 g, 3.20 mmol, 1.3 
equiv) in THF (12 mL) at 0 ºC was added n-BuLi (1.26 mL, 2.15 M in hexanes, 2.71 
mmol, 1.1 equiv) dropwise. The mixture was stirred at 0 ºC for 30 mins before 
dropwise addition of 228 (971 mg, 2.46 mmol, 1 equiv) in THF (5 mL). The reaction 
mixture was stirred at 0 ºC for 1 h then diluted with Et2O (200 mL), washed with H2O 
(200 mL) then brine (200 mL), dried (MgSO4) and concentrated under reduced 
pressure. Purification by silica gel chromatography (Petrol) afforded 229 as a 
colourless oil (865 mg, 90 %); Rf 1.00 (5 % EtOAc in petrol); [!]D22 +9.5 (c 1.40, 
CHCl3); !max (film) 2951, 2930, 2858, 1655, 1470, 1379, 1361, 1341, 1251, 1070, 
1036 cm-1; "H (CDCl3, 400 MHz) 4.79 (1H, s, C=CH2), 4.48 (1H, s, C=CH2), 4.12 
(1H, m, H-9), 2.44 (1H, m, H-14), 1.86 (1H, m), 1.69-1.56 (3H, m), 1.53-0.93 (13H, 
m), 0.89 (3H, d, J 6.0 Hz, H-21), 0.84 (6H, m, H-26/27) 0.83 (9H, s, (CH3)3Si), 0.49 
(3H, s, H-18), 0.00 (3H, s, CH3Si), –0.05 (3H, s, CH3Si); "C (CDCl3, 100 MHz) 151.3 
(C-8), 106.7 (C=CH2), 73.1 (C-9), 56.3 (C-17), 49.4 (C-14), 45.1 (C-13), 39.5, 36.2, 
34.7, 32.1, 28.0, 27.8 ((CH3)3CSi), 25.8, 24.0, 22.9, 22.6, 21.8, 18.8, 18.1, 11.2 (C-
18), –4.6 (CH3Si), –5.1 (CH3Si); m/z (CI) 410 [M+NH4]+, 335, 261, 230 (Found 
[M+H]+, 393.3548. C25H48OSi requires [M+H]+, 393.3552). 
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De-A,B-9!-hydroxy-8-methylenecholestane (223) 
 
 
 
To 229 (3.95 g, 10.1 mmol, 1 equiv) in THF (21 mL) was added 
tetrabutylammonnium fluoride trihydrate (9.52 g, 30.2 mmol, 3 equiv). The reaction 
mixture was stirred at rt for 72 h, then diluted with EtOAc, washed with H2O, dried 
(MgSO4) and concentrated under reduced pressure. Purification by silica gel 
chromatography (0-15 % EtOAc in heptane) afforded 223 as a colourless waxy solid 
(2.65 g, 95 %); mp 34-38 ºC; Rf 0.75 (10 % EtOAc in petrol); [!]D25 +22.2 (c 1.20, 
CHCl3); !max (film) 3234, 2949, 2868, 1652, 1467, 1377, 1334, 1017, 959, 909 cm-1; 
"H (CDCl3, 400 MHz) 4.88 (1H, s, C=CH2), 4.52 (1H, s, C=CH2), 4.15 (H-9), 2.38 
(1H, m, H-14), 2.07 (1H, s, OH), 1.82 (1H, m), 1.74-1.53 (4H, m), 1.50-0.88 (14H, 
m), 0.83 (3H, d, J 6.0 Hz, H-21), 0.78 (3H, d, J 2.0 Hz, H-26/27), 0.76 (3H, d, J 2.0 
Hz, H-26/27), 0.45 (3H, s, H-18); "C (CDCl3, 100 MHz) 150.8 (C-8), 108.8 (C=CH2), 
72.6 (CHOH), 56.2, 49.3, 45.1 (C-13), 39.5, 36.1, 36.1, 34.6, 30.4, 28.0, 27.6, 23.9, 
22.8, 22.6, 22.0, 18.8 (C-21), 11.0 (C-18); m/z (CI) 296 [M+NH4]+, 278 [M]+, 261 
(Found [M+NH4]+, 296.2957. C19H34O requires [M+NH4]+, 296.2954). 
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De-A,B-8-methylenecholestan-9!-yl 2-tosylacetate (219) 
 
 
 
To a solution of 223 (725 mg, 2.60 mmol, 1 equiv) and 2-tosylacetic acid (560 mg, 
2.60 mmol, 1 equiv) in CH2Cl2 (5 mL) at 0 ºC was added DMAP (15 mg, 0.13 mmol, 
0.05 equiv) followed by dropwise addition of DIC (450 µL, 2.86 mmol, 1.1 equiv). 
The reaction mixture was stirred at 0 ºC fo 30 mins before diluting with Et2O (50 mL) 
and filtering through Celite®, further washing the solids with Et2O (10 mL). The 
filtrate was concentrated under reduced pressure and purified by silica gel 
chromatography (10% EtOAc in petrol) to afford 219 as a colourless oil (943 mg, 76 
%); Rf 0.60 (10% EtOAc in petrol); [!]D23 +32.3 (c 1.10, CHCl3); !max (film) 2953, 
2932, 2870, 1736, 1654, 1598, 1466, 1332, 1275, 1151, 1086 cm-1; "H (CDCl3, 400 
MHz) 7.82 (2H, d, J 8.0 Hz, o-Ts), 7.36 (2H, d, J 8.0 Hz, m-Ts), 5.33 (1H, s, H-9), 
5.08 (1H, s, C=CH2), 4.76 (1H, s, C=CH2), 4.10 (2H, s, TsCH2), 2.47 (3H, s, CH3Ar), 
2.17 (1H, m, H-14), 1.98–0.99 (17H, m), 0.93 (3H, d, J 6.0 Hz, H-21), 0.90 (3H, d, J 
2.0 Hz, H-26/27), 0.88 (3H, d, J 2.0 Hz, H-26/27), 0.55 (3H, s, H-18); "C (CDCl3, 100 
MHz) 161.6 (CO), 145.3 (C=CH2), 145.0 (Ar), 135.8 (Ar), 129.8 (m-Ts), 128.5 (o-
Ts), 112.4 (C=CH2), 77.1 (C-9), 61.4 (TsCH2), 56.0, 50.3 (C-14), 44.6, 39.5, 36.1, 
34.9, 28.2, 28.0, 27.6, 23.9, 22.8, 22.6, 21.9, 21.8 (CH3Ar), 18.8, 11.1 (C-18); m/z 
(CI) 492 [M+NH4]+, 476 [M+H]+, 391, 338, 261, 188, 174 (Found [M+NH4]+, 
492.3138. C28H42O4S requires [M+NH4]+, 492.3148). 
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3-(Des-A,B-8(9)-cholesten-8-yl)-2-tosylpropanoic acid (220) 
 
 
 
To 219 (500 mg, 1.05 mmol, 1 equiv) in CH3CN (3.5 mL) was added Et3N (176 µL, 
1.26 mmol, 1.2 equiv) and BSA (773 µL, 3.16 mmol, 3 equiv). The mixture was 
heated to 60 ºC and stirred for 30 min. The mixture was then diluted with EtOAc (20 
mL) and washed with 2 N HCl (5 mL), then dried (Na2SO4) and concentrated under 
reduced pressure. Purification by silica gel chromatography (20 % EtOAc in petrol + 
10 % MeOH + 1 % AcOH) afforded a 2:1 mixture of C-Ts epimers of 220 as a white 
foamy solid (423 mg, 85 %); Rf 0.70 (15 % EtOAc in petrol + 10% MeOH + 1 % 
AcOH); mp 58-60 °C; !max (film) 3419, 2955, 1732, 1598, 1468, 1381, 1322, 1149, 
1086 cm-1; "H (CDCl3, 400 MHz) 7.81 (2H, m, o-Ts), 7.37 (2H, m, m-Ts) 5.30 (1H, s, 
H-9 major), 5.26 (1H, s, H-9 minor), 4.12 (1H, m, CHTs major), 4.08 (1H, m, CHTs 
minor); 2.47 (3H, s, CH3Ar), 2.71–2.44 (2H, m), 2.10–1.81 (5H, m), 1.64–0.90 (13H, 
m), 0.92 (3H, d, J 6.5 Hz, H-21), 0.90 (3H, d, J 2.0 Hz, H-26/27), 0.88 (3H, d, J 2.0 
Hz, H-26/27), 0.62 (3H, s, H-18); "C (CDCl3, 100 MHz) 170.0 (CO), 145.6 (Ar), 
133.9 (Ar), 132.8 (C-8 major), 132.3 (C-8 minor), 129.8 (m-Ts), 128.4 (o-Ts), 124.3 
(C-9 major), 123.3 (C-9 minor), 69.8 (CH-Ts), 54.3, 51.1, 49.4, 42.4, 42.3, 36.1, 35.8, 
32.9, 31.5, 28.2, 28.0, 24.6, 23.8, 22.8, 22.5, 21.7 (CH3Ar), 18.7 (C-21), 11.1 (C-18); 
m/z (CI) 448 [M-CO2+NH4]+, 174 (Found C, 70.74; H, 8.84%. C28H42O4S requires C, 
70.85; H, 8.92%). 
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 (±)-Ethyl 3-hydroxy-4-methylpent-4-enoate (234) 
 
 
 
To a stirred solution of diisopropylamine (10.6 mL, 75.8 mmol, 1.2 equiv) in THF 
(60 mL) at !78 °C was added n-BuLi (29.6mL, 2.25M in hexanes, 66.7 mmol, 1.1 
equiv) dropwise. After 15 min EtOAc (6.50 mL, 66.70 mmol, 1.1 equiv) was added 
dropwise. After a further 30 min methacrolein (233) (5.00 mL, 60.64 mmol, 1 equiv) 
was added dropwise. The reaction mixture was stirred for 90 min, allowing it to warm 
to !30 °C, before being poured onto an ice-cold mixture of sat. NH4Cl (100 mL) and 
EtOAc (200 mL). After 10 min vigorous stirring the organic layer was separated, and 
the aqueous layer further extracted with EtOAc (2 x 100 mL). The combined organic 
layers were dried (Na2SO4), concentrated under reduced pressure to give a yellow oil 
which was distilled under reduced pressure to give 234 (9.42 g, 98 %) as a colourless 
oil; Rf 0.45 (10 % EtOAc in petrol); !max (film) 3459, 2982, 1738, 1651, 1372, 1163, 
1023 cm-1; "H (CDCl3, 400 MHz) 5.03 (1H, s, C=CH2), 4.88 (1H, s, C=CH2), 4.48 
(1H, m, CHOH), 4.18 (2H, q, J 7.0 Hz, CH2O), 3.05 (1H, br s, OH), 2.57 (2H, m, 
CH2CO2Et), 1.76 (3H, s, CH3C=C), 1.28 (3H, t, J 7.0 Hz, CH3CH2); "C (CDCl3, 100 
MHz) 172.6 (CO), 145.5 (C=CH2), 111.4 (C=CH2), 71.6 (CHOH), 60.9 (CH2O), 40.2 
(CH2CO2Et), 18.3 (CH3C=C), 14.3 (CH3CH2); m/z (CI) 334, 246, 176 [M+NH4]+, 
159 [M+H]+, 141. In agreement with published data.6 
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(±)-Ethyl 3-(2-methoxy-2-propyloxy)-4-methylpent-4-enoate (235) 
 
 
 
To 234 (1.00 g, 6.32 mmol, 1 equiv) in 2-methoxypropene (32 mL) at 0 °C was added 
PPTS. The reaction was allowed to warm to rt and stirred for 90 min. The reaction 
mixture was diluted with CH2Cl2 (100 mL) and washed with water (50 mL) and brine 
(50 mL), dried (Na2SO4) and concentrated under reduced pressure. Silica gel 
chromatography (5 % EtOAc in petrol) gave 235 as a colourless oil (1.24 g, 85 %); Rf 
0.80 (10 % EtOAc in petrol); !max (film) 2988, 2943, 1739, 1651, 1446, 1372, 1209, 
1156, 1075, 1030 cm-1; "H (CDCl3, 400 MHz) 4.96 (1H, s, C=CH2), 4.84 (1H, s, 
C=CH2), 4.48 (1H, t, J 7.0 Hz, CHOMIP), 4.12 (2H, dq, J 7.0, 2.0 Hz, CH2O), 3.18 
(3H, s, CH3O), 2.55 (2H, m, CH2CO2Et), 1.76 (3H, s, CH3C=C), 1.36 (3H, s, Me), 
1.33 (3H, s, Me), 1.26 (3H, t, J 7.0 Hz, CH3CH2); "C (CDCl3, 100 MHz) 171.0 (CO), 
145.9 (C=CH2), 112.4 (C=CH2), 101.1 (C(CH3)2OMe) 72.0 (CHOMIP), 60.4 
(CH2O), 49.3 (CH3O), 41.2 (CH2CO2Et), 25.2 (Me), 25.0 (Me), 17.1 (CH3C=C), 14.2 
(CH3CH2). 
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(±)-Ethyl 3-(2-methoxy-2-propyloxy)-4-methylpent-4-enal (236) 
 
 
 
To 235 (250 mg, 1.09 mmol, 1 equiv) in CH2Cl2 (2 mL) at –78ºC was added 
DIBAL-H (0.95 mL, 1.2 M in PhMe, 1.14 mmol, 1.05 equiv). After stirring for at 
-78 ºC for 1 h the reaction mixture was poured into Rochelle’s salt (10 mL). Et2O (20 
mL) and H2O (3 mL) were added. The resultant biphasic mixture was stirred 
vigorously for 1 h. The organic layer was separated, and the aqueous layer was 
further extracted with Et2O (2 x 10 mL). The combined organic layers were washed 
with brine (10 mL), dried (Na2SO4) and concentrated under reduced pressure to give 
236 as a colourless oil (175 mg, 86 %). No further purification required; Rf 0.65 
(10 % EtOAc in petrol); !max (film) 2991, 2946, 1730, 1458, 1382, 1374, 1262, 1210, 
1184, 1150, 1075, 1059, 1034 cm-1; "H (CDCl3, 400 MHz) 9.76 (1H, s, CHO), 5.05 
(1H, s, C=CH2), 4.90 (1H, s, C=CH2), 4.68 (1H, t, J 6.0 Hz, CHOMIP), 3.20 (3H, s, 
CH3O), 2.60 (2H, m, CH2CHO), 1.77 (3H, s, CH3C=C), 1.38 (3H, s, Me), 1.34 (3H, 
s, Me); "C (CDCl3, 100 MHz) 201.6 (CHO), 145.9 (C=CH2), 112.2 (C=CH2), 101.4 
(C(CH3)2OMe) 70.0 (CHOMIP), 49.4 (CH3O), 48.6 (CH2CHO), 25.2 (Me), 24.9 
(Me), 17.8 (CH3C=C). 
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(±)-3-Hydroxy-N-methoxy-N,4-dimethylpent-4-enamide (240) 
 
 
 
To 234 (5.00 g, 31.6 mmol, 1 equiv) and N,O-dimethylhydroxylamine hydrochloride 
(9.21 g, 94.8 mmol, 3 equiv) in THF (160 mL) at –30 ºC was added i-PrMgCl (94.0 
mL, 2 M in THF, 188.0 mmol, 5.95 equiv) dropwise. The reaction mixture was 
stirred at 0 ºC for 3 h before being poured into sat. NH4Cl (100 mL) and extracted 
with CH2Cl2 (3 x 200 mL). The combined organic layers were dried (Na2SO4) and 
concentrated under reduced pressure. Silica gel chromatography (20–50% EtOAc in 
petrol) gave 240 as a colourless oil (3.59 g, 66 %); Rf 0.35 (50 % EtOAc in petrol); 
!max (film) 3430, 2972, 2942, 1651, 1443, 1389, 1179, 1106, 998 cm-1; "H (CDCl3, 
400 MHz) 5.07 (1H, s, C=CH2), 4.90 (1H, s, C=CH2), 4.49 (1H, m, CHOH), 3.88 
(1H, d, J 3.0 Hz, OH), 3.71 (3H, s, OCH3), 3.22 (3H, s, NCH3), 2.66 (2H, m, CH2), 
1.79 (3H, s, CH3C=C); "C (CDCl3, 100 MHz) 173.6 (CO), 145.8 (C=CH2), 111.2 
(C=CH2), 71.3 (CHOH), 61.3 (OCH3), 36.9 (NCH3), 31.9 (CH2), 18.5 (CH3C=C). m/z 
(CI) 191 [M+NH4]+, 174 [M+H]+, 156 (Found [M+H]+, 174.1131. C8H15NO3 requires 
[M+H]+, 174.1130). 
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(±)-6-Hydroxy-7-methyl-1,7-octadien-4-one (238) 
 
 
 
To 240 (300 mg, 1.73 mmol, 1 equiv) in THF (17 mL) at 0 ºC was added 
allylmagnesium chloride (1.73 mL, 2 M in THF, 3.46 mmol, 2 equiv) dropwise. The 
mixture was stirred at 0 ºC for 30 min, then rt for 2 h before being poured into sat. 
NH4Cl (20 mL), the organic layer was separated and the aqueous layer was further 
extracted with DCM (6 x 20 mL). The combined organic layers were dried (Na2SO4) 
and concentrated under reduced pressure to give 238 as a yellow oil (243 mg, 91 %). 
No further purification; Rf 0.30 (10 % EtOAc in petrol), !max (film) 3427, 2975, 2921, 
1713, 1652, 1393, 1080 cm-1; "H (CDCl3, 400 MHz) 6.00!5.89 (1H, m, CH=CH2), 
5.27!5.15 (2H, m, CH=CH2), 5.04 (1H, s, C=CH2), 4.89 (1H, s, C=CH2), 4.54 (1H, t, 
J 6.0 Hz, CHOH), 3.25 (2H, d, J 6.0 Hz, CH2CH=CH2), 2.92 (1H, bs, OH), 2.71 (2H, 
d, J 6.0 Hz, CH2C=O), 1.77 (3H, s, CH3C=C); "C (CDCl3, 100 MHz) 209.2 (CO), 
145.6 (C=CH2), 129.2 (CH=CH2), 119.4 (CH=CH2), 111.3 (C=CH2), 71.0 (CHOH), 
48.5 (CH2C=C), 47.2 (CH2CO), 18.3 (CH3C=C). m/z (CI) 172 [M+NH4]+, 155 
[M+H]+, 137 (Found [M+H]+, 155.1071. C9H14O2 requires [M+H]+, 155.1072). 
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(±)-5-Hydroxy-2-methyl-1,7-octadien-3-yl benzoate (241) 
 
 
 
To crude 238 (90 mg, 0.58 mmol, 1 equiv) in THF (1.7 mL) was added benzaldehyde 
(240 !L, 2.33 mmol, 4 equiv). The mixture was cooled to –10 ºC and SmI2 (1.9 mL, 
0.1 M in THF, 0.19 mmol, 0.3 equiv) was added over 2 min. The reaction mixture 
was stirred at –10 ºC for 30 min. The reaction mixture was diluted with Et2O (10 mL) 
and washed with sat. NaHCO3 (10 mL), dried (Na2SO4) and concentrated under 
reduced pressure. Silica gel chromatography (5-10 % EtOAc in petrol) gave 241 as a 
yellow oil (57 mg, 38 %, >99:1 anti/syn); Rf 0.50 (10 % EtOAc in petrol); "max (film) 
3489, 307600, 2920, 1719, 1654, 1451, 1315, 1269, 1111, 1070 cm-1; #H (CDCl3, 400 
MHz) 8.12!8.06 (2H, m, o-Ph), 7.65!7.58 (1H, m, p-Ph), 7.53!7.45 (2H, m, m-Ph), 
5.92!5.80 (1H, m, CH=CH2), 5.73 (1H, dd, J 10.5 Hz, 3.0 Hz, CHOBz), 5.16 (1H, s, 
CH=CH2), 5.14 (1H, s, CH=CH2), 5.12 (1H, s, C=CH2), 4.96 (1H, s, C=CH2), 
3.78!3.68 (1H, m, CHOH), 2.79 (1H, d, J 3.5 Hz, OH), 2.33!2.27 (2H, m, CH2), 
2.02!1.78 (2H, m, CH2C=C), 1.88 (3H, s, CH3); #C (CDCl3, 100 MHz) 166.6 (CO), 
143.5 (C=CH2), 134.6 (CH=CH2), 133.2 (p-Ph), 130.0 (ipso-Ph) 129.7 (o-Ph), 128.5 
(m-Ph), 117.9 (CH=CH2), 112.6 (C=CH2), 74.9 (CHOBz), 66.8 (CHOH), 41.8 
(CH2C=C), 40.9 (CH2), 18.7 (CH3C=C). m/z (CI) 278 [M+NH4]+, 261 [M+H]+, 243, 
230 (Found [M+H]+, 261.1493. C16H20O3 requires [M+H]+, 261.1491). 
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(±)-5-Hydroxy-2-methylcyclohex-2-enyl benzoate (242) 
 
 
To 241 (100 mg, 0.38 mmol, 1 equiv) in CH2Cl2 (7 mL) was added Grubbs 2nd 
generation catalyst (16 mg, 0.019 mmol, 0.05 equiv). The reaction mixture was 
heated to 40 ºC for 2 h, before being cooled, filtered through Celite® and 
concentrated under reduced pressure. Purification by silica gel chromatography (10% 
EtOAc in petrol) afforded 242 as a brown oil (95 mg, >99 %); Rf 0.20 (15 % EtOAc 
in petrol); !max (film) 3416, 2920, 1715, 1452, 1338, 1316, 1269, 1110, 1025 cm-1; "H 
(CDCl3, 400 MHz) 8.10–8.04 (2H, m, o-Ph), 7.61–7.55 (1H, m, p-Ph), 7.50–7.42 
(2H, m, m-Ph), 5.69–5.61 (2H, m, C=CH + CHOBz), 4.23–4.11 (1H, m, CHOH), 
2.57–2.47 (1H, m, ring CH2), 2.24–2.16 (1H, m, ring CH2), 2.11–2.00 (1H, m, ring 
CH2), 1.99–1.89 (1H, m, ring CH2), 1.77 (1H, bs, OH), 1.76 (3H, s, CH3); "C (CDCl3, 
100 MHz) 166.2 (CO), 133.0 (p-Ph), 131.8 (C=CH), 130.5 (ipso-Ph), 129.6 (o-Ph), 
128.4 (m-Ph), 125.1 (CH=C), 71.9 (CHOBz), 64.4 (CHOH), 37.8 (CH2), 34.6 (CH2), 
20.2 (CH3); m/z (CI) 482, 360, 250 [M+NH4]+ (Found [M+H]+, 233.1181. C14H16O3 
requires [M+H]+, 233.1177). 
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(±)-5-(Tert-butyldimethylsilyloxy)-2-methylcyclohex-2-enyl benzoate (279) 
 
 
 
To 242 (95 mg, 0.41 mmol, 1 equiv) in DMF (0.5 mL) at 0 ºC was added imidazole 
(70 mg, 1.02 mmol, 2.5 equiv) followed, after 5 min, by tert-
butyldimethylsilylchloride (74 mg, 0.49 mmol, 1.2 equiv). The reaction mixture was 
stirred at rt for 3 h then diluted with Et2O (25 mL), washed with H2O (4x10 mL), 
dried (Na2SO4) and concentrated under reduced pressure. Purification by silica gel 
chromatography (10 % EtOAc in petrol) afforded 279 as a colourless oil (117 mg, 
82 %); Rf 0.65 (20 % EtOAc in petrol); !max (film) 2954, 2928, 2857, 1717, 1264, 
1098 cm-1; "H (CDCl3, 400 MHz) 8.11–8.05 (2H, m, o-Ph), 7.61–7.55 (1H, m, p-Ph), 
7.50–7.43 (2H, m, m-Ph), 5.67–5.60 (2H, m, C=CH + CHOBz), 4.21–4.12 (1H, m, 
CHOTBS), 2.45–2.35 (1H, m, ring CH2), 2.14–2.00 (2H, m, ring CH2), 1.99–1.88 
(1H, m, ring CH2), 1.75 (3H, s, CH3C=C), 0.90 (9H, s, C(CH3)3), 0.08 (6H, s, 
Si(CH3)2); "C (CDCl3, 100 MHz) 166.2 (CO), 132.9 (p-Ph), 131.6 (C=CH), 130.6 
(ipso-Ph), 129.6 (o-Ph), 128.3 (m-Ph), 125.8 (CH=C), 72.4 (CHOBz), 65.0 
(CHOTBS), 38.3 (CH2), 35.3 (CH2), 25.9 (C(CH3)3), 20.3 (CH3C=C), 18.2 
(C(CH3)3), –4.70 (SiCH3), –4.74 (SiCH3); m/z (ESI) 347 [M+H]+, 328, 300, 284 
(Found [M+H]+, 347.2038. C20H30O3Si requires [M+H]+, 347.2032). 
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(±)-5-(Tert-butyldimethylsilyloxy)-2-methylcyclohex-2-enol (243) 
 
 
To 279 (117 mg, 0.34 mmol, 1 equiv) in MeOH (0.5 mL) at 0 ºC was added KOH (28 
mg, 0.51 mmol, 1.5 equiv). The reaction was allowed to warm to rt and stirred 
overnight. 1 N HCl (3 mL) was added and the reaction mixture diluted with Et2O 
(10 mL). The aqueous layer was separated and further extracted with Et2O (2 x 10 
mL). The combined organic layers were dried (Na2SO4) and concentrated under 
reduced pressure before purification by silica gel chromatography (20 % EtOAc in 
petrol) afforded 243 as a colourless oil (77 mg, 93 %); Rf 0.20 (10 % EtOAc in 
petrol); !max (film) 3319, 2928, 2857, 1472, 1463, 1447, 1376, 1252, 1101 cm-1; "H 
(CDCl3, 400 MHz) 5.37–5.32 (1H, m, CH=C), 4.09–4.02 (1H, m, CHOH), 4.02–3.93 
(1H, m, CHOTBS), 2.26–2.16 (1H, m, ring CH2), 1.92–1.81 (2H, m, ring CH2), 1.74–
1.64 (1H, m, ring CH2), 1.71 (3H, s, CH3C=C), 1.42 (1H, d, J 6.0 Hz, OH), 0.82 (9H, 
s, C(CH3)3), 0.01 (3H, s, SiCH3), 0.00 (3H, s, SiCH3); "C (CDCl3, 100 MHz) 134.8 
(C=CH), 123.1 (C=CH), 69.6 (CHOH), 64.6 (CHOTBS), 41.3 (CH2), 35.5 (CH2), 
25.9 (C(CH3)3), 20.3 (CH3C=C), –4.61 (SiCH3), –4.66 (SiCH3); m/z (CI) 260 
[M+NH4]+, 242 [M]+, 225, 202, 185 (Found [M+NH4]+, 260.2046. C13H26O2Si 
requires [M+NH4]+, 260.2051). 
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2-Iodo-2-cyclohexenone (245) 
 
 
 
To Et2O (40 mL) and pyridine (40 mL) at rt was added I2 (27.7 g, 109.2 mmol, 2.1 
equiv) slowly. After allowing the resulting dark brown mixture to stir for 20 min it 
was cooled to 0 °C before dropwise addition of 2-cyclohexen-1-one (244) (5.00 g, 
52.0 mmol, 1 equiv). The reaction mixture was the allowed to stir at rt for 2 h before 
being diluted with Et2O (200 mL) and washed with 2 N HCl (2 x 100 mL), 20 % 
Na2S2O3 (3 x 100 mL) and brine (100 mL). The organic layer was separated, dried 
(Na2SO4) and concentrated under reduced pressure to give a yellow solid. 
Recrystallisation (2:1 Et2O/pentane) afforded 245 as a pale yellow solid (3.60 g, 31 
%); Rf 0.35 (10 % EtOAc in petrol); mp 46!47 °C; "max (film) 2932, 1676, 1583 cm-
1; #H (CDCl3, 400 MHz) 7.80 (1H, t, J 4.5 Hz, C=CH), 2.70 (2H, m, CH2CO), 2.47 
(2H, m, CH2CH=C), 2.12 (2H, m, CH2); #C (CDCl3, 100 MHz) 192.2 (CO), 159.4 
(C=CH), 103.9 (C=CI), 37.3 (CH2CO), 29.9 (CH2CH=C), 22.9 (CH2); m/z (ESI) 240 
[M+NH4]+, 223 [M+H]+, 194, 114, 97. In agreement with published data.7 
O O
I
244 245
Experimental 
 133 
2-Methyl-2-cyclohexenone (246) 
 
 
 
To 2-iodo-2-cyclohexenone (245) (500 mg, 2.25 mmol, 1 equiv), Fe(acac)3 (40 mg, 
0.11 mmol, 0.05 equiv) and N-methylpyrrolidone (2 mL) in THF (3 mL) at 15 °C was 
added methylmagnesium chloride (0.83 mL, 2.48 mmol, 1.1 equiv, 3M in THF) 
dropwise. After 1 h, 2 N HCl (5 mL) was added and the mixture extracted with Et2O 
(3 x 10 mL). The combined organic layers were washed with sat. NaHCO3 (10 mL) 
then brine (10 mL), dried (Na2SO4) and concentrated under reduced pressure to give a 
brown oil. Purification by silica gel chromatography (5 % EtOAc in petrol) afforded 
246 as a yellow oil (178 mg, 72 %); Rf 0.50 (10 % EtOAc in petrol); !H (CDCl3, 400 
MHz) 6.75 (1H, m, CH=CCH3), 2.42 (2H, m, CH2CO), 2.32 (2H, m, CH2C=C), 1.99 
(2H, m, CH2), 1.77 (3H, s, CH3); !C (CDCl3, 100 MHz) 200.1 (CO), 145.6 (C=CH), 
135.7 (C=CCH3), 38.3 (CH2CO), 26.0 (CH2CH=C), 23.3 (CH2), 16.0 (CH3). In 
agreement with published data.8 
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(±)-2-Methyl-2-cyclohexenol (251) 
 
 
 
To 2-methyl-2-cyclohexenone (246) (360 mg, 3.27 mmol, 1 equiv) in MeOH (16 mL) 
at 0 °C was added NaBH4 (136 mg, 3.60 mmol, 1.1 equiv). The reaction was stirred 
overnight at rt. H2O (10 mL) and CH2Cl2 (20 mL) were added, and the mixture 
poured into brine (20 mL). The organic layer was separated, and the aqueous layer 
further extracted with CH2Cl2 (2 x 20 mL). The combined organic layers were dried 
(Na2SO4) and concentrated under reduced pressure. Silica gel chromatography 
afforded 247 as a yellow oil (238 mg, 65 %); Rf 0.25 (10 % EtOAc in petrol); !max 
(film) 3563, 3523, 3386, 3060, 2989, 2923, 1469, 1452, 1284, 1242, 1227, 1161, 
1030 cm-1; "H (CDCl3, 400 MHz) 5.52 (1H, m, CH=CCH3), 3.97 (1H, m, CHOH), 
3.17 (1H, q, J 7.5 Hz, OH), 2.10#1.83 (2H, m, ring CH2), 1.81#1.32 (2H, m, ring 
CH2), 1.77 (3H, s, CH3); "C (CDCl3, 100 MHz) 135.2 (C=CMe), 125.4 (C=CH), 68.4 
(CHOH), 32.2 (CH2CHOH), 25.4 (CH2CH=C), 20.6 (CH2), 18.1 (CH3); m/z (CI) 130 
[M+NH4]+. In agreement with published data.9 
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(4S,6S)-(+)-Carveol (249) 
 
 
 
To CeCl3.7H2O (4.96 g, 13.3 mmol, 1 equiv) in MeOH (35 mL) was added (S)-
carvone (248) (2.00 g, 13.3 mmol, 1 equiv), followed by slow portion-wise addition 
of NaBH4 (505 mg, 13.3 mmol, 1 equiv). After stirring for 10 min the reaction 
mixture was poured into H2O (35 mL) and the mixture extracted with Et2O (2 x 50 
mL). The combined organic layers were dried (Na2SO4) and concentrated under 
reduced pressure. Silica gel chromatography (10 % EtOAc in petrol) gave 249 as a 
colourless oil (1.65 g, 82 %, 95:5 syn/anti); Rf 0.45 (10 % EtOAc in petrol); [!]D25 
+33.7 (c 1.16, CHCl3); "max (film) 3325, 2920, 1645, 1453, 1438, 1038 cm-1; #H 
(CDCl3, 400 MHz) 5.61 (1H, m, C=CH anti), 5.52 (1H, m, C=CH syn), 4.75 (2H, s, 
C=CH2), 4.21, (1H, m, CHOH syn), 4.04 (1H, m, CHOH anti), 2.29 (1H, m, ring 
CH), 2.22–2.05 (2H, m, ring CH2), 2.03–1.93 (1H, m, ring CH2) 1.78 (3H, s, CH3), 
1.76 (3H, s, CH3), 1.63 (1H, bs, OH), 1.58$1.47 (1H, m, ring CH2); #C (CDCl3, 100 
MHz) 149.0 (C=CH2), 136.2 (C=CH), 123.9 (C=CH), 109.2 (C=CH2), 70.9 (CHOH), 
40.4 (ring CH), 38.0 (ring CH2), 31.0 (ring CH2), 20.7 (CH3), 19.0 (CH3); m/z (CI) 
152 [M]+, 135 [M-OH]+. In agreement with published data.10 
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(4S,6R)-(+)-Carvyl benzoate (250) 
 
 
 
To 249 (1.00 g, 6.56 mmol, 1 equiv), benzoic acid (2.41 g, 19.7 mmol, 3 equiv) and 
PPh3 (5.17 g, 19.7 mmol, 3 equiv) in THF (50 ml) at 0 °C was added DIAD (3.91 
mL, 19.7 mmol, 3 equiv) dropwise. The reaction mixture was stirred for 20 h at rt 
before diluting with Et2O (150 mL), and washing with sat. NaHCO3 (2 x 50 mL). The 
combined aqueous layers were then further extracted with Et2O (100 mL). The 
combined organic layers were dried (Na2SO4) and concentrated under reduced 
pressure. To the resulting orange oil was added 50% Et2O in petrol (20 ml) and the 
resultant precipitate removed by filtration. The filtrate was concentrated under 
reduced pressure. Purification by silica gel chromatography (5 % EtOAc in petrol) 
afforded 250 as a yellow oil (1.69 g, >99%, 9:1 anti/syn); Rf 0.45 (10 % Et2O in 
petrol); [!]D25 +14.1 (c 1.00, CHCl3); "max (film) 2918, 1715, 1644, 1602, 1451, 
1268, 1109, 1025 cm-1; #H (CDCl3, 400 MHz) 8.10 (2H, d, J 7.5 Hz, o-Ph), 7.59 (1H, 
dd, J 7.5, 7.5 Hz, p-Ph), 7.47 (2H, dd, J 7.5, 7.5 Hz, m-Ph), 5.82 (1H, m, C=CH anti), 
5.73 (1H, m, C=CH syn) 5.69 (1H, m, CHOBz syn), 5.54 (1H, m, CHOBz anti), 4.77 
(1H, s, C=CH2), 4.75 (1H, s, C=CH2), 2.45 (1H, m, ring CH), 2.34–2.24 (1H, m, ring 
CH2), 2.16–2.08 (1H, m, ring CH2), 2.00–1.89 (1H, m, ring CH2), 1.76 (6H, s, 
CH3x2) 1.75 (1H, m, ring CH2); #C (CDCl3, 100 MHz) 166.4 (CO), 148.7 (C=CH2), 
132.9 (C=CH), 131.1 (p-Ph), 129.7 (o-Ph), 128.9 (ipso-Ph), 128.4 (m-Ph), 127.9 
(C=CH), 109.3 (C=CH2), 71.3 (CHOBz), 36.0 (CH), 33.8 (ring CH2), 31.0 (ring CH2-
), 20.9 (CH3), 20.8 (CH3); m/z (CI) 408, 378, 274 [M+NH4]+, 256 [M]+, 244, 152, 135 
(Found [M+NH4]+, 274.1811. C17H20O2 requires [M+NH4]+, 274.1807). 
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(4S,6R)-(+)-Carveol (251) 
 
 
 
To 250 (500 mg, 1.95 mmol, 1 equiv) was added a methanolic solution of KOH (1.5 
mL, 2 M, 2.92 mmol, 1.5 equiv). The mixture was stirred for 14 h at rt. The reaction 
was neutralized with 1 N HCl and extracted with Et2O (3 x 20 mL). The combined 
organic layers were washed with sat. NaHCO3 (20 mL) and brine (20 mL), dried 
(Na2SO4) and concentrated under reduced pressure. Purification of the crude oil by 
silica gel chromatography (5 % EtOAc in petrol) gave 251 as a colourless oil (239 
mg, 81 %, 9:1 anti/syn); Rf 0.45 (10 % EtOAc in petrol); [!]D25 +108.7 (c 0.87, 
CHCl3); "max (film) 3326, 2915, 1645, 1440, 1055, 1032 cm-1; #H (CDCl3, 400 MHz) 
5.61 (1H, m, CH=C anti), 5.52 (1H, m, CH=C syn), 4.77 (1H, s, C=CH2), 4.75 (1H, s, 
C=CH2) 4.22 (1H, m, CHOH syn), 4.05 (1H, m, CHOH anti), 2.35 (1H, m, CH), 
2.22–2.11 (1H, m, ring CH2), 1.99–1.85 (2H, m, ring CH2), 1.82 (3H, s, CH3), 1.77 
(3H, s, CH3), 1.63–1.57 (1H, m, ring CH2); #C (CDCl3, 100 MHz) 149.2 (C=CH2), 
134.3 (C=CH), 125.4 (C=CH), 109.1 (C=CH2), 68.6 (CHOH), 36.7 (ring CH), 35.2 
(ring CH2), 31.0 (ring CH2), 20.9 (CH3), 20.8 (CH3); m/z (CI) 152 [M]+, 135 [M-
OH]+. In agreement with published data.10 
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(4S,6R)-Carvyl 3-(des-A,B-8(9)-cholesten-8-yl)-2-tosylpropanoate (252) 
 
 
 
To 220 (192 mg, 0.40 mmol, 1 equiv) and 251 (62 mg, 0.40 mmol, 1 equiv) in 
CH2Cl2 (1 mL) at rt was added DMAP (5 mg, 0.04 mmol, 0.1 equiv) followed by 
DIC (70 µL, 0.44 mmol, 1.1 equiv). The reaction mixture was stirred for 4 days 
before being subjected directly to silica gel chromatography (5% EtOAc in petrol) to 
afford 252 as a colourless oil (130 mg, 54 %); Rf 0.90 (15 % EtOAc in petrol; !max 
(film) 2955, 1732, 1598, 1442, 1323, 1262, 1147, 1085, 1021 cm-1; !H (CDCl3, 400 
MHz) 7.80–7.76 (2H, m, o-Ts), 7.40–7.33 (2H, m, m-Ts), 5.77 (1H, s, CH=C 
carveyl), 5.32–5.20 (2H, m, CH-ester + H-9), 4.81–4.66 (2H, m, C=CH2), 4.16–4.05 
(1H, m,  CHTs), 2.75–2.50 (2H, m, CH), 2.49–2.45 3H, m, CH3Ar), 2.33–0.96 (23H, 
m), 1.75 (3H, s, CH3C=CH2), 1.65 (3H, s, CH3C=CH), 0.96–0.87 (9H, m, H-21 + H-
26/27), 0.67–0.61 (3H, m, H-18); !C (CDCl3, 100 MHz) 165.5 (CO), 148.5 (C=CH2), 
145.3 (Ar), 130.4 (C=CH), 130.2 (C=CH), 129.7 (m-Ts), 129.4 (o-Ts), 128.5 (Ar), 
128.4 (C=CH), 124.4 (C=CH), 109.2 (C=CH2), 72.4 (CH-ester), 69.7 (CHTs), 54.3, 
49.4, 42.3, 39.4, 36.1, 35.5, 33.4, 33.2, 30.9, 28.2, 28.0, 24.6, 24.5, 23.8, 22.8, 22.6, 
21.7, 21.0, 20.2, 18.7, 11.2 (C-18); m/z (CI) 626 [M+NH4]+, 448, 174, 152, 135 
(Found [M+NH4]+, 626.4244. C38H56O4S requires [M+NH4]+, 626.4243) (Found C, 
75.06; H, 9.18%. C38H56O4S requires C, 74.95; H, 9.27%). 
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 (4S,6R)-(+)-Carvyl 2-tosylacetate (254) 
 
 
 
To 251 (500 mg, 3.28 mmol, 1 equiv) and 2-tosylacetic acid (704 mg, 3.28 mmol, 1 
equiv) in CH2Cl2 (10 mL) at rt was added DMAP 40 mg, 0.33 mmol, 0.1 equiv) then 
DIC (562 µL, 3.61 mmol, 1.1 equiv) dropwise. The mixture was stirred for 20 min 
before filtering through Celite®, washing the solids with Et2O (20mL), and 
concentrating the filtrate under reduced pressure. Purification by silica gel 
chromatography (10 % EtOAc in petrol) afforded 254 as a colourless oil (1.00 g, 
88 %, 10:1 anti/syn); Rf 0.50 (10% EtOAc in petrol); [!]D25 +143.0 (c 1.54, CHCl3) 
!max (film) 2954, 1733, 1466, 1598, 1441, 1325, 1141, 1085 cm-1; "H (CDCl3, 400 
MHz) 7.83 (2H, d, J 8.0 Hz, o-Ts), 7.37 (2H, d, J 8.0 Hz, m-Ts), 5.77 (1H, m, C=CH 
anti), 5.62 (1H, m, C=CH syn), 5.44 (1H, m, CH-O syn), 5.27 (1H, m, CH-O anti), 
4.77 (1H, m, C=CH2 anti), 4.75 (1H, m, C=CH2 syn), 4.69 (1H, m, C=CH2), 4.13 
(2H, s, CH2Ts), 2.47 (3H, s, CH3Ar), 2.24-2.14 (2H, m, ring CH), 1.90-1.79 (2H, m, 
ring CH), 1.73 (3H, s, CH3), 1.68 (3H, s, CH3), 1.63–1.57 (1H, m, ring CH); m/z (CI) 
366 [M+NH4]+, 152 [M-TsCH2CO2]+, 135 (Found [M+NH4]+, 366.1739. C19H24O4S 
requires [M+NH4]+, 366.1739). 
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(4S,6R)-(+)-Carvyl 2-tosylpenten-4-enoate (255) 
 
 
 
To 254 (300 mg, 0.86 mmol, 1 equiv), n-Bu4NI (318 mg, 0.86 mmol, 1 equiv) and 
DBU (258 µL, 1.72 mmol, 2 equiv) in DMF (1.0 mL) was added a solution of allyl 
bromide (75 µL, 0.86 mmol, 1 equiv) in DMF (2.5 mL) dropwise. After stirring at rt 
for 2 h the mixture was diluted with CH2Cl2 (20 mL) and washed with 1 N HCl (5 
mL). The aqueous layer was further extracted with CH2Cl2 (2 x 10 mL), the 
combined organics dried (Na2SO4) and concentrated under reduced pressure. 
Purification by silica gel chromatography (5-10 % EtOAc in petrol) afforded a 1:1 
mixture of C-Ts epimers of 255 as a colourless oil (265 mg, 79 %); Rf 0.70 (10 % 
EtOAc in petrol); !max (film) 2968, 2919, 1732, 1644, 1598, 1441, 1327, 1239, 1176, 
1148, 1086, 914 cm-1; "H (CDCl3, 400 MHz) 7.82–7.75 (2H, m, o-Ts), 7.40–7.34 (2H, 
m, m-Ts), 5.76 (1H, m, C=CH), 5.74–5.64 (1H, m, CH=CH2), 5.26 and 5.22 (1H, m, 
CH-O), 5.20–5.07 (2H, m, CH=CH2), 4.78–4.75 (1H, m, C=CH2), 4.72–4.67 (1H, m, 
C=CH2), 4.05 and 4.02 (1H, d, J 3.5 Hz, CH2Ts), 2.87–2.78 (1H, m, ring CH), 2.77–
2.65 (1H, m, ring CH2), 2.47 and 2.46 (3H, s, CH3Ar), 2.27–2.13 (2H, m, ring CH), 
1.93–1.82 (1H, m, ring CH), 1.73 (3H, s, CH3), 1.70–1.65 (2H, m, ring CH), 1.61 
(3H, s, CH3); "C (CDCl3, 100 MHz) 165.3 (CO), 148.4 (C=CH2), 145.5 (C=CH), 
145.4 (C=CH), 131.7, 131.6, 130.1, 130.0, 129.8 (m-Ts), 129.4 (o-Ts), 128.8, 128.7, 
119.1 and 119.0 (CH=C), 109.4 and 109.3 (C=CH2), 73.3 and 72.8 (CH-ester), 70.1 
and 69.9 (CHTs), 35.6, 35.5, 33.4, 33.2, 31.2, 31.1, 30.8, 30.7, 21.7, 20.9, 20.7, 20.6, 
20.5; m/z (CI) 406 [M+NH4]+, 252, 228, 174, 152, 135 (Found [M+NH4]+, 406.2057. 
C22H28O4S requires [M+NH4]+, 406.2052) (Found C, 68.16; H, 7.37%. C22H28O4S 
requires C, 68.01; H, 7.26%). 
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(4R,6S)-(–)-Limonen-6-yl tosylmethane (256) 
 
 
 
To 254 (100 mg, 0.29 mmol, 1 equiv) and KOAc (3 mg, 0.03 mmol, 0.1 equiv) in a 
capped microwave vial was added BSA (355 µL, 1.45 mmol, 5 equiv). The mixture 
was heated by microwave irradiation at 180 °C for 3 ! 1 min (including a 1 min 
cooling period between each 1 min heating period). Purification of the crude reaction 
mixture by silica gel chromatography (10 % EtOAc in petrol) afforded 256 as a white 
solid (78 mg, 88 %, 9:1 anti/syn); Rf 0.30 (5 % EtOAc in petrol); mp 89-91 °C; ["]D24 
–38.1 (c 0.70, CHCl3); !H (CDCl3, 400 MHz) 7.83 (2H, d, J 8.0 Hz, o-Ts), 7.38 (2H, 
d, J 8.0 Hz, m-Ts), 5.55 (1H, m, C=CH syn), 5.48 (1H, m, C=CH anti), 4.73 (1H, m, 
C=CH2), 4.68 (1H, m, C=CH2), 3.13 (1H, m, TsCH2), 3.11 (1H, s, TsCH2), 2.62–2.56 
(1H, m, ring CH), 2.47 (3H, s, CH3Ar), 2.12–2.00 (3H, m, ring CH), 1.91–1.81 (1H, 
m, ring CH), 1.70 (3H, s, CH3), 1.60–1.54 (1H, m, ring CH), 1.53 (3H, s, CH3); !C 
(CDCl3, 100 MHz) 148.7 (C=CH2), 144.6 (Ar), 136.8 (Ar), 132.8 (C=CH), 129.9 
(m-Ts), 128.0 (o-Ts), 124.6 (C=CH), 109.1 (C=CH2), 58.3 (CH2Ts), 35.6, 34.4, 31.6, 
30.6, 21.8 (CH3), 21.6 (CH3), 20.8 (CH3); m/z (CI) 322 [M+NH4]+, 148 (Found 
[M+NH4]+, 322.1854. C18H24O2S requires [M+NH4]+, 322.1841) (Found C, 71.14; H, 
8.05%. C18H24O2S requires C, 71.01; H, 7.95%). 
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1-(4R,6S)-Limonen-6-yl-1-tosylbut-3-ene (257) and 4-tosylbut-1-ene (258) 
 
 
 
To 255 (80 mg, 0.21 mmol, 1 equiv) and KOAc (4 mg, 0.04 mmol, 0.2 equiv) in a 
capped microwave vial was added BSA (252 µL, 1.03 mmol, 5 equiv). The mixture 
was heated by microwave irradiation at 180 °C for 3 ! 1 min (including a 1 min 
cooling period between each heating period). Purification of the crude reaction 
mixture by silica gel chromatography (5 % EtOAc in petrol) afforded 257 as a white 
solid (20 mg, 26 %) and 258 as a colourless oil (17 mg, 39 %). 
Data for 257: Rf 0.40 (5 % EtOAc in petrol); mp 70-72 °C; !max (film) 2921, 1726, 
1643, 1598, 1446, 1314, 1302, 1287, 1144, 1087 cm-1; "H (CDCl3, 400 MHz) 7.83–
7.77 (2H, m, o-Ts), 7.40–7.34 (2H, m, m-Ts), 5.75–5.46 (2H, m, C=CH + CH=CH2), 
5.13–4.86 (2H, CH=CH2), 4.86–4.71 (1H, C=CH2), 4.71–4.65 (1H, CH=CH2), 3.50-
3.38 and 3.18–3.10 (1H, m, CHTs), 3.02–1.19 (9H, m), 2.47 (3H, s, CH3Ar); "C 
(CDCl3, 100 MHz) 148.8 (Ar), 144.5 (C=CH2), 135.3 and 135.1 (CH=CH2), 132.4 
(Ar), 131.2 (C=CH), 129.8 (m-Ts), 128.9 (o-Ts), 128.6 (Ar), 126.2 and 125.2 
(C=CH), 117.4 and 117.2 (CH=CH2), 109.3 and 109.1 (C=CH2), 68.2 and 65.7 
(CHTs), 40.8 (CH2CH=CH2), 37.4, 37.2, 36.4, 33.3, 31.3, 30.4, 29.5, 29.4, 29.0, 27.3, 
23.4, 21.7, 21.5, 21.4 (CH3), 20.8 (CH3); m/z (CI) 362 [M+NH4]+, 240 (Found 
[M+NH4]+, 362.2148. C21H28O2S requires [M+NH4]+, 362.2154). 
Data for 258: Rf 0.20 (5 % EtOAc in petrol); "H (CDCl3, 400 MHz) 7.81 (2H, d, J 8.0 
Hz, o-Ts), 7.39 (2H, d, J 8.0 Hz, m-Ts), 5.81–5.68 (1H, m, CH=CH2), 5.11–5.02 (2H, 
m, CH=CH2), 3.20–3.13 (2H, m, CH2Ts), 2.51–2.43 (2H, m, CH2CH=CH2), 2.48 
(3H, s, CH3Ar); "C (CDCl3, 100 MHz) 144.8 (Ar), 136.0 (Ar), 133.9 (CH=CH2), 
130.0 (m-Ts), 128.1 (o-Ts), 117.1 (CH=CH2), 55.5 (CH2Ts), 27.0 (CH3Ar), 21.7 
(CH2CH=CH2). 
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2-Methylenecyclohexanol (268) 
 
 
 
To KOH (1.85 g, 46.3 mmol, 3 equiv) in DMSO (30 mL) at rt was added 
cyclohexanone (267) (1.60 mL, 15.4 mmol, 1 equiv). The mixture was heated to 110 
°C for 90 min. The reaction mixture was cooled, diluted with Et2O (200 mL) and 
washed with 1 N HCl (3 x 30 mL). The aqueous layer was further extracted with Et2O 
(100 mL), the combined organics were dried (Na2SO4) and concentrated under 
reduced pressure. Purification by silica gel chromatography (10 % EtOAc in petrol) 
afforded 268 as an orange oil (697 mg, 40 %); Rf 0.50 (15 % EtOAc in petrol); !max 
(film) 3552, 2934, 1858, 1655, 1448, 1344, 1288, 1080, 897 cm-1; "H (CDCl3, 400 
MHz) 4.91 (1H, s, C=CH2), 4.78 (1H, s, C=CH2), 4.15–4.09 (CHOH), 2.48–2.38 (1H, 
m, ring CH), 2.09–1.95 (2H, m, ring CH), 1.88–1.78 (1H. m, ring CH), 1.72–1.58 
(2H, m, ring CH and OH), 1.55–1.34 (3H, m, ring CH); "C (CDCl3, 100 MHz) 151.6 
(C=CH2), 105.0 (C=CH2), 72.6 (CHOH), 36.7 (ring CH2), 33.5 (ring CH2), 27.7 (ring 
CH2), 23.8 (ring CH2); m/z (CI) 175, 130 [M+NH4]+, 112 [M]+, 95 [M-H2O]+, 52 
(Found [M+NH4]+, 130.1235. C7H12O requires [M+NH4]+, 130.1232). In agreement 
with published data.11 
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2-Methylenecyclohexyl 2-tosylacetate (269) 
 
 
 
To 268 (200 mg, 1.78 mmol, 1 equiv) and 2-tosylacetic acid (382 mg, 1.78 mmol, 1 
equiv) in CH2Cl2 (6 mL) at 0 °C was added DMAP (22 mg, 0.18 mmol, 0.1 equiv) 
then DIC (305 µL, 1.96 mmol, 1.1 equiv). The reaction mixture was stirred at rt for 1 
h then filtered through Celite®. The solids were washed with Et2O (20 mL), and the 
filtrate concentrated under reduced pressure. Purification by silica gel 
chromatography (10 % EtOAc in petrol) afforded 269 as a colourless oil (511 mg, 93 
%); Rf 0.40 (15 % EtOAc in petrol); !max (film) 2939, 1739, 1658, 1598, 1448, 1402, 
1330, 1278, 1157, 1086 cm-1; "H (CDCl3, 400 MHz) 7.84 (2H, d, J 8.0 Hz, o-Ts), 
7.38 (2H, d, J 8.0 Hz, m-Ts), 5.26–5.21 (1H, m, CH-O), 4.82 (1H, s, C=CH2), 4.80 
(1H, s, C=CH2), 4.15 (2H, s, CH2Ts), 2.48 (3H, s, CH3Ar), 2.36–2.27 (1H, m, ring 
CH2), 2.13–2.04 (1H, m, ring CH2), 1.85–1.45 (6H, m, ring CH2); "C (CDCl3, 100 
MHz) 161.6 (CO), 145.4 (C=CH2), 145.1 (Ar), 135.7 (Ar), 129.9 (m-Ts), 128.6 (o-
Ts), 108.9 (C=CH2), 76.6 (CH-O), 61.3 (CH2Ts), 32.9 (ring CH2), 32.8 (ring CH2), 
27.2 (ring CH2), 22.7 (ring CH2), 21.7 (CH3Ar); m/z (ESI) 372, 326 [M+NH4]+, 224 
(Found [M+NH4]+, 326.1432. C16H20O4S requires [M+NH4]+, 326.1426) (Found C, 
62.38; H, 6.64%. C16H20O4S requires C, 62.31; H, 6.54%). 
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3-Cyclohexenyl-2-tosylpropionic acid (270) 
 
 
 
To a solution of 269 (300 mg, 0.97 mmol, 1 equiv) in CH3CN (3.5 mL) was added 
Et3N (177 µL, 1.17 mmol, 1.2 equiv) then BSA (714 µL, 2.92 mmol, 3 equiv). The 
reaction mixture was heated to 60 °C for 30 min, before being cooled, diluted with 
EtOAc (30 mL), washed with 1 N HCl (15 mL), dried (Na2SO4), and concentrated 
under reduced pressure. Purification by silica gel chromatography (10 % EtOAc in 
petrol + 10 % MeOH + 1 % AcOH) afforded 270 as an off-white solid (290 mg. 97 
%); Rf 0.60 (15 % EtOAc in petrol); mp 48-49 °C; !max (film) 3381, 2927, 1770, 
1614, 1381, 1289, 1143, 1085 cm-1; "H (CDCl3, 400 MHz) 7.83 (2H, d, J 8.0 Hz, o-
Ts), 7.34 (2H, d, J 8.0 Hz, m-Ts), 4.53 (1H, s, CH=C), 4.19 (1H, s, CHTs), 2.70–2.51 
(2H, m, CH2), 2.45 (3H, s, CH3Ar), 1.96–1.67 (4H, m, ring CH2), 1.60–1.33 (4H, m, 
ring CH2); "C (CDCl3, 100 MHz) 145.36 (Ar), 134.0 (Ar), 131.8 (C=CH), 129.8 (m-
Ts), 129.4 (o-Ts), 125.0 (CH=C), 69.5 (CHTs), 35.2 (CH2CHTs), 27.9 (ring CH2), 
25.1 (ring CH2), 22.6 (ring CH2), 21.9 (ring CH2), 21.7 (CH3Ar); m/z (CI) 340, 326 
[M+NH4]+, 324, 322, 282 [M+NH4-CO2]+, 174. 
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(4R,6S)-(+)-Carvyl 3-cyclohexenyl-2-tosylpropanoate (264) 
 
 
 
To 251 (128 mg, 0.84 mmol, 1 equiv) and 270 (260 mg, 0.84 mmol, 1 equiv) in 
CH2Cl2 (2 mL) at 0 °C was added DMAP (10 mg, 0.08 mmol, 0.1 equiv) then DIC 
(145 µL, 0.92 mmol, 1.1 equiv). The reaction mixture was stirred at rt for 1 h then 
filtered through Celite®. The solids were washed with Et2O (20 mL), and the filtrate 
concentrated under reduced pressure. Purification by silica gel chromatography (5 % 
EtOAc in petrol) afforded a 1:1 mixture of C-Ts epimers of 264 as a colourless oil 
(252 mg, 68 %); Rf 0.75 (15 % EtOAc in petrol); !max (film) 2928, 1732, 1645, 1598, 
1440, 1324, 1155, 1085, 915 cm-1; "H (CDCl3, 400 MHz) 7.81–7.75 (2H, m, o-Ts), 
7.39–7.33 (2H, m, m-Ts), 5.78–5.72 (1H, m, C=CH), 5.48–5.41 (1H, m, CH-ester), 
5.28–5.22 (1H, m, C=CH), 4.79–4.73 (1H, m, C=CH2), 4.71–4.66 (1H, m, C=CH2), 
4.14 (1H, dd, J 11.0, 4.5 Hz, CHTs), 2.70–2.55 (2H, m), 2.47 and 2.46 (3H, s, 
CH3Ar), 2.33–2.13 (2H, m), 2.00–1.41 (10H, m), 1.74 (3H, s, CH3), 1.60 (3H, s, 
CH3); "C (CDCl3, 100 MHz) 165.9 and 165.7 (CO), 148.5 and 148.5 (C=CH), 145.3 
(Ar), 134.2 and 134.1 (C=CH), 131.8 and 131.7 (C=CH2), 130.3 and 130.1 (Ar), 
129.7 (m-Ts), 129.5 and 129.4 (o-Ts), 128.6 and 128.5 (C=CH), 125.1 and 125.0 
(C=CH), 109.3 and 109.2 (C=CH2), 72.8 and 72.5 (CH-ester), 69.4 and 69.3 (CHTs), 
35.6, 35.5, 35.3, 35.2, 33.2, 33.1, 28.0, 25.1, 25.0, 22.6, 22.0, 21.9, 21.7 (CH3Ar), 
20.9 and 20.8 (CH3), 20.5 and 20.3 (CH3); m/z (ESI) 506, 481, 460 [M+NH4]+, 224 
(Found [M+NH4]+, 460.2529. C26H34O4S requires [M+NH4]+, 460.2522) (Found C, 
70.69; H, 7.86%. C26H34O4S requires C, 70.55; H, 7.74%). 
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2-(4R,6S)-Limonen-6-yl-2-tosylacetic acid (273) 
 
 
 
To a solution of 254 (478 mg, 1.37 mmol, 1 equiv) in CH3CN (5 mL) was added Et3N 
(250 µL, 1.65 mmol, 1.2 equiv) then BSA (1.00 mL, 4.12 mmol, 3 equiv). The 
reaction mixture was heated to reflux for 2 h, before being cooled, diluted with 
EtOAc (50 mL), washed with 1 N HCl (20 mL), dried (Na2SO4), and concentrated 
under reduced pressure. Purification by silica gel chromatography (10 % EtOAc in 
petrol + 10 % MeOH + 1 % AcOH) afforded a 5:3 mixture of C-Ts epimers of 273 as 
an off-white solid (444 mg. 93 %); Rf 0.65 (15 % EtOAc in petrol; mp 57-58 °C; !max 
(film) 3476, 2921, 1714, 1644, 1598, 1453, 1379, 1304, 1144, 1086, 912 cm-1; "H 
(CDCl3, 400 MHz) 7.86 (2H, d, J 8.0 Hz, o-Ts), 7.37 (2H, d, J 8.0 Hz, m-Ts major), 
7.33 (2H, d, J 8.0 Hz, m-Ts minor), 5.62 (1H, s, CH=C major), 5.52 (1H, s, CH=C 
minor), 4.70 (1H, s, CH2=C), 4.65 (1H, s, CH2=C minor), 4.60 (1H, s, CH2=C major), 
4.24 (1H, s, CHTs major), 4.14 (1H, d, J 7.5 Hz, CHTs minor), 2.92 (1H, m, 
CHCHTs major), 3.01 (1H, m, CHCHTs minor), 2.39–1.76 (5H, m), 2.46 (3H, s, 
CH3Ar major), 2.43 (3H, s, CH3Ar minor), 1.69 (3H, s, CH3 minor), 1.67 (3H, s, CH3 
major), 1.62 (3H, s, CH3); "C (CDCl3, 100 MHz) 175.0 (CO), 148.9 and 148.5 
(C=CH), 145.2 and 144.9 (Ar), 135.7 and 135.2 (C=CH2), 129.8 and 129.7 (m-Ts), 
129.3 and 129.2 (o-Ts), 126.3 (C=CH), 109.0 and 108.8 (C=CH2), 70.1 (CHTs), 39.0, 
37.1, 36.5, 35.0, 30.8, 29.7, 28.6, 23.4, 22.6, 21.7 (CH3Ar), 21.4 and 21.2 (CH3), 20.7 
(CH3); m/z (CI) 364 [M+NH4]+, 322, 242, 228. 
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2-Methylenecyclohexyl 2-(4S,6R)-limonen-6-yl-2-tosylacetate (266) 
 
 
 
To 268 (77 mg, 0.68 mmol, 1 equiv) and 273 (240 mg, 0.68 mmol, 1 equiv) in 
CH2Cl2 (2 mL) at 0 °C was added DMAP (8 mg, 0.07 mmol, 0.1 equiv) then DIC 
(118 µL, 0.76 mmol, 1.1 equiv). The reaction mixture was stirred at rt for 18 h then 
filtered through Celite®. The solids were washed with Et2O (20 mL), and the filtrate 
concentrated under reduced pressure. Purification by silica gel chromatography (5 % 
EtOAc in petrol) afforded a complex mixture of stereoisomers of 266 as a colourless 
oil (110 mg, 37 %); Rf 0.75 (15 % EtOAc in petrol); !max (film) 2936, 2861, 1740, 
1646, 1598, 1449, 1327, 1142, 1086 cm-1; "H (CDCl3, 400 MHz) 7.89–7.81 (2H, m, -
o-Ts), 7.38–7.29 (2H, m, m-Ts), 5.63–5.51 (1H, m, C=CH), 5.28–5.03 (1H, m, CH-
ester), 4.89–4.47 (4H, m, C=CH2), 4.25–4.05 (1H, m, CHTs), 3.32–2.98 (1H, m, 
CHCHTs), 2.46–2.43 (3H, m, CH3Ar), 2.36–1.07 (19 H, m); "C (CDCl3, 100 MHz) 
165.5 (CO) 165.1 (CO), 164.6 (CO), 148.9, 148.4, 148.3, 145.1, 145.0, 144.9, 135.4, 
135.3, 135.2, 130.7, 130.6, 129.7, 129.6, 129.5, 129.4, 129.1, 129.0, 126.9, 126.7, 
126.6, 126.5, 126.4, 109.4, 109.3, 109.0, 108.9, 108.6, 108.5, 76.1, 76.0, 74.5, 74.3, 
70.6, 70.4, 70.1, 70.0, 41.1, 39.9, 39.8, 38.6, 38.4, 37.4, 37.3, 36.2, 35.9, 35.1, 33.8, 
33.1, 32.8, 32.6, 32.4, 30.9, 30.8, 30.5, 30.0, 29.8, 28.5, 28.4, 27.1, 23.8, 23.5, 22.8, 
22.6, 22.5, 22.4, 21.6, 21.5, 21.2, 21.0, 20.8, 20.6; m/z (ESI) 506, 481, 460 [M+NH4]+ 
(Found [M+NH4]+, 460.2525. C26H34O4S requires [M+NH4]+, 460.2522) (Found C, 
70.69; H, 7.86%. C26H34O4S requires C, 70.55; H, 7.74%). 
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1-(2-Cyclohexenyl-1-(4S,6R)-limonen-6-ylethylsulfonyl)-4-methylbenzene (265) 
Method A: 
 
To 264 (100 mg, 0.23 mmol, 1 equiv) and KOAc (4.5 mg, 0.05 mmol, 0.2 equiv) in a 
capped microwave vial was added BSA (276 µL, 1.13 mmol, 5 equiv). The mixture 
was heated by microwave irradiation at 180 °C for 3 ! 1 min (including a 1 min 
cooling period between each 1 min heating period). Purification of the crude reaction 
mixture by silica gel chromatography (5 % EtOAc in petrol) afforded a 1.1:1 mixture 
of C-Ts epimers of 265 as a colourless oil (24 mg, 26 %). 
Method B: 
 
To 266 (43 mg, 0.10 mmol, 1 equiv) and KOAc (2 mg, 0.02 mmol, 0.2 equiv) in a 
capped microwave vial was added BSA (119 µL, 0.49 mmol, 5 equiv). The mixture 
was heated by microwave irradiation at 180 °C for 3 ! 1 min (including a 1 min 
cooling period between each 1 min heating period). Purification of the crude reaction 
mixture by silica gel chromatography (5 % EtOAc in petrol) afforded a 1.2:1 mixture 
of C-Ts epimers of 265 as a colourless oil (40 mg, >99 %). 
Rf 0.45 (5 % EtOAc in petrol); !max (film) 2924, 1644, 1598, 1447, 1312, 1300, 1142, 
1086 cm-1; "H (CDCl3, 400 MHz) 7.78 (2H, d J 8.0 Hz, o-Ts major), 7.73 (2H, d J 8.0 
Hz, o-Ts minor), 7.34 (2H, d J 8.0 Hz, m-Ts major), 7.31 (2H, d J 8.0 Hz, m-Ts 
minor), 5.67 (1H, s, CH=C minor), 5.59 (1H, s, CH=C major), 5.42 (1H, s, CH=C 
minor), 5.39 (1H, s, CH=C major), 4.80–4.74 (1H, m, C=CH2), 4.71 (1H, s, C=CH2), 
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3.69–3.56 (1H, m, CHTs major), 3.41–3.33 (1H, m, CHTs minor), 3.15 (1H, s, 
CHCHTs minor), 2.80 (1H, s, CHCHTs major), 2.76–2.67 (1H, m, CH major), 2.51 –
0.83 (14H, m), 2.46 (3H, s, CH3Ar major), 2.45 (3H, s, CH3Ar minor), 1.80 (3H, s 
CH3C=CH major), 1.77 (3H, s CH3C=CH2 minor), 1.76 (3H, s CH3C=CH2 major), 
1.65 (3H, s CH3C=CH minor); !C (CDCl3, 100 MHz) 148.9, 148.3, 144.2, 143.8, 
138.5, 136.8, 132.8, 132.4, 131.1, 129.5 (Ar), 129.2 (Ar), 128.7 (Ar), 128.6 (Ar), 
126.7, 125.6, 125.5, 124.6, 109.2 and 109.0 (C=CH2), 64.1 and 62.1 (CHTs), 37.5, 
36.8, 36.7, 34.5, 31.9, 30.3, 29.7, 28.1, 27.3, 27.1, 25.2, 25.1, 23.1, 22.6, 22.3, 22.0, 
21.6 (CH3), 21.5 (CH3), 21.3 (CH3), 21.1 (CH3); m/z (ESI) 462, 416 [M+NH4]+, 399 
[M+H]+ (Found [M+H]+, 399.2361. C25H34O2S requires [M+H]+, 399.2358). 
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 151 
De-A,D-8-methylenecholestan-9-yl 2-(4S,6R)-limonen-6-yl-2-tosylacetate (275) 
 
 
 
To 223 (140 mg, 0.50 mmol, 1 equiv) and 273 (175 mg, 0.50 mmol, 1 equiv) in 
CH2Cl2 (2 mL) at 0 °C was added DMAP (6 mg, 0.05 mmol, 0.1 equiv) then DIC (86 
µL, 0.55 mmol, 1.1 equiv). The reaction mixture was stirred at rt for 6 h then filtered 
through Celite®. The solids were washed with Et2O (20 mL), and the filtrate 
concentrated under reduced pressure. Purification by silica gel chromatography (5 % 
EtOAc in petrol) afforded an epimeric mixture of 275 as a colourless oil (176 mg, 58 
%); Rf 0.90 (15 % EtOAc in petrol); !max (film) 2954, 2870, 1739, 1646, 1598, 1453, 
1329, 1139 1086 cm-1; "H (CDCl3, 400 MHz) 7.88–7.77 (2H, m, o-Ts), 7.38–7.27 
(2H, m, m-Ts), 5.65–4.54 (6H, m, CH=C, 2 x C=CH2, H-9), [1H, 4.18 (d, J 3.0 Hz) 
and 4.02 (d, J 6.0 Hz), CHTs], 3.11–2.96 (1H, m, CHCHTs), 2.43(3H, s, CH3Ar), 
2.36–0.96 (32H, m), 0.94-0.86 (H-21 + H-26/27), 0.54–0.48 (3H, s, H-18); "C 
(CDCl3, 100 MHz) 165.2, 164.5, 149.0, 148.1, 145.0, 144.9, 144.8, 135.7, 135.2, 
132.1, 131.0, 129.7, 129.6, 129.6, 129.5, 129.2, 126.3, 126.2, 112.1, 111.9, 109.0, 
108.9, 76.5, 76.4, 74.4, 70.4, 56.1, 50.5, 50.4, 44.5, 39.5, 38.4, 37.1, 36.2, 36.1, 35.9, 
35.3, 35.1, 34.9, 33.9, 31.1, 29.8, 28.4, 28.2, 28.0, 27.5, 27.5, 23.9, 23.7, 23.3, 22.8, 
22.6, 21.9, 21.8, 21.7, 21.6, 21.3, 20.6, 18.8, 11.1, 11.0; m/z (ESI) 672, 626 
[M+NH4]+ (Found [M+NH4]+, 626.4236. C38H56O4S requires [M+NH4]+, 626.4243) 
(Found C, 74.80; H, 9.20%. C38H56O4S requires C, 74.95; H, 9.27%). 
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1-(2-(Des-A,B-8(9)-cholesten-8-yl)-1-(4S,6R)-limonen-6-ylethylsulfonyl)-4-
methylbenzene (276) 
 
 
 
To 275 (70 mg, 0.11 mmol, 1 equiv) and KOAc (2 mg, 0.02 mmol, 0.2 equiv) in a 
capped microwave vial was added BSA (150 µL, 0.55 mmol, 5 equiv). The mixture 
was heated by microwave irradiation at 180 °C for 3 ! 1 min (including a 1 min 
cooling period between each 1 min heating period). Purification of the crude reaction 
mixture by silica gel chromatography (5 % EtOAc in petrol) afforded an epimeric 
mixture of 276 as a colourless oil (56 mg, 90 %); Rf 0.90 (5 % EtOAc in petrol); !max 
(film) 2928, 1452, 1302, 1144 cm-1; "H (CDCl3, 400 MHz) 7.80–7.71 (2H, m, o-Ts), 
7.36–7.29 (2H, m, m-Ts), 5.68–5.51 (1H, m, CH=C), [1H, 5.28–5.51 (m) and 5.04–
4.95 (m), CH=C], 4.80–4.66 (2H, m, C=CH2), [1H, 3.65–3.58 (m) and 3.47–3.40 (m), 
CHTs), 2.91 (1H, bs, CHCHTs), 2.67–0.82 (40H, m), 2.45 (CH3Ar), 0.60–0.48 (3H, 
m, H-18); m/z (ESI) 582 [M+NH4]+, 565 [M+H]+, 479 (Found [M+H]+, 565.4093. 
C37H56O2S requires [M+H]+, 565.4079). 
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(R)-Ethyl 3-hydroxy-4-methylpent-4-enoate (234) 
 
 
 
To 234 (25.0 g, 158.0 mmol, 1 equiv) and (+)-diisopropyl L-tartrate (15.0 mL, 71.1 
mmol, 0.45 equiv) in CH2Cl2 (300 mL) was added 4Å MS (10 g). The reaction 
mixture was cooled to –25 ºC before adding Ti(Oi-Pr)4 (18.7 mL, 63.2 mmol, 0.4 
equiv). After stirring for a further 30 min t-BuOOH (39.5 mL, 4.0 M in CH2Cl2, 
158.0 mmol, 1 equiv) was added dropwise over 1 h. The reaction mixture was then 
stirred at –25 ºC for 96 h. A prepared solution of FeSO4 (60 g) and citric acid (20 g) 
in H2O (180 mL) was added was added slowly and the reaction mixture allowed to 
return to rt. The aqueous layer was separated and further extracted with CH2Cl2 (500 
mL). The combined organics were dried (MgSO4) and concentrated under reduced 
pressure. Purification by silica gel chromatography (2-25% EtOAc in heptane) 
afforded (R)-234 as a colourless oil (11.3 g, 45 %, 86 % ee); [!]D23 + 37.3 (c 0.90, 
CHCl3). All other data as for racemic 234. Enantiomeric excess was determined by 
addition of tris[3-[(trifluoromethyl)hydroxymethylene]-(+)-camphorato]europium(III) 
to the 1H-NMR sample. 
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(R)-3-Hydroxy-N-methoxy-N,4-dimethylpent-4-enamide (240) 
 
 
 
To a suspension of N,O-dimethylhydroxylamine hydrochloride (7.32 g, 75.1 mmol, 
2.2 equiv) in THF (70 mL) at -10 ºC was added AlMe3 (37.5 mL, 2 M in heptane, 
75.1 mmol, 2.2 equiv) dropwise. The mixture was stirred at rt for 1 h before adding a 
solution of (R)-234 (5.40 g, 34.1 mmol, 1 equiv) in THF (35 mL) dropwise. The 
resulting mixture was stirred at rt for 45 min. before slow addition of sat. NH4Cl (50 
mL) (CAUTION - HIGHLY EXOTHERMIC QUENCH), Rochelle’s salt (50 mL), 
and EtOAc (100 mL). The mixture was stirred overnight at rt before separating and 
further extracting the aqueous layer with EtOAc (2 x 200 mL). The combined organic 
layers were dried (MgSO4) and concentrated under reduced pressure. Silica gel 
chromatography (30%-70% EtOAc in heptane) afforded (R)-240 as a colourless oil 
(5.26 g, 89 %); [!]D24 +48.9 (c 1.50, CHCl3). All other data as for racemic 240. 
OH
OEt
O OH
N
O
O
(R)-234 (R)-240
Experimental 
 155 
(R)-6-Hydroxy-7-methyl-1,7-octadien-4-one (238) 
 
 
 
To (R)-240 (4.65 g, 26.9 mmol, 1 equiv) in THF (135 mL) at 0 ºC was added 
allylmagnesium chloride (26.9 mL, 2 M in THF, 53.7 mmol, 2 equiv) dropwise. The 
mixture was stirred at 0 ºC for 30 min, then rt for 2 h before being poured into sat. 
NH4Cl (200 mL), the organic layer was separated and the aqueous layer was further 
extracted with EtOAc (2 x 300 mL). The combined organic layers were dried 
(MgSO4) and concentrated under reduced pressure to give (R)-238 as a yellow oil 
(3.73 g, 90 %). No further purification required; [!]D25 +62.1 (c 1.25, CHCl3). All 
other data as for racemic 238. 
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(3R,5S)-5-Hydroxy-2-methyl-1,7-octadien-3-yl benzoate (241) 
 
 
 
To crude (R)-238 (~26.9 mmol, 1 equiv) in THF (90 mL) was added benzaldehyde 
(10.9 mL, 108 mL, 4 equiv). The mixture was cooled to –10 ºC and SmI2 (81 mL, 0.1 
M in THF, 8.1 mmol, 0.3 equiv) was added over 2 min. The reaction mixture was 
stirred at –10 ºC for 30 min. The reaction mixture was diluted with Et2O (100 mL) 
and washed with sat. NaHCO3 (100 mL), dried (MgSO4) and concentrated under 
reduced pressure. Silica gel chromatography (5-20% EtOAc in heptane) gave 
(3R,5S)-241 as a colourless oil (3.15 g, 45 % over two steps, >99:1 anti/syn); [!]D25 
+10.0 (c 1.00, CHCl3). All other data as for racemic 241. 
OH O
238
O OH
O
Ph
241
Experimental 
 157 
(1R,5S)-5-Hydroxy-2-methylcyclohex-2-enyl benzoate (242) 
 
 
 
To (3R,5S)-241 (1.90 g, 7.30 mmol, 1 equiv) in CH2Cl2 (150 mL) was added Grubbs 
2nd generation catalyst (310 mg, 0.36 mmol, 0.05 equiv). The reaction mixture was 
heated to 40 ºC for 90 min, before being cooled, filtered through Celite® and 
concentrated under reduced pressure. Purification by silica gel chromatography (10-
30 % EtOAc in heptane) afforded (1R,5S)-242 as a brown oil (1.68 g, 99 %); [!]D25 
+150.0 (c 0.60, CHCl3). All other data as for racemic 242. 
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(1R,5S)-5-(Tert-butyldimethylsilyloxy)-2-methylcyclohex-2-enyl benzoate (279) 
 
 
 
To (1R,5S)-242 (2.51 g, 10.8 mmol, 1 equiv) in CH2Cl2 (25 mL) at 0 ºC was added 
imidazole (1.48 g, 21.7 mmol, 2 equiv), followed after 5 min by tert-
butyldimethylsilylchloride (3.24 g, 21.7 mmol, 2 equiv). The reaction mixture was 
stirred at rt for 15 h then diluted with CH2Cl2 (300 mL), washed with H2O (200 mL) 
and brine (200 mL), dried (MgSO4) and concentrated under reduced pressure. 
Purification by silica gel chromatography (0-10 % EtOAc in heptane) afforded 
(1R,5S)-279 as a colourless oil (3.48 g, 93 %); [!]D24 +0.43 (c 1.30, CHCl3). All other 
data as for racemic 279. 
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(3R,5S)-5-Hydroxy-2-methyl-1,7-octadien-3-yl propionate (277) 
 
 
 
To (R)-238 (1.30 g, 8.43 mmol, 1 equiv) in THF (22 mL) at –10 ºC was added 
propionaldehyde (2.42 mL, 33.7 mmol, 4 equiv). After 5 min stirring, SmI2 (25.2 mL, 
0.1 M in THF, 2.52 mmol, 0.3 equiv) was added over 1 min. After the green/blue 
colour had abated (~2 min) the reaction mixture was stirred for a further 30 min 
before adding sat. NaHCO3 (20 mL) and extracting with Et2O (3 x 50 mL). The 
combined organic layers were dried (MgSO4) and concentrated under reduced 
pressure. Purification by silica gel chromatography (0-10 % EtOAc in petrol) 
afforded 277 as a yellow oil (1.57 g, 88 %); Rf 0.60 (10 % EtOAc in petrol); [!]D24 
+42.9 (c 0.70, CHCl3); !max (film) 3443, 2360, 1723, 1642, 1438, 1365, 1277, 1191, 
1082 cm-1; "H (CDCl3, 400 MHz) 5.92–5.79 (1H, m, CH=CH2), 5.45 (1H, dd, J 10.0, 
3.0 Hz, CH-ester), 5.17–5.09 (2H, m, CH=CH2), 5.02–5.00 (1H, m, CH2=C), 4.92–
4.90 (1H, m, CH2=C), 3.68–3.59 (1H, m, CHOH), 2.62 (1H, d, J 4.0 Hz, OH), 2.40 
(2H, q, J 7.5 Hz, CH3CH2), 2.29–2.24(2H, m, CH2), 1.85–1.66(2H, m, CH2CH=CH2), 
1.77 (3H, s, CH3), 1.18 (3H, t, J 7.5 Hz, CH3CH2); "C (CDCl3, 100 MHz) 174.6 (CO), 
143.6 (C=CH2), 134.6 (CH=CH2), 117.8 (CH=CH2), 112.2 (C=CH2), 74.1 (CH-ester), 
66.8 (CHOH), 41.7 (CH2CH=CH2), 40.6 (CH2), 27.8 (CH2CH3), 18.6 (CH3C=C), 9.2 
(CH3CH2); m/z (CI) 230 [M+NH4]+, 213 [M+H]+, 139, 121 (Found [M+NH4]+, 
230.1757. C12H20O3 requires [M+NH4]+, 230.1756). 
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(1R,5S)-5-Hydroxy-2-methylcyclohex-2-enyl propionate (278) 
 
 
 
To 277 (900 mg, 4.24 mmol, 1 equiv) in CH2Cl2 (85 mL) at 40 ºC was added Grubbs 
2nd generation catalyst (108 mg, 0.13 mmol, 0.03 equiv) in three equal portions 
separated by 45 min intervals. After addition was complete the reaction mixture was 
stirred for a further 3 h, before being cooled, filtered through Celite® and 
concentrated under reduced pressure. Purification by silica gel chromatography (20-
30 % EtOAc in petrol) afforded 278 as a brown oil (715 mg, 92 %); Rf 0.25 (15 % 
EtOAc in petrol); [!]D23 +114.8 (c 0.90, CHCl3); !max (film) 3338, 2972, 2921, 1732, 
1452, 1365, 1274, 1187, 1082, 1061, 1023 cm-1; "H (CDCl3, 400 MHz) 5.62–5.57 
(1H, m, CH=C), 5.42–5.37 (1H, m, CH-ester), 4.12–4.01 (1H, m, CHOH), 2.52–2.43 
(1H, m, ring CH2) 2.37 (2H, q, J 7.5 Hz, CH3CH2), 2.09–1.94 (2H, m, ring CH2), 
1.88–1.76 (1H, m, ring CH2), 1.75 (1H, bs, OH), 1.70 (3H, s, CH3C=C), 1.18 (3H, t, J 
7.5 Hz, CH3CH2); "C (CDCl3, 100 MHz) 174.2 (CO), 131.8 (C=CH), 124.9 (CH=C), 
71.0 (CH-ester), 64.2 (CHOH), 37.7 (ring CH2), 34.6 (ring CH2), 27.9 (CH2CH3), 
20.1 (CH3C=C), 9.2 (CH3CH2); m/z (CI) 202 [M+NH4]+, 185 [M+H]+, 153, 128 
(Found [M+H]+, 185.1183. C10H16O3 requires [M+H]+, 185.1177). 
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(1R,5S)-5-(Tert-butyldimethylsilyloxy)-2-methylcyclohex-2-enyl propionate (280) 
 
 
 
To 278 (520 mg, 2.82 mmol, 1 equiv) in CH2Cl2 (15 mL) at 0 ºC was added 
imidazole (384 mg, 5.64 mmol, 2 equiv), followed after 5 min by tert-
butyldimethylsilylchloride (850 mg, 5.64 mmol, 2 equiv). The reaction mixture was 
stirred at rt for 5 h then diluted with CH2Cl2 (100 mL), washed with H2O (50 mL) and 
brine (50 mL), dried (MgSO4) and concentrated under reduced pressure. Purification 
by silica gel chromatography (0-10 % EtOAc in petrol) afforded 280 as a colourless 
oil (718 mg, 85 %); Rf 0.55 (10 % EtOAc in petrol); [!]D24 +58.9 (c 1.30, CHCl3); 
!max (film) 2955, 2929, 2857, 1737, 1463, 1361, 1255, 1183, 1106 cm-1; "H (CDCl3, 
400 MHz) 5.61–5.56 (1H, m, CH=C), 5.39–5.34 (1H, m, CH-ester), 4.66–3.97 (1H, 
m, CHOTBS), 2.40–2.28 (3H, m, CH3CH2 + ring CH2), 2.04–1.92 (2H, m, ring CH2), 
1.85–1.73 (1H, m, ring CH2), 1.69 (3H, s, CH3C=C), 1.19 (3H, t, J 7.5 Hz, CH3CH2), 
0.90 (9H, s, C(CH3)3), 0.08 (3H, s, SiCH3), 0.07 (3H, s, SiCH3); "C (CDCl3, 100 
MHz) 174.2 (CO), 131.5 (C=CH), 125.8 (CH=C), 71.6 (CH-ester), 64.8 (CHOH), 
38.3 (CH2), 35.3 (CH2), 27.9 (CH3CH2), 25.8 (C(CH3)3), 20.2 (CH3C=C), 18.2 
(C(CH3)3), 9.4 (CH3CH2), –4.7 (SiCH3), –4.8 (SiCH3); m/z (CI) 316 [M+NH4]+, 299 
[M+H]+, 242, 225, 167 (Found [M+H]+, 299.2036. C16H30O3Si requires [M+H]+, 
299.2042). 
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(1R,5S)-5-(Tert-butyldimethylsilyloxy)-2-methylcyclohex-2-enol (243) 
Method A: 
 
 
To (1R,5S)-279 (1.00 g, 2.89 mmol, 1 equiv) in MeOH (13 mL) at 0 ºC was added 
methanolic KOH (8.67 mL, 1 M in MeOH, 8.67 mmol, 3 equiv). The reaction was 
allowed to warm to rt and stirred for 12 h. 1 N HCl (20 mL) was added and the 
reaction mixture diluted with Et2O (150 mL). The aqueous layer was separated and 
further extracted with Et2O (2 x 50 mL). The combined organic layers were dried 
(MgSO4) and concentrated under reduced pressure before purification by silica gel 
chromatography (5-25 % EtOAc in heptane) afforded (1R,5S)-243 as a colourless oil 
(677 mg, 97 %). 
Method B: 
 
To 280 (658 mg, 2.20 mmol, 1 equiv) in MeOH (6 mL) at 0 ºC was added methanolic 
KOH (5 mL, 1 M in MeOH, 5 mmol, 2.3 equiv). The reaction was allowed to warm 
to rt and stirred for 16 h. 1 N HCl (15 mL) and the resulting mixture extracted with 
Et2O (3 x 50 mL). The combined organic layers were dried (MgSO4) and 
concentrated under reduced pressure before purification by silica gel chromatography 
(20 % EtOAc in petrol) afforded (1R,5S)-243 as a colourless oil (468 mg, 88 %); 
 [!]D23 +83.3 (c 1.00, CHCl3). All other data as for racemic 243. 
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(1R,5S)-5-(Tert-butyldimethylsilyloxy)-2-methylcyclohex-2-enyl 2-tosylacetate 
(260) 
 
 
 
To (1R,5S)-243 (1.34 g, 5.53 mmol, 1 equiv) and 2-tosylacetic acid (1.18 g, 5.53 
mmol, 1 equiv) in CH2Cl2 (50 mL) at 0 °C was added DMAP (68 mg, 0.55 mmol, 0.1 
equiv) then DIC (950 µL, 6.08 mmol, 1.1 equiv). The reaction mixture was stirred at 
rt for 2 h then filtered through Celite®. The solids were washed with Et2O (20 mL), 
and the filtrate concentrated under reduced pressure. Purification by silica gel 
chromatography (5-20 % EtOAc in heptane) afforded 260 as a colourless oil 2.23 g, 
92 %); Rf 0.15 (15 % EtOAc in petrol); [!]D23 +60.6 (c 1.10, CHCl3); !max (film) 
2928, 2856, 1734, 1598, 1472, 1387, 1329, 1261, 1156, 1103, 1083 cm-1; "H (CDCl3, 
400 MHz) 7.78 (2H, d, J 8.0 Hz, o-Ts), 7.32 (2H, d, J 8.0 Hz, m-Ts), 5.55–5.50 (1H, 
m, CH=C), 5.33–5.28 (1H, m, CH-ester), 4.05 (2H, s, CH2Ts), 3.93–3.84 (1H, m, 
CHOTBS), 2.41 (3H, s, CH3Ar), 2.30–2.19 (1H, ring CH2), 1.96–1.82 (2H, m, ring 
CH2), 1.76–1.67 (1H, m, ring CH2), 1.59 (3H, s, CH3C=C), 0.82 (9H, s, C(CH3)3), 
0.00 (6H, s, SiCH3); "C (CDCl3, 100 MHz) 162.2 (CO), 145.4 (C=CH), 136.0 (Ar), 
130.4 (Ar), 129.9 (m-Ts), 128.6 (o-Ts), 126.7 (CH=C), 74.3 (CH-ester), 64.4 
(CHOTBS), 61.2 (CH2Ts), 37.8 (CH2), 35.2 (CH2), 25.8 (C(CH3)3), 21.7 (CH3Ar), 
20.1 (CH3C=C), 18.1 (C(CH3)3), –4.7 (SiCH3), –4.8 (SiCH3); m/z (ESI) 502, 477, 461 
[M+Na]+, 456 [M+NH4]+ (Found [M+Na]+, 461.1795. C22H34O5SSi requires 
[M+Na]+, 461.1794). 
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2-((1S,5R)-5-(Tert-butyldimethylsilyloxy)-2-methylcyclohex-2-enyl)-2-tosylacetic 
acid (261) 
 
To a solution of 260 (2.08 g, 4.74 mmol, 1 equiv) in CH3CN (16 mL) was added Et3N 
(795 µL, 5.69 mmol, 1.2 equiv) then BSA (3.48 mL, 14.22 mmol, 3 equiv). The 
reaction mixture was heated to reflux for 3 h, before being cooled, diluted with 
EtOAc (150 mL), washed with 1 N HCl (50 mL), dried (Na2SO4), and concentrated 
under reduced pressure. Purification by silica gel chromatography (10-30 % EtOAc in 
heptane + 10 % MeOH + 1 % AcOH) afforded a 3:1 mixture of C-Ts epimers of 261 
as an off-white foamy solid (1.91 g. 92 %); Rf 0.55 (10 % EtOAc in petrol + 10 % 
MeOH + 1 % AcOH); mp 60-61 °C; !max (film) 3450, 3182, 2955. 2929, 2857, 1739, 
1598, 1382, 1324, 1255, 1148, 1086 cm-1; "H (CDCl3, 400 MHz) 7.84–7.77 (2H, m, 
o-Ts), 7.37–7.30 (2H, m, m-Ts), 5.42 (1H, s, CH=C), 4.31 (1H, d, J 3.0 Hz, CHTs 
major), 4.20–4.09 (1H, m, CHOTBS minor), 4.11 (1H, d, J 5.5 Hz, CHTs minor) 
4.00–3.93 (1H, m, CHOTBS major), 3.22–3.14 (1H, m, CHCHTs major), 3.09–3.03 
(1H, m, CHCHTs minor), 2.44 (3H, s, CH3Ar), 1.61 (3H, s, CH3C=C), 0.86 (9H, s, 
C(CH3)3 minor), 0.84 (9H, s, C(CH3)3 major), 0.06 (3H, s, SiCH3 minor), 0.02 (3H, s, 
SiCH3 major), 0.00 (3H, s, SiCH3 major), –0.02 (3H, s, SiCH3 minor); "C (CDCl3, 
100 MHz) 170.3 (CO major), 169.2 (CO minor), 145.5 (Ar), 135.3 (Ar major), 135.2 
(Ar minor), 131.2 (C=CH minor), 130.1 (C=CH major), 130.0 (m-Ts major), 129.8 
(m-Ts minor), 129.4 (o-Ts minor), 129.2 (o-Ts major), 125.2 (CH=C minor), 124.1 
(CH=C major), 72.9 (CHTs minor), 69.8 (CHTs major), 64.5 (CHOTBS major), 64.1 
(CHOTBS minor), 38.8 (CHCHTs minor), 36.4 (CHCHTs major), 36.3 (CH2 minor), 
35.3 (CH2 minor), 34.1 (CH2 major), 32.1 (CH2 major), 25.8 (C(CH3)3), 22.7 (CH3Ar 
minor), 21.7 (CH3Ar major), 21.3 (CH3C=C), 18.1 (C(CH3)3), –4.5 (SiCH3 minor), –
4.6 (SiCH3 major), –4.7 (SiCH3 minor), –4.8 (SiCH3 major); m/z (ESI) Found 
[M+Na]+, 461.1798. C22H34O5SSi requires [M+Na]+, 461.1794). 
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De-A,B-8-methylenecholestan-9!-yl 2-((1S,5R)-5-(tert-butyldimethylsilyloxy)-2-
methylcyclohex-2-enyl)-2-tosylacetate (262) 
 
 
 
To 223 (1.27 g, 4.56 mmol, 1 equiv) and 261 (2.00 g, 4.56 mmol, 1 equiv) in CH2Cl2 
(50 mL) at rt was added DMAP (55 mg, 0.46 mmol, 0.1 equiv) then DIC (782 µL, 
5.02 mmol, 1.1 equiv). The reaction mixture was stirred at rt for 6 h then filtered 
through Celite®. The solids were washed with Et2O (20 mL), and the filtrate 
concentrated under reduced pressure. Purification by silica gel chromatography (0-10 
% EtOAc in heptane) afforded an epimeric mixture of 262 as a white waxy solid 
(2.52 g, 79 %); mp 43-45 °C; Rf 0.80 (5 % EtOAc in petrol); !max (film) 2953, 2928, 
2856, 1731, 1470, 1327, 1141. 1104, 1086 cm-1; "H (CDCl3, 400 MHz) 7.87–7.80 
(2H, m, o-Ts), 7.37–7.30 (2H, m, m-Ts), 5.43 (1H, s, CH=C major), 5.36 (1H, s, 
CH=C minor), 5.31 (1H, s, CH-ester major), 5.17 (1H, s, CH-ester minor), 5.02 (1H, 
s, C=CH2), 4.78–4.65 (1H, m, C=CH2), 4.34–4.29 (1H, m, CHTs major), 4.20–4.11 
(1H, CHOTBS minor), 4.06–3.98 (2H, CHTs minor + CHOTBS major), 3.34–3.01 
(1H, m, CHCHTs), 2.45 (3H, s, CH3Ar), 2.35–0.99 (25H, m), 0.97–0.84 (18H, m, H-
21 + H-26/27 + C(CH3)3) 0.54 (3H, s, H-18 major), 0.53 (3H, s, H-18 minor), 0.13–
0.3 (SiCH3); "C (CDCl3, 100 MHz) 164.3 (CO), 144.9 (C=CH2), 131.0 (Ar), 129.6 
(m-Ts), 129.5 (C=CH), 129.2 (o-Ts), 124.9 (Ar), 123.4 (C=CH), 112.0 (C=CH2), 76.4 
and 73.7 (CH-ester), 70.0 (CHOTBS), 64.6 and 64.1 (CHTs), 56.2, 56.1, 50.5, 50.4 
(C-14), 44.5, 44.4, 39.5, 38.7, 37.5, 36.1, 36.0, 35.9, 35.7, 35.1, 34.8, 34.0, 31.9, 31.8, 
29.0, 28.3, 28.0, 27.5, 25.9 (C(CH3)3), 23.9, 22.9, 22.8, 22.7, 22.5, 21.9, 21.8 
(CH3Ar), 21.6, 21.5, 18.8, 14.1, 11.1, –4.6 (CH3Si), –4.9 (CH3Si)  m/z (ESI) 721 
[M+Na]+ (Found [M+Na]+, 721.4315. C41H66O5SSi requires [M+Na]+, 721.4298). 
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Tert-butyldimethyl((1R,5S)-4-methyl-5-(2-(des-A,B-8(9)-cholesten-8-yl)-1-
tosylethyl))cyclohex-3-enyloxy)silane (263) 
 
 
 
To 262 (411 mg, 0.59 mmol, 1 equiv) and KOAc (6 mg, 0.06 mmol, 0.1 equiv) in a 
capped microwave vial was added BSA (500 µL, 2.05 mmol, 3.5 equiv). The mixture 
was heated by microwave irradiation at 180 °C for 5 ! 1 min (including a 1 min 
cooling period between each 1 min heating period). Purification of the crude reaction 
mixture by silica gel chromatography (0-5 % EtOAc in heptane) afforded 263 as a 
colourless oil (340 mg, 88 %). Further silica gel chromatography (5% Et2O in 
heptane) furnished separate epimers 263a (217 mg, 56%) and 263b (113mg, 30%). 
Data for major epimer 263a: Rf 0.65 (25 % EtOAc in heptane); ["]D25 –19.3 (c 1.45, 
CHCl3); !max (film) 2953, 2927, 1463, 1378, 1341, 1301, 1251, 1143, 1088 cm-1; "H 
(CDCl3, 400 MHz) 7.74 (2H, d, J 8.0 Hz, o-Ts), 7.30 (2H, d, J 8.0 Hz, m-Ts), 5.37 
(1H, s, CH=C cyclohexenyl), 5.02 (1H, s, H-9), 4.12–4.04 (1H, m, CHOTBS), 3.65–
3.58 (1H, m, CHTs), 3.10–3.01 (1H, m, CHCHTs), 2.59 (1H, dd, J 16.0, 7.0 Hz, 
CH2CHTs), 2.42 (3H, s, CH3Ar), 2.27 (1H, dd, J 16.0 Hz, 5.0 Hz, CH2CHTs), 2.04–
0.93 (22H, m), 1.56 (3H, s, CH3C=C), 0.90 (3H, d, J 6.5 Hz, H-21), 0.88–0.84 (15H, 
m, H-26/27 + C(CH3)3), 0.55 (3H, s, H-18), 0.08 (3H, s, SiCH3), 0.05 (3H, s, SiCH3); 
"C (CDCl3, 100 MHz) 144.1 (Ar), 137.3 (Ar), 134.1 (C-8), 131.9 (C=CH 
cyclohexenyl), 129.6 (m-Ts), 128.5 (o-Ts), 123.1 (CH=C cyclohexenyl), 122.1 (C-9), 
65.3 (CHOTBS), 63.3 (CHTs), 54.4 (C-17), 51.2 (C-14), 42.4 (C-13), 39.5, 36.1 
(CHCHTs), 36.0, 35.8, 34.1, 31.7, 28.9 (CH2CHTs), 28.3, 28.0, 25.9 (C(CH3)3), 24.5, 
23.9, 22.8, 22.6, 21.6 (CH3Ar), 21.5, 18.8 (C-21), 18.1 (C(CH3)3), 11.1 (C-18), –4.5 
(SiCH3), –4.8 (SiCH3); m/z (ESI) 713, 693, 672 [M+NH4]+, 655 [M+H]+, 523 (Found 
[M+H]+, 655.4594. C40H66O3SSi requires [M+H]+, 655.4580). 
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Data for minor epimer 263b: Rf 0.60 (25 % EtOAc in heptane); [!]D25 –12.9 (c 0.93, 
CHCl3); !max (film) 2953, 2927, 1463, 1378, 1312, 1301, 1250, 1142, 1087 cm-1; "H 
(CDCl3, 400 MHz) 7.75 (2H, d, J 8.0 Hz, o-Ts), 7.32 (2H, d, J 8.0 Hz, m-Ts), 5.37 
(1H, s, CH=C cyclohexenyl), 5.26–5.22 (1H, m, C-9), 4.28–4.22 (1H, m, CHOTBS), 
3.61–3.53 (1H, m, CHTs), 3.04–2.96 (1H, m, CHCHTs), 2.45 (3H, s, CH3Ar), 2.41–
2.28 (3H, m), 2.20–2.11 (1H, m), 2.10–0.92 (23H, m), 0.92–0.84 (18H, m, H-21 + H-
26/27 + C(CH3)3), 0.56 (3H, s, H-18), 0.00 (6H, s, SiCH3); "C (CDCl3, 100 MHz) 
144.1 (Ar), 137.7 (Ar), 133.7 (C-8), 133.3 (C=CH cyclohexenyl), 129.5 (m-Ts), 128.5 
(o-Ts), 125.2 CH=C cyclohexenyl), 120.9 (C-9), 65.2 (CHOTBS), 63.3 (CHTs), 54.1 
(C-17), 51.5 (C-14), 42.3 (C-13), 39.5, 36.1, 36.1, 35.9, 35.7, 34.4, 32.6, 32.2, 29.7, 
28.2, 28.0, 25.9 (C(CH3)3), 24.5, 23.8, 22.8, 22.6, 22.5, 21.6 (CH3Ar), 18.8 (C-21), 
18.2 (C(CH3)3), 11.4 (C-18), –4.5 (SiCH3), –4.7 (SiCH3); m/z (CI) 718, 693, 672 
[M+NH4]+, 655 [M+H]+, 523 (Found [M+H]+, 655.4604. C40H66O3SSi requires 
[M+H]+, 655.4580). 
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(1R,5S)-4-Methyl-5-(2-(des-A,B-8(9)-cholesten-8-yl)-1-tosylethyl))cyclohex-3-
enol (281) 
 
 
 
To 263a (350 mg, 0.53 mmol, 1 equiv) in THF (2 mL) at rt was added tetra-
butylammonium fluoride (1.06 mL, 1.0M in THF, 1.06 mmol, 2 equiv). The reaction 
was stirred for 15 h before being diluted with EtOAc (25 mL) and washed with H2O 
(10 mL). The organic layer was dried (MgSO4) and concentrated under reduced 
pressure. Purification by silica gel chromatography (40% EtOAc in heptane) afforded 
281 as a colourless foamy solid (271 mg, 95 %); mp 54-56 °C; Rf 0.10 (25 % EtOAc 
in heptane); [!]D20 –8.0 (c 1.00, CHCl3); !max (film) 3491, 2952, 1598, 1466, 1379, 
1300, 1288, 1140, 1086 cm-1; "H (CDCl3, 400 MHz) 7.76 (2H, d, J 8.0 Hz, o-Ts), 
7.32 (2H, d, J 8.0 Hz, m-Ts), 5.43 (1H, s, CH=C cyclohexenyl), 5.00 (1H, s, H-9), 
4.20–4.13 (1H, m, CHOH), 3.68–3.60 (1H, m, CHTs), 3.19–3.10 (1H, m, CHCHTs), 
2.56 (1H, dd, J 16.0, 6.5 Hz, CH2CHTs), 2.43 (3H, s, CH3Ar), 2.33–2.16 (2H, m, 
CH2CHTs + other CH2), 2.16–1.65 (8H, m), 1.60 (3H, s, CH3C=C), 1.58–1.46 (2H, 
m), 1.41–0.94 (14H, m), 0.90 (3H, d, J 6.5 Hz, H-21), 0.88 (3H, d, J 2.0 Hz, H-
26/27), 0.86 (3H, d, J 2.0 Hz, H-26/27), 0.54 (3H, s, H-18); "C (CDCl3, 100 MHz) 
144.3 (Ar), 137.0 (Ar), 133.7 (C-8), 132.4 (C=CH cyclohexenyl), 129.6 (m-Ts), 128.5 
(o-Ts), 122.7 (CH=C cyclohexenyl), 122.1 (C-9), 64.6 (CHOH), 62.9 (CHTs), 54.4 
(C-17), 51.1 (C-14), 42.4 (C-13), 39.5, 36.1 (CHCHTs), 35.8, 35.2, 32.9, 31.1, 28.8 
(CH2CHTs), 28.2, 28.0, 27.9, 24.5, 23.8, 22.8, 22.7, 22.5, 21.6 (CH3Ar), 21.5, 18.7 
(C-21), 11.1 (C-18); m/z (ESI) 605, 579, 558 [M+NH4]+, 541 [M+H]+, 431 (Found 
[M+H]+, 541.3707. C34H52O3S requires [M+H]+, 541.3715). 
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(1S,3S,5S,6R)-6-Methyl-5-(2-(des-A,B-8(9)-cholesten-8-yl)-1-tosylethyl)-7-
oxabicyclo[4.1.0]heptan-3-ol (282) 
 
 
 
To 281 (326 mg, 0.60 mmol, 1 equiv) in CH2Cl2 (6 mL) at –10 °C was added 
VO(acac)2 (5 mg, 0.02 mmol, 3 mol %) followed by dropwise addition of t-BuOOH 
(208 !L, 4.33 M in CH2Cl2, 0.90 mmol, 1.5 equiv). The resulting red reaction 
mixture was stirred at –10 °C for 4 h before diluting with EtOAc (50 mL) and washed 
with sat. NaHCO3 (20 mL) then brine (20 mL). The organic layer was dried (MgSO4) 
and concentrated under reduced pressure. Purification by silica gel chromatography 
(20-50 % EtOAc in heptane) afforded 282 as a colourless foamy solid (319 mg, 96 
%); Rf 0.10 (25 % EtOAc in heptane); mp 53-55 °C; [!]D20 +21.8 (c 1.10, CHCl3); 
"max (film) 3510, 2953, 1598, 1454, 1381, 1314, 1301, 1289, 1145, 1086, 1052 cm-1; 
#H (CDCl3, 400 MHz) 7.76 (2H, d, J 8.0 Hz, o-Ts), 7.34 (2H, d, J 8.0 Hz, m-Ts), 5.03 
(1H, s, H-9), 4.00–3.89 (1H, m, CHOH), 3.62–3.54 (1H, m, CHTs), 3.18–3.04 (3H, 
m, OH + CH(epoxide) + CHCHTs), 2.72 (1H, dd, J 17.0, 6.5 Hz, CH2CHTs), 2.45 
(3H, s, CH3Ar), 2.32–2.22 (2H, m, CH2CHTs + cyclohexyl CH2), 2.21–2.12 (1H, m, 
cyclohexyl CH2), 2.06–0.94 (20H, m), 1.30 (3H, s, CH3(epoxide)), 0.90 (3H, d, J 6.5 
Hz, H-21), 0.88 (3H, d, J 2.0 Hz, H-26/27), 0.86 (3H, d, J 2.0 Hz, H-26/27), 0.57 
(H-18); #C (CDCl3, 100 MHz) 144.7 (Ar), 136.9 (Ar), 133.4 (C-8), 129.8 (m-Ts), 
128.6 (o-Ts), 122.1 (C-9), 64.5 (CHOH), 63.3 (CHTs), 62.0 (CHO), 60.2 (CH3CO), 
54.4 (C-14), 51.3 (C-17), 42.4 (C-13), 39.5, 36.1, 35.7, 33.8 (CHCHTs), 31.2, 30.1, 
29.7, 28.2, 28.0, 24.6, 23.8, 22.8, 22.7, 22.6, 22.4, 21.6 (CH3Ar), 18.8 (C-21), 11.2 
(C-18); m/z (ESI) 557 [M+H]+, 540 [M–O]+, 401 (Found [M+H]+, 557.3663. 
C34H52O4S requires [M+H]+, 557.3664). 
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Tert-butyldimethyl((1S,3S,5S,6R)-6-methyl-5-(2-(des-A,B-8(9)-cholesten-8-yl)-1-
tosylethyl)-7-oxabicyclo[4.1.0]heptan-3-yloxy)silane (283) 
 
 
 
To 282 (174 mg, 0.31 mmol, 1 equiv) in CH2Cl2 (1.5 mL) at 0 ºC was added 
imidazole (43 mg, 0.62 mmol, 2 equiv), followed after 5 min by tert-
butyldimethylsilylchloride (94 mg, 0.62 mmol, 2 equiv). The reaction mixture was 
stirred at rt for 18 h then diluted with Et2O (25 mL), washed with H2O (20 mL) and 
brine (20 mL), dried (MgSO4) and concentrated under reduced pressure. Purification 
by silica gel chromatography (5-10 % EtOAc in petrol) afforded 283 as a colourless 
oil (200 mg, 96 %); Rf 0.55 (30 % EtOAc in heptane); [!]D25 +13.7 (c 1.30, CHCl3); 
!max (film) 2953, 2929, 1598, 1463, 1382, 1315, 1300, 1255, 1146, 1104, 1088 cm-1; 
"H (CDCl3, 400 MHz) 7.75 (2H, d, J 8.0 Hz, o-Ts), 7.32 (2H, d, J 8.0 Hz, m-Ts), 5.00 
(1H, s, H-9), 4.05–3.95 (1H, m, CHOTBS), 3.56–3.49 (1H, m, CHTs), 2.97–2.88 
(2H, m, CH(epoxide) + CHCHTs), 2.72 (1H, dd, J 16.5, 7.5 Hz, CH2CHTs), 2.44 
(3H, s, CH3Ar), 2.35–2.15 (2H, m, CH2CHTs + cyclohexyl CH2), 2.05–0.96 (24H, 
m), 1.17 (3H, s, CH3(epoxide)), 0.95–0.82 (15H, m, C(CH3)3 + H-21 + H-26/27), 0.58 
(3H, s, H-18), 0.00 (6H, CH3Si); "C (CDCl3, 100 MHz) 143.5 (Ar), 136.4 (Ar), 132.7 
(C-8), 128.7 (m-Ts), 127.5 (o-Ts), 120.9 (C-9), 63.1 (CHTs), 62.1 (CHOTBS), 58.7 
(CHO), 57.2 (CH3CO), 53.4 (C-14), 50.3 (C-17), 41.4 (C-13), 38.5, 35.9 (CHCHTs), 
35.1, 34.7, 32.3, 30.9, 29.9, 29.5, 27.2, 27.0, 24.9 (C(CH3)3), 23.6, 22.8, 21.8, 21.7, 
21.6 (CH3Ar), 21.5, 17.8 (C-21), 17.0 (C(CH3)3), 13.1, 10.2 (C-18), –5.4 (CH3Si), –
5.8 (CH3Si); m/z (ESI) 693 [M+Na]+, 671 [M+H]+ (Found [M+Na]+, 693.4355. 
C40H66O4SSi requires [M+Na]+, 693.4349). 
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(1S,2S,4S)-4-(Tert-butyldimethylsilyloxy)-1-methyl-2-(2-(des-A,B-8(9)-cholesten-
8-yl)-1-tosylethyl)cyclopentanecarbaldehyde (286) 
 
 
 
Rf 0.60 (20 % EtOAc in heptane); [!]D25 +19.5 (c 1.00, CHCl3); !H (CDCl3, 400 
MHz) 9.40 (1H, s, CHO), 7.74 (2H, d, J 8.0 Hz, o-Ts), 7.32 (2H, d, J 8.0 Hz, m-Ts), 
5.19 (1H, s, H-9), 4.37–4.32 (1H, m, CHOTBS), 3.44–3.37 (1H, m, CHTs), 3.00–
2.92 (1H, m, CHCHTs), 2.72–2.63 (1H, m, CH2CHTs), 2.44 (3H, s, CH3Ar), 2.28 
(1H, dd, J 14.0, 5.5 Hz, CH2CCHO), 2.13–0.95 (25H, m), 0.93–0.89 (12H, m, 
C(CH3)3 + H-21), 0.88 (3H, d, J 2.0 Hz, H-26/27), 0.86 (3H, d, J 2.0 Hz, H-26/27), 
0.59 (3H, s, H-18), 0.07 (3H, s, SiCH3), 0.04 (3H, s, SiCH3); !C (CDCl3, 100 MHz) 
203.6 (CHO), 143.5 (Ar), 134.0 (Ar), 132.9 (C-8), 128.6 (m-Ts), 128.2 (o-Ts), 121.9 
(C-9), 70.4 (CHOTBS), 58.8 (CHTs), 53.7 (CCHO), 53.3, 49.5, 45.4 (CHCHTs), 
43.4 (CH2CCHO), 41.4 (C-13), 38.5, 37.1, 35.1, 34.6, 30.9, 29.9, 28.7, 27.2, 27.0, 
24.8 (C(CH3)3), 23.6, 22.8, 21.8, 21.5, 20.8, 20.6, 17.7, 16.9, 10.3 (C-18), –5.8 
(SiCH3), –5.9 (SiCH3); m/z (ESI) 693 [M+Na]+ (Found [M+Na]+, 693.4311. 
C44H66O4SSi requires [M+Na]+, 693.4349). 
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(2R,3S,5S)-5-(Tert-butyldimethylsilyloxy)-2-methyl-3-(2-(des-A,B-8(9)-cholesten-
8-yl)-1-tosylethyl)cyclohexanone (287) 
 
 
 
Rf 0.65 (30 % EtOAc in heptane); [!]D24 +6.9 (c 0.50, CHCl3); !max (film) 2954, 
2930, 2857, 1720, 1598, 1464, 1316, 1302, 1148 cm-1; "H (CDCl3, 400 MHz) 7.76 
(2H, d, J 8.0 Hz, o-Ts), 7.34 (2H, d, J 8.0 Hz, m-Ts), 5.44 (1H, s, H-9), 4.49 (1H, s, 
CHOTBS), 3.36 (1H, dd, J 10.5, 2.5 Hz, CHTs), 2.81–2.69 (2H, m, CHCHTs + 
CH2CHTs), 2.63–2.51 (1H, CH2CHTs), 2.49–2.28 (5H, m), 2.46 (3H, s, CH3Ar); 
2.15–1.84 (7H, m), 1.63–0.82 (32H, m), 1.23 (3H, s, CH3CHC=O), 0.62 (3H, s, H-
18), 0.12 (3H, s, SiCH3), 0.08 (SiCH3); "C (CDCl3, 100 MHz) 209.0 (CO), 144.5 
(Ar), 135.5 (Ar), 134.8 (C-8), 129.8 (m-Ts), 128.7 (o-Ts), 124.4 (H-9), 68.3 
(CHOTBS), 61.9 (CHTs), 54.3, 50.6, 49.4, 47.5, 42.7, 39.5, 37.1, 36.1, 36.0, 35.9, 
33.6, 30.0, 29.7, 28.2, 28.0, 25.8 (C(CH3)3), 24.7, 23.9, 23.8, 22.8, 22.5, 22.4, 21.6, 
18.7, 18.0, 12.2, 11.1 (C-18), –4.8 (SiCH3), –5.1 (SiCH3); m/z (ESI) 734, 709, 693 
[M+Na]+, 688 [M+NH4]+, 671 [M+H]+, 539 (Found [M+H]+, 671.4536. C40H66O4SSi 
requires [M+H]+, 671.4529). 
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3-(Tert-butyldimethylsilyloxy)-6-tosylcholestenol (288) 
 
 
 
To 283 (40 mg, 65 !mol, 1 equiv) in CH2Cl2 (1.3 mL) at –78 ºC was added a 
pre-prepared solution of trifluoromethanesulfonic acid (6 !L, 1 % v/v in CH2Cl2, 65 
!mol, 1 equiv). The reaction mixture was stirred vigorously and allowed to warm to  
–40 ºC over 2 h before being diluted with CH2Cl2 (10 mL) and washed with brine (5 
mL), dried (MgSO4) and concentrated under reduced pressure. Purification by silica 
gel chromatography (10 % EtOAc in petrol) afforded 288 as a colourless oil (27 mg, 
68 %); Rf 0.60 (30 % EtOAc in heptane); [!]D25 +54.0 (c 1.25, CHCl3); "max (film) 
3493, 2954, 2929, 2858, 1598, 1464, 1384, 1366, 1314, 1302, 1286, 1259, 1147, 
1087, 1056 cm-1; #H (CDCl3, 400 MHz) 7.77 (2H, d, J 8.0 Hz, o-Ts), 7.35 (2H, d, J 
8.0 Hz, m-Ts), 4.34 (1H, d, J 9.0 Hz, OH), 4.32–4.26 (1H, m, H-3), 3.81–3.74 (1H, 
m, H-1), 3.37–3.29 (1H, m, H-6), 2.65–2.57 (1H, m, H-5), 2.46 (3H, s, CH3Ar), 2.46–
2.36 (2H, m, allyl CH2 + H-7), 2.25–2.10 (3H, m, contains H-4 + H-2), 1.98–1.03 (H, 
m), 0.97 (3H, s, H-18), 0.95–0.91 (12H, m, H-21 + C(CH3)3), 0.86 (3H, d, J 2.5 Hz, 
H-26/27), 0.84 (3H, d, J 2.5 Hz, H-26/27), 0.16 (3H, s, SiCH3), 0.14 (3H, s, SiCH3); 
#C (CDCl3, 100 MHz) 144.2 (Ar), 139.8 (olefin C), 136.1 (olefin C), 135.4 (Ar), 
129.8 (m-Ts), 128.2 (o-Ts), 73.3 (C-1), 68.7 (C-3), 61.7 (C-6), 50.3 (C-10), 48.1 (C-
17), 39.0 (C-13), 37.9, 35.7, 35.2, 32.6, 31.9 (C-5), 31.5 (allyl-CH), 29.7, 28.6, 28.0, 
27.8, 26.5, 25.8 (C(CH3)3), 25.4, 23.1, 22.7, 22.6, 21.6 (CH3Ar), 20.3, 20.2, 19.5, 
18.0, 17.9, –4.8 (SiCH3), –5.4 (SiCH3); m/z (ESI) 693 [M+Na]+, 671 [M+H]+  (Found 
[M+H]+, 671.4525. C40H66O4S requires [M+H]+, 671.4529). 
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6-Tosylcholesten-1,3-diol (289) 
 
 
 
To 288 (26 mg, 39 !mol, 1 equiv) in CH2Cl2 (1.5 mL) at 0 ºC was added imidazole (5 
mg, 78 !mol, 2 equiv), followed after 5 min by tert-butyldimethylsilylchloride (12 
mg, 78 !mol, 2 equiv). The reaction mixture was stirred at rt for 20 h then diluted 
with Et2O (15 mL), washed with H2O (5 mL) and brine (5 mL), dried (MgSO4) and 
concentrated under reduced pressure. Purification by silica gel chromatography (5-10 
% EtOAc in petrol) afforded 289 as a colourless oil (16 mg, 74 %); Rf 0.15 (30 % 
EtOAc in petrol); [!]D23 +35.4 (c 0.75, CHCl3); "max (film) 3392, 2927, 1454, 1382, 
1285, 1145, 1086, 1066 cm-1; #H (CDCl3, 400 MHz) 7.78 (2H, d, J 8.0 Hz, o-Ts), 
7.37 (2H, d, J 8.0 Hz, m-Ts), 4.30 (1H, s H-3), 3.84 (1H, s, H-1), 3.33–3.23 (1H, m, 
H-5), 2.47 (3H, s, CH3Ar), 2.45–2.33 (2H, m, allyl-CH + H-7), 2.30–0.77 (23H, m), 
0.97 (3H, s, H-19), 0.93 (3H, s, H-18), 0.92 (3H, d, J 6.0 Hz, H-21), 0.85 (3H, d, J 2.5 
Hz, H-26/27), 0.84 (3H, d, J 2.5 Hz, H-26/27); #C (CDCl3, 100 MHz) 144.5 (Ar), 
139.7 (olefin C), 135.8 (olefin C), 135.4 (Ar), 129.9 (m-Ts), 128.3 (o-Ts), 73.2 (C-1), 
67.5 (C-3), 61.9 (C-6), 50.3 (C-10), 47.8 (C-17), 41.2, 38.9, 37.9, 35.7, 35.0, 31.9, 
31.7, 31.4, 28.9, 28.0, 27.7, 26.5, 25.4, 23.0, 22.7, 22.6, 22.6, 21.7, 20.4, 20.2, 19.4 
(C-19), 18.0 (C-18); m/z (ESI) 579 [M+Na]+ (Found [M+Na]+, 579.3476. C34H52O4S 
requires [M+Na]+, 579.3484). 
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6-Tosylcholestenyl bis-1,3-(4-bromo)benzoate (290) 
 
To 289 (33 mg, 0.06 mmol, 1 equiv) in CH2Cl2 (2.0 mL) was added 4-bromobenzoic 
acid (24 mg, 0.12 mmol, 2 equiv) and DMAP (1.5 mg, 0.012 mmol, 0.1 equiv), 
followed after 5 mins with DIC (20 !L, 0.126 mmol, 2.1 equiv). The reaction was 
stirred at rt overnight. The mixture was directly submitted to purification by silica gel 
chromatography (5 % EtOAc in petrol) to afford 290 as an off-white foamy solid (45 
mg, 82 %); Rf 0.45 (5 % EtOAc in petrol); [!]D23 +18.5 (c 0.40, CHCl3); "max (film) 
2928, 1718, 1591, 1452, 1398, 1286, 1148, 1119, 1103, 1013 cm-1; #H (CDCl3, 400 
MHz) 7.77 (2H, d, J 8.0 Hz, o-Ts), 7.55 (2H, d, J 8.0 Hz, o-Ar), 7.51 (2H, d, J 8.0 
Hz, o-Ar), 7.41 (2H, d, J 8.0 Hz, m-Ts), 7.28 (2H, d, J 8.0 Hz, m-Ar), 7.18 (2H, d, J 
8.0 Hz, m-Ar), 5.40–5.35 (1H, m, H-3), 5.30–5.25 (1H, m, H-1), 3.50–3.41 (1H, m, 
H-6), 2.58–2.38 (5H, m), 2.42 (3H, s, CH3Ar), 2.23–2.06 (4H, m), 2.00–1.74 (6H, m), 
1.56–0.82 (9H, m), 1.06 (3H, s, H-18), 0.97 (3H, d, J 6.0 Hz, H-21), 0.92 (3H, s, H-
19), 0.89 (3H, d, J 2.5 Hz, H-26/27), 0.87 (3H, d, J 2.5 Hz, H-26/27); #C (CDCl3, 100 
MHz) 146.2 (Ar), 144.3 (Ar), 141.3 (Ar), 139.2 (olefin C), 136.1 (olefin C), 135.4 
(Ar), 131.6 (Ar), 131.3 (Ar), 131.0 (Ar), 130.9 (Ar), 129.8 (Ar), 129.1 (Ar), 128.3 
(Ar), 127.8 (Ar), 74.9 (C-1), 68.5 (C-3), 61.2 (C-6), 50.5 (C-10), 47.7 (C-17), 40.1, 
39.0 (C-13), 38.0, 35.7, 34.6, 33.8, 31.5 (allyl-CH), 28.2, 28.0, 27.8, 26.9, 25.4, 24.9, 
23.0, 22.8, 22.7, 22.6, 21.7, 20.2, 19.6, 19.1 (C-19), 17.9 (C-18); m/z (ESI) 945 
[M+Na]+ (Found [M+Na]+, 945.2228. C48H58O6SBr81Br79 requires [M+Na]+, 
945.2198). 
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De-A,B-9!-(triethylsilyloxy)cholestan-8-one (300) 
 
 
 
To 217 (1.88 g, 6.70 mmol, 1 equiv) in CH2Cl2 (35 mL) at 0 ºC was added imidazole 
(912 mg, 13.40 mmol, 2 equiv), followed after 5 min by triethylsilyl chloride 
(2.25mL, 13.40 mmol, 2 equiv). The reaction mixture was stirred at rt for 1 h then 
diluted with CH2Cl2 (200 mL), washed with H2O (100 mL) and brine (100 mL), dried 
(MgSO4) and concentrated under reduced pressure. Purification by silica gel 
chromatography (2 % EtOAc in petrol) afforded 300 as a colourless oil (2.32 g, 91 
%); Rf 0.60 (2 % EtOAc in petrol); [!]D24 –15.4 (c 1.30, CHCl3); !max (film) 2955, 
1724, 1467, 1384, 1239, 1085 cm-1; "H (CDCl3, 400 MHz) 3.94–3.90 (1H, m, H-9), 
3.21 (1H, dd, J 12.0, 7.0 Hz, H-14), 2.00–1.83 (5H, m), 1.80–1.68 (1H, m), 1.61–0.99 
(11H, m), 0.99–0.91 (12H, m, H-21 + CH3CH2Si), 0.90 (3H, d, J 2.0 Hz, H-26/27), 
0.88 (3H, d, J 2.0 Hz, H-26/27), 0.63–0.56 (9H, m, H-18 + CH2Si); "C (CDCl3, 100 
MHz) 211.4 (CO), 75.3 (C-9), 56.7 (C-17), 56.4 (C-14), 51.1 (C-17), 39.5, 36.0, 35.6, 
34.0, 33.0, 28.0, 27.6, 23.8, 22.8, 22.6, 18.7, 18.5, 12.1 (C-18), 6.7 (CH3CH2Si), 4.6 
(CH2Si); m/z (CI) 412 [M+NH4]+, 395 [M+H]+, 365, 132 (Found [M+H]+, 395.3342. 
C24H46O2Si requires [M+H]+, 395.3345). 
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(E)-De-A,B-9!-(triethylsilyloxy)-8-bromomethylenecholestane (303) and 
De-A,B-9!-(triethylsilyloxy)-8-methylenecholestane (302) 
 
 
 
To bromomethyltriphenylphosphonium bromide (3.31 g, 7.60 mmol, 3 equiv) in THF 
(13 mL) at –60 ºC was added NaHMDS (3.49 mL, 2 M in THF, 6.97 mmol, 2.75 
equiv) dropwise. After 2 h stirring, 300 (1.00 g, 2.53 mmol, 1 equiv) in THF (2 mL) 
was added dropwise. The reaction mixture was stirred at –60 ºC for 3h, –40 ºC for 2 
h, then –5 ºC for 15 h. After allowing to warm to rt, the reaction mixture was poured 
into sat. NH4Cl (25 mL) and extracted with Et2O (2 x 75 mL). The combined organic 
layers were washed with brine (50 mL), dried (MgSO4) and concentrated under 
reduced pressure. Purification by silica gel chromatography (Petrol) afforded an 
inseparable mixture of desired product E-301 (809 mg, 68 %) and methylene-
derivative 302 (188 mg, 19%) as a colourless oil. 
Data for mixture: Rf 1.00 (5 % EtOAc in petrol); !max (film) 2954, 2875, 1466, 1380, 
1083, 1038 cm-1; m/z (CI) 490, 488 [M(301)+NH4]+, 443, 392 [M(302)]+, 391 
[M(301)-Br]+, 276, 261, 259 (Found [M+NH4]+, 488.2913. C25H47BrOSi requires 
[M(301)+NH4]+, 488.2924). 
NMR data for E-301: "H (CDCl3, 400 MHz) inter alia 6.18 (1H, d, J 1.5 Hz, CH=C), 
4.16–4.12 (1H, m, H-9), 2.61 (1H, ddd, J 13.0, 6.5, 1.0 Hz, H-14), 2.46–2.33 (1H, m), 
1.98–0.99 (16H, m), 0.99–0.92 (12H, m, H-21 + CH3CH2Si), 0.90 (3H, d, J 2.0 Hz, 
H-26/27), 0.88 (3H, d, J 2.0 Hz, H-26/27), 0.71 (3H, s, H-18), 0.58 (6H, q, J 8.0 Hz, 
CH2Si); "C (CDCl3, 100 MHz) inter alia 145.7 (C=CHBr), 100.0 (CH=C), 74.5 (C-9), 
55.1 (C-14), 49.8 (C-17), 46.4, 39.5, 36.2, 24.7, 32.2, 28.2, 28.0, 24.0, 23.7, 22.8, 
22.6, 19.0, 11.8 (C-18), 6.8 (CH2Si), 4.8 (CH3Si). 
NMR data for 302: "H (CDCl3, 400 MHz) inter alia 4.87–4.85 (1H, m, CH2=C), 
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4.55–4.52 (1H, m, CH2=C), 4.20–4.17 (1H, m, H-9), 2.56–2.50 (1H, m, H-14), 1.98–
0.99 (15H, m), 0.99–0.92 (12H, m, H-21 + CH3CH2Si), 0.90 (3H, d, J 2.0 Hz, H-
26/27), 0.88 (3H, d, J 2.0 Hz, H-26/27), 0.71 (3H, s, H-18), 0.58 (6H, q, J 8.0 Hz, 
CH2Si); !C (CDCl3, 100 MHz) inter alia 151.4 (C=CH2), 106.7 (CH2=C), 72.8 (C-9), 
56.2 (C-14), 49.3 (C-17), 45.1, 39.5, 36.2, 34.7, 32.2, 27.7, 23.9, 23.7, 22.8, 22.6, 
21.8, 18.8, 11.2 (C-18), 6.9 (CH2Si), 4.9 (CH3Si) 
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(E)-De-A,B-9!-(triethylsilyloxy)-8-(trimethylsilyl)methylenecholestane (303) 
 
 
 
A mixture of E-301 (773 mg, 1.64 mmol, 1 equiv) and 302 (179 mg) in Et2O (3.5 
mL) at –78 ºC was added t-BuLi (2.11 mL, 1.55M in pentane, 3.28 mmol, 2 equiv) 
dropwise. After stirring for 2 h at  –78 ºC, TMSCl (416 !L, 3.28 mmol, 2 equiv) was 
added dropwise and the reaction allowed to warm to rt overnight. The reaction 
mixture was poured into sat. NH4Cl (25 mL) and extracted with petrol (2 x 50 mL), 
The combined organic layers were dried (MgSO4) and concentrated under reduced 
pressure. Purification by silica gel chromatography (Petrol) gave an inseparable 
mixture of the desired product E-303 (747 mg, 98%) and methylene-derivative 302 
(191 mg; 12 mg, 2 % from this step). 
Data for 302 as reported above. 
Data for E-303: Rf 0.90 (Petrol); "max (film) 2953, 1625, 1467, 1378, 1248, 1078, 
1037 cm-1; #H (CDCl3, 400 MHz) inter alia 5.40 (1H, CH=C), 4.06–4.02 (1H, m, H-
9), 2.79–2.68 (1H, m, H-14), 2.00–1.84 (1H, m), 1.78–1.00 (16H, m), 0.98–0.86 
(18H, m, CH3CH2Si + H-21, 26, 27), 0.62–0.54 (9H, m, CH2Si + H-18), 0.13 (9H, s, 
CH3Si); #C (CDCl3, 100 MHz) inter alia 160.4 (C=CH), 122.4 (CH=C), 79.8 (C-9), 
55.8 (C-14), 51.0 (C-17), 46.6, 45.0, 39.5, 36.0, 34.9, 32.5, 28.0, 27.9, 24.2, 23.9, 
22.8, 22.5, 21.8, 18.9, 11.7 (C-18), 6.9 (CH3CH2Si), 4.9 (CH2Si) 2.0 (CH3Si); m/z 
(CI) 465 [M+H]+, 350, 333, 261 (Found [M+H]+, 465.3953. C28H56OSi2 requires 
[M+H]+, 465.3948). 
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(E)-De-A,B-9!-hydroxy-8-(trimethylsilyl)methylenecholestane (297) 
 
 
 
To a E-303 (85 mg, 0.18 mmol, 1 equiv) in 10% H2O/THF (1.2 mL) cooled to 0 ºC 
was added DDQ (4 mg, 0.02 mmol, 0.1 equiv). The reaction was allowed to warm to 
rt and stirred overnight. The reaction mixture was directly purified by silica gel 
chromatography (1-5 % EtOAc in petrol) to afford E-297 as a colourless oil (52 mg, 
82 %); Rf 0.45 (5 % EtOAc in petrol); [!]D24 +36.3 (c 1.15, CHCl3); !max (film) 3334, 
2952, 1623, 1468, 1381, 1248, 1014 cm-1; "H (CDCl3, 400 MHz) 5.53 (1H, s, CH=C), 
4.17–4.10 (1H, m, H-9), 2.75–2.63 (1H, m, H-14), 2.01–1.01 (18H, m), 0.96 (3H, d, J 
6.0 Hz, H-21), 0.92–0.85 (6H, m, H-26-27), 0.62 (3H, s, H-18), 0.15 (9H, CH3Si); "C 
(CDCl3, 100 MHz) 158.8 (C=CH), 126.4 (CH=C), 79.8 (C-9), 55.7 (C-14), 50.9 (C-
17), 46.7, 39.5, 36.1, 35.9, 34.7, 30.7, 28.0, 27.8, 24.6, 23.8, 22.8, 22.6, 18.9, 11.7 (C-
18), 1.52 (CH3Si); m/z (CI) 368 [M+NH4]+, 350 [M]+, 333 [M–OH]+, 261 (Found 
[M+NH4]+, 368.3346. C22H42OSi requires [M+NH4]+, 368.3349). 
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(Z)-De-A,B-9!-(triethylsilyloxy)-8-(trimethylsilyl)methylenecholestane (303) 
 
 
 
To Me3SiCH2SiMe2(OMe) (1.12 g, 6.34 mmol, 1.2 equiv)) in pentane (18 mL) at rt 
was added t-BuLi (4.10 mL, 1.55 M in pentane, 6.34 mmol, 1.2 equiv) dropwise. 
After 2 h stirring at rt the reaction mixture was cooled to –78 ºC and 300 (2.09 g, 5.28 
mmol, 1 equiv) in pentane (5 mL) added dropwise. The reaction was allowed to warm 
to rt overnight, then poured into sat. NH4Cl (25 mL) and extracted with petrol (2 x 
100 mL). The combined organic layers were dried (MgSO4) and concentrated under 
reduced pressure. The crude oil obtained was placed in an oven set at 110 ºC for 3 h. 
Purification by silica gel chromatography (Petrol) afforded 303 as a colourless oil 
(811 mg, 33 %, 3:2 Z/E). 
Data for E-303 as reported above. 
Data for Z-303: Rf 0.90 (Petrol); !max (film) 2953, 2875, 1625, 1466, 1248, 1080, 
1048, 836 cm-1; "H (CDCl3, 400 MHz) 4.99 (1H, s, CH=C), 4.52–4.48 (1H, m, H-9), 
2.81–2.69 (1H, m, H-14), 1.97–1.86 (1H, m), 1.77–0.99 (16H, m), 0.99–0.85 (18H, 
m, H-21, 26, 27, CH3CH2Si), 0.61 (6H, q, J 8.0 Hz, CH2Si), 0.52 (3H, s, H-18), 0.15 
(9H, s, (CH3)3Si); "C (CDCl3, 100 MHz) 160.0 (C=CHTMS), 118.3 (CH=C), 71.0 
(C-9), 56.7 (C-14), 51.2 (C-17), 46.1, 39.5, 36.2, 36.1, 34.7, 32.5, 28.0, 27.7, 24.0, 
22.9, 22.6, 21.7, 18.8, 11.2 (C-18), 7.0 (CH3CH2Si), 5.3 (CH2Si), 0.8 ((CH3)3Si); m/z 
(CI) 465 [M+H]+, 333 (Found [M+H]+, 465.3937. C28H56OSi2 requires [M+H]+, 
465.3948). 
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(Z)-De-A,B-9!-hydroxy-8-(trimethylsilyl)methylenecholestane (297) 
 
To 303 (790 mg, 1.69 mmol, 1 equiv, 3:2 Z/E) in 10% H2O/THF (11 mL) cooled to 
0 ºC was added DDQ (39 mg, 0.17 mmol, 0.1 equiv). The reaction was allowed to 
warm to rt and stirred for 18 h. The reaction mixture was directly purified by silica 
gel chromatography (1-5 % EtOAc in petrol) to afford 297 as a colourless oil 
(240 mg, 41 %, 15:1 Z/E). 
Data for E-297 as reported above. 
Data for Z-297: Rf 0.50 (5 % EtOAc in petrol); !max (film) 3334, 2952, 1623, 1468, 
1380, 1248, 1014 cm-1; "H (CDCl3, 400 MHz) 5.20 (1H, d, J 2.0 Hz, CH=C), 4.54–
4.51 (1H, m, CHOH), 2.61–2.54 (1H, m, H-14), 1.97–1.85 (1H, m), 1.86–0.99 (17H, 
m), 0.95 (3H, d, J 6.0 Hz, H-21), 0.90 (3H, d, J 2.0 Hz, H-26/27), 0.88 (3H, d, J 2.0 
Hz, H-26/27), 0.54 (3H, s, H-18), 0.16 (9H, s, (CH3)3Si); "C (CDCl3, 100 MHz) 159.5 
(C=CH), 122.9 (CH=C), 70.2 (C-9), 56.5 (C-14), 51.5 (C-17), 45.7, 39.5, 36.1, 34.7, 
30.3, 28.0, 27.4, 23.9, 22.8, 22.6, 22.1, 18.8, 11.1 (C-18), 0.6 ((CH3)3Si); m/z (CI) 
350 [M]+, 333 [M–OH]+, 261, 90 (Found [M+NH4]+, 368.3341. C22H42OSi requires 
[M+NH4]+, 368.3349). 
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(1R,5S)-5-(4-Methoxybenzyloxy)-2-methylcyclohex-2-enyl propionate (304) 
 
 
 
To 278 (574 mg, 3.11 mmol, 1 equiv) and PMBTCA (1.32 g, 4.67 mmol, 1.5 equiv) 
in PhMe (62 mL) at rt was added lanthanum trifluoromethanesulfonate hydrate (91 
mg, 0.16 mmol, 0.05 equiv). The reaction mixture was stirred for 40 min before 
pouring onto a silica gel plug, eluting first with petrol to remove PhMe, then Et2O to 
elute the crude product containing some p-methoxybenzylalcohol. Further 
purification by silica gel chromatography (5-10 % EtOAc in petrol) afforded 304 as a 
colourless oil (842 mg, 89 %); Rf 0.70 (10 % EtOAc in petrol); [!]D23 +39.4 (c 1.10, 
CHCl3); !max (film) 2940, 1838, 1732, 1613, 1514, 1462, 1358, 1248, 1183 cm-1; "H 
(CDCl3, 400 MHz) 7.30–7.26 (2H, m, m-PMB), 6.91–6.87 (2H, m, o-PMB), 5.61–
5.57 (1H, m, CH=C), 5.42–5.38 (1H, m, CH-ester), 4.53 (1H, d, J 11.5 Hz, benzyl 
CH2), 4.49 (1H, d, J 11.5 Hz, benzyl CH2), 3.82 (3H, s, CH3O), 3.80–3.71 (1H, m, 
CHOPMB), 2.52–2.43 (1H, m, ring CH2), 2.35 (2H, dq, J 7.5, 1.5 Hz, CH3CH2), 
2.14–1.99 (2H, m, ring CH2), 1.90–1.82 (1H, m, ring CH2), 1.68 (3H, s, CH3), 1.17 
(3H, t, J 7.5 Hz, CH3CH2); "C (CDCl3, 100 MHz) 174.2 (CO), 159.2 (Ar), 131.8 
(C=CH), 130.7 (Ar), 129.3 (m-PMB), 125.1 (C=CH), 113.8 (o-PMB), 71.0 
(CH-ester), 70.4 (CHOPMB), 69.9 benzyl CH2), 55.3 (CH3O), 34.4 (ring CH2), 32.0 
(ring CH2), 27.9 (CH2CH2), 20.1 (CH3C=C), 9.2 (CH3CH2); m/z (CI) 442, 322 
[M+NH4]+, 231, 138, 121 (Found [M+NH4]+, 322.2011. C18H24O4 requires 
[M+NH4]+, 322.2019). 
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(1R,5S)-5-(4-Methoxybenzyloxy)-2-methylcyclohex-2-enol (305) 
 
 
To 304 (825 mg, 2.71 mmol, 1 equiv) in MeOH (7 mL) at 0 ºC was added methanolic 
KOH (5.4 mL, 1 M in MeOH, 5.40 mmol, 2 equiv). The reaction was allowed to 
warm to rt and stirred for 15 h before diluting with Et2O (100 mL) and washing with 
1 N HCl (10 mL) then sat. NaHCO3 (20 mL). The organic layer was dried (MgSO4) 
and concentrated under reduced pressure before purification by silica gel 
chromatography (10-25 % EtOAc in petrol) afforded 305 as a colourless oil (557 mg, 
83 %); Rf 0.15 (10 % EtOAc in petrol); [!]D23 +50.0 (c 1.00, CHCl3); !max (film) 
3400, 2915, 1613, 1514, 1452, 1356, 1302, 1248, 1172, 1095, 1033 cm-1; "H (CDCl3, 
400 MHz) 7.32–7.27 (2H, m, m-PMB), 6.93–6.87 (2H, m, o-PMB), 5.49–5.44 (1H, 
m, CH=C), 4.53 (2H, s, benzyl CH2), 4.21–4.16 (1H, m, CHOH), 3.85–3.77 (1H, m, 
CHOPMB), 3.83 (3H, s, CH3O), 2.50–2.40 (1H, m, ring CH2), 2.18–2.11 (1H, m, 
ring CH2), 2.08–1.98 (1H, m, ring CH2), 1.87–1.78 (1H, m, ring CH2), 1.81 (2H, s, 
CH3C=C); "C (CDCl3, 100 MHz) 159.1 (Ar), 135.0 (C=CH), 130.9 (Ar), 129.2 (m-
PMB), 122.7 (C=CH), 113.8 (o-PMB), 70.4 (CHOPMB), 69.9 (benzyl CH2), 69.2 
(CHOH), 55.3 (CH3O), 37.6 (ring CH2), 32.1 (ring CH2), 20.3 (CH3C=C); m/z (CI) 
266 [M+NH4]+, 248 [M]+, 231, 138, 121 (Found [M+NH4]+, 266.1748. C15H20O3 
requires [M+NH4]+, 266.1756). 
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(1R,5S)-5-(4-Methoxybenzyloxy)-2-methylcyclohex-2-enyl 2-tosylacetate (306) 
 
 
 
To 305 (524 mg, 2.11 mmol, 1 equiv) and 2-tosylacetic acid (452 mg, 2.11 mmol, 1 
equiv) in CH2Cl2 (11 mL) at 0 °C was added DMAP (26 mg, 0.21 mmol, 0.1 equiv) 
then DIC (361 µL, 2.32 mmol, 1.1 equiv). The reaction mixture was stirred at rt for 3 
h then filtered through Celite®. The solids were washed with Et2O (20 mL), and the 
filtrate concentrated under reduced pressure. Purification by silica gel 
chromatography (10 % EtOAc in petrol) afforded 306 as a colourless oil (858 mg, 91 
%); Rf 0.20 (10 % EtOAc in petrol); [!]D24 +39.4 (c 1.10, CHCl3); !max (film) 2924, 
1735, 1613, 1514, 1328, 1248, 1156, 1085 cm-1; "H (CDCl3, 400 MHz) 7.84 (2H, d, J 
8.0 Hz, o-Ts), 7.38 (2H, d, J 8.0 Hz, m-Ts), 7.31–7.26 (2H, m, m-PMB), 6.91–6.87 
(2H, m, o-PMB), 5.645.59 (1H, m, CH=C), 5.40–5.36 (1H, m, CH-ester), 4.50 (2H, s, 
benzyl CH2), 4.12 (2H, s, CH2Ts), 3.82 (3H, s, CH3O), 3.76–3.68 (1H, m, 
CHOPMB), 2.50–2.41 (1H, m, ring CH2), 2.46 (3H, s, CH3Ar), 2.14–1.98 (2H, m, 
ring CH2), 1.86–1.78 (1H, m, ring CH2), 1.65 (3H, s, CH3C=C); "C (CDCl3, 100 
MHz) 162.2 (CO), 159.2 (Ar), 145.4 (Ar), 135.9 (C=CH), 130.7 (Ar), 130.6 (Ar), 
129.9 (m-Ts), 129.3 (m-PMB), 128.5 (o-Ts), 126.3 (CH=C), 113.8 (o-PMB), 73.9 
(CH-ester), 70.3 (benzyl CH2), 70.1 (CHOPMB), 61.2 (CH2Ts), 55.3 (CH3O), 34.2 
(ring CH2), 31.9 (ring CH2), 21.7 (CH3Ar), 20.1 (CH3C=C); m/z (ESI) 504, 483, 467 
[M+Na]+, 462 [M+NH4]+ (Found [M+Na]+, 467.1503. C24H28O6S requires [M+Na]+, 
467.1505). 
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2-((1S,5R)-5-(4-Methoxybenzyloxy)-2-methylcyclohex-2-enyl)-2-tosylacetic acid 
(307) 
 
 
 
To a solution of 306 (770 mg, 1.73 mmol, 1 equiv) in CH3CN (6 mL) was added Et3N 
(290 µL, 2.07 mmol, 1.2 equiv) then BSA (1.27 mL, 5.19 mmol, 3 equiv). The 
reaction mixture was heated to reflux for 6 h, before being cooled, diluted with 
EtOAc (75 mL), washed with 1 N HCl (20 mL), dried (MgSO4), and concentrated 
under reduced pressure. Purification by silica gel chromatography (10 % EtOAc in 
petrol + 10 % MeOH + 1 % AcOH) afforded a 7:3 mixture of epimers of 307 as a 
white solid (620 mg. 81 %); Rf 0.30 (10 % EtOAc in petrol); mp 69-70 °C; !max (film) 
3440, 2924, 1732, 1613, 1514, 1318, 1304, 1248, 1146, 1086, 1035 cm-1; "H (CDCl3, 
400 MHz) 7.89–7.82 (2H, m, o-Ts), 7.38–7.33 (2H, m, m-Ts), 7.32–7.25 (2H, m, 
m-PMB), 6.91–6.86 (2H, m, o-PMB), 5.47 (1H, s, CH=C), 4.57 (1H, d, J 11.5 Hz, 
benzyl CH2 major), 4.41 (1H, d, J 11.5 Hz, benzyl CH2 major), 4.35 (2H, d, J 2.5 Hz, 
benzyl CH2 minor), 3.82 (CH3O), 3.76–3.70 (1H, m, CHOPMB), 3.25–3.16 (1H, m, 
CHTs major), 3.16–3.09 (1H, m, CHTs minor). 2.58–2.00 (5H, m, ring CH2), 2.47 
(3H, s, CH3Ar major), 2.45 (3H, s, CH3Ar minor), 1.65 (3H, s, CH3C=C minor), 1.64 
(3H, s, CH3C=C major); "C (CDCl3, 100 MHz) 168.6 (CO), 159.1 (Ar), 145.6 (Ar), 
135.2 (C=CH), 130.8 (Ar), 130.7 (Ar), 130.0 (m-Ts), 129.8 (m-PMB), 129.4 (m-PMB 
major), 129.4 (m-PMB minor), 129.1 (o-Ts), 125.0 (CH=C minor), 124.0 (CH=C 
major), 113.8 (o-PMB), 72.5 (CHTs minor), 70.2 (CHOPMB), 69.8 (CHTs major), 
69.5 (benzyl CH2), 53.3 (CH3O), 38.7 (CHCHTs minor), 35.8 (CHCHTs major), 31.2 
(ring CH2), 27.8 (ring CH2), 22.7, 21.7 (CH3Ar), 21.3 (CH3C=C); m/z (ESI) 467 
[M+Na]+, 462 [M+NH4]+, 423 [M+Na–CO2]+ (Found [M+Na]+, 467.1512. C24H28O6S 
requires [M+NH4]+, 467.1505). 
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(E)-De-A,B-8-(trimethylsilyl)methylenecholestan-9!-yl 2-((1S,5R)-5-(4-methoxy-
benzyloxy)-2-methylcyclohex-2-enyl)-2-tosylacetate (308) 
 
 
 
To E-297 (237 mg, 0.67 mmol, 1 equiv) and 307 (300 mg, 0.67 mmol, 1 equiv) in 
CH2Cl2 (4 mL) at rt was added DMAP (8 mg, 0.07 mmol, 0.1 equiv) then DIC (115 
µL, 0.74 mmol, 1.1 equiv). The reaction mixture was stirred at rt for 48 h then filtered 
through Celite®. The solids were washed with Et2O (10 mL), and the filtrate 
concentrated under reduced pressure. Purification by silica gel chromatography (10 % 
EtOAc in petrol) afforded E-308 as a colourless oil (338 mg, 65 %); Rf 0.65 (10 % 
EtOAc in petrol); !max (film) 2952, 1738, 1598, 1514, 1328, 1248, 1145, 1087 cm-1; 
"H (CDCl3, 400 MHz) 7.89–7.81 (2H, m, o-Ts), 7.37–7.26 (4H, m, m-Ts, m-PMB), 
6.92–6.86 (2H, m, o-PMB), 5.58–5.54 (1H, m, H-9), 5.50–5.39 (1H, m, CH=C), 
5.25–5.17 (1H, m, TMSCH=C), 4.63 (1H, d, J 11.5 Hz, benzyl CH2), 4.43 (1H, d, J 
11.5 Hz, benzyl CH2), 4.35 (1H, d, J 2.5 Hz, CHTs), 3.83–3.79 (3H, m , CH3O), [1H, 
3.78–3.72 (m) and 3.40–3.30 (m), CHCHTs], 2.44 (3H, s, CH3Ar), 2.57–0.96 (23H, 
m), 1.70 (3H, m, CH3C=C), 0.97–0.84 (9H, m, H-21, H-26/27), 0.52–0.47 (3H, m, H-
18), 0.09–0.05 (9H, m, CH3Si); "C (CDCl3, 100 MHz) 164.1 (CO), 159.1 (C=CTMS), 
153.0 (C=CH), 144.9 (Ar), 135.9 (Ar), 131.2 (Ar), 130.9 (Ar), 129.8 (Ar), 129.6 (Ar), 
129.5 (Ar), 129.3 (Ar), 129.2(Ar), 125.6 (TMSCH=C), 123.7 (CH=C), 113.7 (Ar), 
75.1 (C-9), 70.3, 70.1 (CHCHTs), 69.5 (CHTs), 69.4 (benzyl CH2), 56.6, 55.3, 52.8, 
45.1, 40.9, 39.5, 36.0, 35.2, 34.6, 31.3, 28.4, 28.3, 28.0, 27.7, 27.4, 23.9, 22.8, 22.6, 
22.0, 21.7, 21.6, 20.8, 18.8, 17.4, 17.3, 14.7, 11.2 and 11.1 (C-18), 7.9, 0.3 (CH3Si), 
0.2 (CH3Si); m/z (ESI) 799 [M+Na]+ (Found [M+Na]+, 799.4429. C46H68O6SSi 
requires [M+Na]+, 799.4404). 
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(Z)-De-A,B-8-(trimethylsilyl)methylenecholestan-9!-yl 2-((1S,5R)-5-(4-methoxy-
benzyloxy)-2-methylcyclohex-2-enyl)-2-tosylacetate (308) 
 
 
 
To Z-297 (240 mg, 0.68 mmol, 1 equiv) and 307 (304 mg, 0.68 mmol, 1 equiv) in 
CH2Cl2 (4 mL) at rt was added DMAP (8 mg, 0.07 mmol, 0.1 equiv) then DIC (117 
µL, 0.74 mmol, 1.1 equiv). The reaction mixture was stirred at rt for 96 h then filtered 
through Celite®. The solids were washed with Et2O (10 mL), and the filtrate 
concentrated under reduced pressure. Purification by silica gel chromatography (10 % 
EtOAc in petrol) afforded Z-308 as a colourless oil (380 mg, 72 %); Rf 0.60 (10 % 
EtOAc in petrol); !max (film) 2953, 1736, 1627, 1613, 1598, 1514, 1466, 1326, 1249, 
1146, 1086 cm-1; "H (CDCl3, 400 MHz) 7.89–7.81 (2H, m, o-Ts), 7.37–7.26 (4H, m, 
m-Ts, m-PMB), 6.92–6.86 (2H, m, o-PMB), 5.60–5.55 (1H, m, H-9), 5.50–5.39 (1H, 
m, CH=C), 5.25–5.20 (1H, m, TMSCH=C), 4.63 (1H, d, J 11.5 Hz, benzyl CH2), 4.43 
(1H, d, J 11.5 Hz, benzyl CH2), 4.35 (1H, d, J 2.5 Hz, CHTs), 3.83–3.79 (3H, m , 
CH3O), [1H, 3.78–3.72 (m) and 3.40–3.30 (m), CHCHTs], 2.44 (3H, s, CH3Ar), 2.57-
–0.96 (23H, m), 1.70 (3H, m, CH3C=C), 0.97–0.84 (9H, m, H-21, H-26/27), 0.52–
0.47 (3H, m, H-18), 0.09–0.05 (9H, m, CH3Si); "C (CDCl3, 100 MHz) 164.1 (CO), 
159.1 (C=CTMS), 153.0 (C=CH), 144.9 (Ar), 135.9 (Ar), 131.2 (Ar), 130.9 (Ar), 
129.8 (Ar), 129.6 (Ar), 129.5 (Ar), 129.3 (Ar), 129.2(Ar), 125.6 (TMSCH=C), 123.7 
(CH=C), 113.7 (Ar), 75.1 (C-9), 70.3, 70.1 (CHCHTs), 69.5 (CHTs), 69.4 (benzyl 
CH2), 56.6, 55.3, 52.8, 45.1, 40.9, 39.5, 36.0, 35.2, 34.6, 31.3, 28.4, 28.3, 28.0, 27.7, 
27.4, 23.9, 22.8, 22.6, 22.0, 21.7, 21.6, 20.8, 18.8, 17.4, 17.3, 14.7, 11.2 and 11.1 (C-
18), 7.9, 0.3 (CH3Si), 0.2 (CH3Si). 
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 (Z)-De-A,B-8-(trimethylsilyl)methylenecholest-9(11)-ene (309) and 1-Methoxy- 
4-(((1R,5S)-4-methyl-5-(tosylmethyl)cyclohex-3-enyloxy)methyl)benzene (310) 
 
 
 
To E-308 (31 mg, 0.04 mmol, 1 equiv) and KOAc (0.5 mg, 0.004 mmol, 0.1 equiv) in 
a capped microwave vial was added BSA (190 µL). The mixture was heated by 
microwave irradiation at 180 °C for 3 ! 1 min (including a 1 min cooling period 
between each 1 min heating period). Purification of the crude reaction mixture by 
silica gel chromatography (5–10 % EtOAc in petrol) afforded Z-309 as a colourless 
oil (8 mg, 60 %) and 310 as a white solid (90 mg, 56 %) along with returned starting 
material Z-308 (10 mg, 32 %). 
Data for Z-309: Rf 1.00 (5 % EtOAc in petrol); ["]D26 +25.9 (c 0.90, CHCl3); !max 
(film) 2954, 2870, 1624, 1574, 1467, 1378, 1248 cm-1; "H (CDCl3, 400 MHz) 6.37–
6.31 (1H, m, H-9), 5.79–5.71 (1H, m, H-11), 5.23 (1H, s, CH=C), 2.36 (1H, dd, J 
18.0, 5.5 Hz, H-12), 2.34–2.26 (1H, m, H-14), 2.24–2.15 (1H, m, H-12), 2.02–1.87 
(1H, m), 1.78–0.98 (18H, m), 0.95 (3H, d, J 6.0 Hz, H-21), 0.91 (3H, d, J 2.0 Hz, H-
26/27), 0.89 (3H, d, J 2.0 Hz, H-26/27), 0.59 (3H, s, H-18), 0.16 (9H, s, CH3Si); "C 
(CDCl3, 100 MHz) 142.0 (C-8), 128.4 (C-11), 122.7 (C-9), 122.0 (C=CHTMS), 57.7, 
(C-14) 43.3, 39.5, 38.9, 36.0, 34.3, 28.0, 27.8, 26.6, 23.8, 22.8, 22.6, 22.2, 18.8, 15.7 
(C-18), 0.89 (CH3Si); m/z (EI) 332 [M]+, 260 [M-TMS]+, 147 (Found [M]+, 
332.2906. C22H40Si requires [M]+, 332.2899). 
Data for 310: Rf 0.30 (10% EtOAc in petrol); ["]D23 –16.7 (c 0.40, CHCl3); !max 
(film) 2926, 1613, 1513, 1454, 1302, 1248, 1145, 1088, 1035 cm-1; "H (CDCl3, 400 
MHz) 7.84 (2H, d, J 8.0 Hz, o-Ts), 7.40 (2H, d, J 8.0 Hz, m-Ts), 7.30 (2H, d, J 8.5 
Hz, m-PMB) 6.91 (2H, d, J 8.5 Hz, o-PMB), 5.37 (1H, m, C=CH), 4.52 (1H, d, J 11.5 
Hz, benzyl-CH2), 4.45 (1H, d, J 11.5 Hz, benzyl-CH2), 3.84 (3H, s, OCH3), 3.59 (1H, 
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m, CHOPMB), 3.17 (1H, dd, J 14.5, 1.5 Hz, TsCH2), 3.00 (1H, dd, J 14.5, 10.0 Hz, 
TsCH2) 2.70 (1H, m, CHCH2Ts), 2.48 (3H, s, Ts-CH3), 2.38-2.22 (2H, m, ring-CH2), 
2.02 (1H, m, ring-CH2), 1.78 (1H, m, ring-CH2), 1.53 (3H, s, C=CCH3); !C (CDCl3, 
100 MHz) 159.1 (Ar), 144.8 (Ar), 136.7, 133.0, 130.7, 130.0 (m-Ts), 129.3 (m-PMB), 
128.0 (o-Ts), 122.7 (o-PMB), 113.8 (C=CH), 69.6 (OCH3), 69.5 (benzyl-CH2), 58.4 
(TsCH2), 55.3 (1/3), 34.4 (CHCH2Ts), 32.1 (ring-CH2), 31.9 (ring-CH2), 21.7 (Ts-
CH3), 21.0 (C=CCH3); m/z (ESI) 423 [M+Na]+ (Found [M+NH4]+, 423.1603. 
C23H28O4S requires [M+Na]+, 423.1606). 
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(E)-De-A,B-8-(trimethylsilyl)methylenecholest-9(11)-ene (309) 
 
 
 
To Z-308 (64 mg, 0.08 mmol, 1 equiv) and KOAc (2 mg, 0.02 mmol, 0.25 equiv) in a 
capped microwave vial was added BSA (200 µL, 1.18 mmol, 15 equiv). The mixture 
was heated by microwave irradiation at 180 °C for 3 ! 1 min (including a 1 min 
cooling period between each 1 min heating period). Purification of the crude reaction 
mixture by silica gel chromatography (0–20 % EtOAc in petrol) afforded E-309 as a 
colourless oil (20 mg, 73 %) and 310 as a white solid (21 mg, 64 %) along with 
returned starting material Z-308 (12 mg, 18 %). 
Data for E-309: Rf 1.00 (5 % EtOAc in petrol); ["]D26 +6.3 (c 0.80, CHCl3); !max 
(film) 2954, 2870, 1623, 1573, 1467, 1379, 1248 cm-1; "H (CDCl3, 400 MHz) 6.04 
(1H, dd, J 9.5, 2.5 Hz, H-9), 5.68–5.61 (1H, m, H-11), 5.41 (1H, s, CH=C), 2.39–2.27 
(1H, m, H-14), 2.37 (1H, dd, J 17.5, 5.5 Hz, H-12), 2.19–2.10 (1H, m H-12), 2.02–
1.87 (2H, m), 1.82–0.72 (20H, m), 0.64 (3H, s, H-18), 0.18 (9H, s, CH3Si); "C 
(CDCl3, 100 MHz) 154.8 (C-8), 134.7 (C-11), 127.8 (C-9), 127.6 (C=CHTMS), 55.6, 
52.7, 44.0, 42.3, 39.5, 36.1, 35.8, 28.1, 28.0, 24.9, 23.8, 22.8, 22.6, 18.5, 11.9 (C-18), 
1.9 (CH3Si); m/z (EI) 332 [M]+, 317, 260 [M-TMS]+, 147 (Found [M]+, 332.2894. 
C22H40Si requires [M]+, 332.2899). 
Data for 310 as reported above. 
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De-A,B-8-methylenecholestan-9!-yl acetate (317) 
 
 
 
To 223 (198 mg, 0.71 mmol, 1 equiv) in CH2Cl2 (5 mL) at rt was added pyridine (230 
!L, 2.84 mmol, 4 equiv), then DMAP (5 mg, 0.04 mmol, 0.05 equiv), then Ac2O (80 
!L, 0.85 mmol, 1.2 equiv). The reaction mixture was stirred for 3 h. H2O (20 mL) 
was added, and the mixture extracted with Et2O (3 x 50 mL). The combined organic 
layers were further washed with H2O (20 mL), 10 % CuSO4 (20 mL) and brine (20 
mL), then dried (MgSO4) and concentrated under reduced pressure. Purification by 
silica gel chromatography (2 % EtOAc in petrol) afforded 317 as a yellow oil (211 
mg, 88 %); Rf 0.85 (10 % EtOAc in petrol); [!]D22 +58.6 (c 2.10, CHCl3); "max (film) 
2952, 2869, 1737, 1657, 1468, 1368, 1238, 1016 cm-1; #H (CDCl3, 400 MHz) 5.35–
5.32 (1H, m, H-9), 5.13–5.10 (1H, m, CH2=C), 4.76–4.74 (1H, m, CH2=C), 2.40–2.32 
(1H, m, H-14), 2.05 (3H, s, CH3CO), 2.00–1.72 (4H, m), 1.65–0.99 (13H, m), 0.95 
(3H, d, J 6.0 Hz, H-21), 0.90 (3H, d, J 2.0 Hz, H-26/27), 0.88 (3H, d, J 2.0 Hz, H-
26/27), 0.59 (3H, s, H-18); #C (CDCl3, 100 MHz) 170.3 (CO), 146.1 (C=CH2), 111.4 
(C=CH2), 74.6 (C-9), 56.1, 50.5, 44.2, 39.5, 36.1, 36.0, 35.2, 28.5, 28.0, 27.6, 23.8, 
22.8, 22.6, 21.9, 21.6, 18.8, 11.2 (C-18); m/z (CI) 338 [M+NH4]+, 321 [M+H]+, 261 
(Found [M+NH4]+, 338.3053. C21H36O2 requires [M+NH4]+, 338.3059). 
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De-A,B-8-methylenecholestan-9!-yl methyl carbonate (318) 
 
 
 
To 223 (200 mg, 0.72 mmol, 1 equiv) in CH2Cl2 (5 mL) at 0 ºC was added pyridine 
(173 !L, 2.15 mmol, 3 equiv), then DMAP (5 mg, 0.04 mmol, 0.05 equiv), then 
methyl chloroformate (67 !L, 0.86 mmol, 1.2 equiv) dropwise. The reaction mixture 
was allowed to warm to rt and stirred for 48 h. H2O (20 mL) was added, and the 
mixture extracted with Et2O (3 x 50 mL). The combined organic layers were further 
washed with H2O (20 mL), 10 % CuSO4 (20 mL) and brine (20 mL), then dried 
(MgSO4) and concentrated under reduced pressure. Purification by silica gel 
chromatography (5 % EtOAc in petrol) afforded 318 as a yellow oil (170 mg, 70 %); 
Rf 0.90 (10 % EtOAc in petrol); [!]D22 +5.0 (c 1.00, CHCl3); "max (film) 2953, 2869, 
1748, 1658, 1442, 1327, 1264 cm-1; #H (CDCl3, 400 MHz) 5.20–5.16 (2H, m, 
CH2C=C + H-9), 4.81–4.78 (1H, m, CH2C=C), 3.78 (CH3O), 2.42–2.33 (1H, m, H-
14), 2.99–1.77 (4H, m), 1.70–0.99 (13H, m), 0.94 (3H, d, J 6.0 Hz, H-21), 0.90 (3H, 
d, J 2.0 Hz, H-26/27), 0.88 (3H, d, J 2.0 Hz, H-26/27), 0.59 (3H, s, H-18); #C (CDCl3, 
100 MHz) 155.1 (CO), 145.4 (C=CH2), 112.1 (CH2=C), 78.7 (C-9), 56.0, 54.4 
(CH3O), 50.2, 44.7, 39.5, 36.1, 36.0, 34.9, 28.5, 28.0, 27.5, 28.0, 27.5, 23.7, 22.8, 
22.6, 21.9, 18.8, 11.1 (C-18); m/z (CI) 354 [M+NH4]+, 261, 147 (Found [M+NH4]+, 
354.3003. C21H36O3 requires [M+NH4]+, 354.3008). 
OH
C8H17
HO
223
H
C8H17
O
318
O
Experimental 
 194 
Methyl 3-(des-A,B-8(9)-cholesten-8-yl)-2-tosylpropionate (319) and 
De-A,B-8-methylenecholest-9(11)-ene (320) 
 
 
 
To 318 (100 mg, 0.30 mmol, 1 equiv) and methyl 2-tosylacetate (75 mg, 0.33 mmol, 
1.1 equiv) in THF (5 mL) was added Pd(PPh3)4 (17 mg, 0.015 mmol, 0.05 equiv). 
The reaction micture was heated to reflux for 5 h. Sat. NH4Cl (5 mL) was added , and 
the mixture extracted with CH2Cl2 (3 x 10 mL). The combined organic layers were 
dried (MgSO4) and concentrated under reduced pressure to give an orange residue. 
Purification by silica gel chromatrography (5–10 % EtOAc in petrol) afforded 319 as 
a colourless oil (47 mg, 32 %) and 320 as a colourless oil (36 mg, 46 %). 
Data for 319: isolated as a 3:2 mixture of C-Ts epimers; Rf 0.45 (10 % EtOAc in 
petrol); !max (film) 2953, 2869, 1746, 1598, 1438, 1328, 1148, 1085 cm-1; "H (CDCl3, 
400 MHz) 7.77 (2H, d, J 8.0 Hz, o-Ts), 7.38 (2H, d, J 8.0 Hz, m-Ts), 5.25 (1H, m, H-
9 major) 5.21 (1H, m, H-9 minor); "C (CDCl3, 100 MHz) 166.4 and 166.1 (CO), 
145.3 (Ar), 134.2 (Ar), 134.1 (Ar), 133.1 and 132.6 (C-8), 129.7 (m-Ts), 129.4 (o-
Ts), 124.4 and 123.4 (C-9), 69.9 and 69.8 (CHTs), 54.3, 54.2, 52.8 and 52.7 (CH3O), 
51.3, 49.5, 42.4, 42.3, 39.5, 36.16, 36.1, 35.9, 35.9, 32.9, 31.6, 28.3, 28.2, 28.0, 24.6, 
23.9, 23.8, 22.9, 22.8, 22.6, 21.7 (CH3Ar), 18.8 and 18.7 (C-21), 11.2 and 11.1 (C-
18); m/z (ESI) 506 [M+NH4]+, 489 [M+H]+ (Found [M+H]+, 489.3033. C29H44O4S 
requires [M+H]+, 489.3039). 
Data for 320: Rf 0.95 (petrol); [!]D25 +90.0 (c 1.00, CHCl3); !max (film) 2954, 2869, 
1639, 1600, 1467, 1379 cm-1; "H (CDCl3, 400 MHz) 6.13 (1H, dd, J 9.5, 2.5 Hz, H-9), 
5.68 (1H, m, H-11), 4.88 (1H, s, C=CH2), 4.73 (1H, s, C=CH2), 2.35 (1H, dd, J 17.5, 
5.5 Hz, H-12), 2.27 (1H, m, H-14), 2.17 (1H, d, J 17.5 Hz, H-12) 1.61-1.01 (13H, m) 
0.96 (3H, d, J 6.5 Hz, H-21), 0.91 (3H, d, J 2.0 Hz, H-26/27), 0.89 (3H, d, J 2.0 Hz, 
H-26/27), 0.61 (3H, s, H-18); "C (CDCl3, 100 MHz) 146.4 (C-8), 129.1 (C-11), 128.6 
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(C-9), 109.3 (C=CH2), 56.4 (C-14), 51.3 (C-13), 43.0, 42.5, 39.5 (C-12), 36.1, 35.9, 
28.0, 27.9, 23.9, 22.8, 22.7, 22.6, 18.4, 11.6 (C-18); m/z (EI) 260 [M]+, 147 (Found 
[M]+, 260.2507. C19H32 requires [M]+, 260.2504). 
Experimental 
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